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If you can keep your head when all about you  
Are losing theirs and blaming it on you;  
If you can trust yourself when all men doubt you,  
But make allowance for their doubting too;  
If you can wait and not be tired by waiting,  
Or, being lied about, don't deal in lies,  
Or, being hated, don't give way to hating,  
And yet don't look too good, nor talk too wise; 
If you can dream - and not make dreams your master;  
If you can think - and not make thoughts your aim;  
If you can meet with triumph and disaster  
And treat those two imposters just the same;  
If you can bear to hear the truth you've spoken  
Twisted by knaves to make a trap for fools,  
Or watch the things you gave your life to broken,  
And stoop and build 'em up with worn-out tools; 
If you can make one heap of all your winnings  
And risk it on one turn of pitch-and-toss,  
And lose, and start again at your beginnings  
And never breath a word about your loss;  
If you can force your heart and nerve and sinew  
To serve your turn long after they are gone,  
And so hold on when there is nothing in you  
Except the Will which says to them: "Hold on"; 
If you can talk with crowds and keep your virtue,  
Or walk with kings - nor lose the common touch;  
If neither foes nor loving friends can hurt you;  
If all men count with you, but none too much;  
If you can fill the unforgiving minute  
With sixty seconds' worth of distance run -  
Yours is the Earth and everything that's in it,  
And - which is more - you'll be a Man my son! 
 
If by Rudyard Kipling (1865-1936) 
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Preface 
 
The inspiration to commence a study of vision and ocular health in patients with 
diabetes is founded on my own professional experience. Through work in low 
vision clinics and hospital eye departments, I have fitted low vision aids to 
patients with visual impairment due to diabetic retinopathy. In private practice and 
in low vision clinics I have detected retinopathy as the first sign of diabetes and 
have made referrals that have resulted in a diagnosis of diabetes.  
 
When I began my journey of research, the Norwegian Directorate of Health had 
not issued the national professional guidelines for diabetes. The Norwegian 
Association of Optometrists had no guidelines for clinical practice. The 
Norwegian Society of General Practitioners’ treatment programme for diabetes 
recommended eye care, but knowledge of the eye care provided in Norway was 
sparse. This was the fuel to explore and address the role of the optometrist in the 
eye care of patients with diabetes.  
 
 
 
 
Vibeke Sundling 
Kongsberg 2012 
Diabetes Eye Care in Norwegian Optometric Practice 
 
2 
 
Diabetes Eye Care in Norwegian Optometric Practice 
3 
 
List of abbreviations 
ACCORD, Action to Control Cardiovascular Risk in Diabetes trial 
BCVA, best corrected visual acuity 
BSc, Bachelor of Science 
CI, Confidence interval 
DCCT, Diabetes Control and Complications Trial  
DR, diabetic retinopathy  
FIELD, Fenofibrate Intervention and Event Lowering in Diabetes study 
GP, general practitioner 
HbA1c, Hemoglobin A1C (glycated haemoglobin) 
HDL, high density lipoprotein 
HUNT, Nord-Trøndelag Health Study 
HVA, habitual visual acuity 
IAPB, International Agency for the Prevention of Blindness  
IGT, impaired glucose tolerance  
IRMA, intraretinal microvascular abnormalities 
KDM, known diabetes  
MSc, Master of Science 
NDA, Norwegian Diabetes Association 
NGT, normal glucose tolerance  
NOF, The Norwegian Association of Optometry 
NPDR, non-proliferative diabetic retinopathy  
OR, odds ratio 
PhD, Doctor of Philosophy 
POR, prevalence odds ratio 
PR, prevalence ratio 
Diabetes Eye Care in Norwegian Optometric Practice 
 
4 
 
REK, Regional Committee for Medical Research Ethics 
SD, standard deviation 
SDDM, screen-detected diabetes  
S-LDL, serum low-density lipoprotein  
SPSS, Statistical Package for the Social Sciences 
UKPDS, UK Prospective Diabetes Study 
VA, visual acuity 
VIMOC, Visual Identification and Management of Ophthalmological Conditions. 
WCO, World Council of Optometry 
WHO, World Health Organization  
Diabetes Eye Care in Norwegian Optometric Practice 
5 
 
1. List of Papers 
 
I. Sundling V, Gulbrandsen P, Bragadottir R, Bakketeig LS, Jervell J, 
Straand J: Optometric practice in Norway: a cross-sectional 
nationwide study. Acta Ophthalmologica Scandinavica 2007, 85(6):671-
676, doi: 10.1111/j.1600-0420.2007.00929.x.  
 
II. Sundling V, Gulbrandsen P, Bragadottir R, Bakketeig LS, Jervell J, 
Straand J: Suspected retinopathies in Norwegian optometric practice 
with emphasis on patients with diabetes: a cross-sectional study. 
BMC Health Services Research 2008, 8:38.  
 
III. Sundling V, Gulbrandsen P, Jervell J, Straand J: Care of vision and 
ocular health in diabetic members of a national diabetes 
organization: a cross-sectional study. BMC Health Services Research 
2008, 8:159.  
 
IV. Sundling V, Platou CGP, Jansson RW, Bertelsen G, Wøllo E, 
Gulbrandsen P: Retinopathy, visual impairment and eye examination 
in diabetes, impaired glucose tolerance and normal glucose 
tolerance – The Nord-Trøndelag Health Study (The HUNT study). Acta 
Ophthalmologica 2012, 90(3): 237-243, doi: 10.1111/j.1755-
3768.2010.01998.x  
 
V. Sundling V, Gulbrandsen P, Straand J: Sensitivity and specificity of 
Norwegian optometrists’ evaluation of diabetic retinopathy in single-
field retinal images. (Revised and copy edited manuscript submitted to 
BMC Health Services Research )  
Diabetes Eye Care in Norwegian Optometric Practice 
 
6 
 
Diabetes Eye Care in Norwegian Optometric Practice 
7 
 
2. Summary of thesis 
 
2.1 Background 
The scope of optometry differs globally, ranging from the dispensing of optical 
aids to the diagnosis and treatment of certain ocular diseases.  In Norway, the 
profession has developed from craftsmanship into a health profession, regulated 
by the Health Personnel Act, which was founded on the principles of responsible 
conduct. The majority of optometrists are employed in private practice and they 
perform more than one million eye examinations every year. Norwegian 
optometrists have various academic backgrounds and the content and quality of 
their eye examinations probably vary, according to their competency level.   
 
About 90 to 120,000 Norwegians have known diabetes, and most of them will 
develop some degree of diabetic retinopathy during the course of their illness. 
The reported prevalence of diabetic retinopathy in Norway is 13% to 28%, 
whereas international population-based studies report a prevalence of 24% to 
36%. The reported prevalence of sight-threatening diabetic retinopathy is 1% to -
13%. Diabetic retinopathy is a leading cause of visual impairment in the working 
age group in Western societies: 5% to13% of blind and partial sight registrations 
are due to diabetic retinopathy. One percent of patients with diabetes are visually 
impaired due to diabetic retinopathy; however, as many as 3% to 9% have visual 
impairment because of concurrent ocular disease.  
 
Diabetic retinopathy can and should be treated before symptoms occur. Most 
cases of visual loss can be prevented by regular eye examination and early 
treatment of retinopathy. Screening for diabetic retinopathy is one of the most 
cost-effective routine interventions for detecting disease. However, establishing a 
robust screening programme, staffed with trained healthcare professionals, 
requires considerable organisation and commitment from the individuals 
involved, as well as appropriate patient education.  
 
Health services research in the field of vision and eye care in Norway is limited. 
Eye care provided by optometrists is not covered under the National Insurance 
Act reimbursement scheme, and systematic knowledge of Norwegian optometric 
practice based on large national studies is lacking. The role of the optometrist in 
the eye care of patients with diabetes is not clearly defined. The prevalence of 
diabetic retinopathy is not accurately reported and the prevalence of visual 
impairment in patients with diabetes is unknown. The national guidelines for 
diabetes recommend regular eye examinations, but little is known about current 
eye care practice and compliance with the recommendations.  
 
2.2 Aim 
The aim of this thesis is to contribute to health services research on Norwegian 
optometric practice and the management of vision and ocular health in patients 
with diabetes. The thesis has four main objectives: (1) to describe Norwegian 
optometric practice in terms of optometrist and patient characteristics, the routine 
eye examination, and the collaboration between optometrists and general 
practitioners and ophthalmologists, (2) to establish the prevalence of visual 
impairment and suspected retinopathies in patients examined in optometric 
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practice, to explore the patient-reported prevalence of diabetic retinopathy and 
visual impairment in patients with diabetes, and to analyse predictors of 
retinopathy, (3) to evaluate the optometrists’ retinal assessment of diabetic 
retinopathy, and (4) to assess compliance with recommended eye care 
guidelines and to measure variables associated with regular eye examination, in 
patients with diabetes.  
 
2.3 Materials and methods  
This research had a cross-sectional design. The data were collected between 
November 2004 and February 2011 using descriptive, clinical, and experimental 
methods.  
Norwegian optometric practice was assessed using a questionnaire, a practice 
registration form, and an experimental, visual identification and management of 
ophthalmological conditions (VIMOC) examination (Papers I, II and V). A VIMOC 
examination tests clinical competency using cases and/or images with 
accompanying multiple choice questions.  
Visual impairment and retinopathy in patients with diabetes were investigated for 
patients examined in optometric practice using a questionnaire and a practice 
registration form (Papers I and II), and by clinical examination of a population 
sample from the Nord-Trøndelag Health Study (HUNT-study) (Paper IV). 
Associations and predictors of clinical findings of retinopathy and patient-reported 
retinopathy were analysed for patients examined in optometric practice (Paper II), 
for patients participating in the clinical examination (Paper IV), and for a sample 
of members of the Norwegian Diabetes Association (NDA)responding to the 
questionnaire (Paper III).  
Eye care in patients with diabetes was described and analysed for a sample of 
members of the NDA(Paper III) and a population sample from the HUNT-study 
using a questionnaire (Paper IV).  
Data were analysed by standard uni-, bi- and multivariate statistical methods, by 
calculation of odds and relative risk ratios, by kappa-analysis, and by calculation 
of sensitivity and specificity. Information about non-participating optometrists and 
non-attendees in the population study was collected and analysed.  
This research followed the tenets of the Declaration of Helsinki for research 
involving humans. All studies were submitted to the Regional Committee for 
Medical Research Ethics (REK). The questionnaire sent to optometrists (Paper I), 
the practice registration form (Papers I and II), and the VIMOC examination 
(Paper V) were not subject to specific evaluation and approval. The 
questionnaires (Papers III and IV) and the clinical examination (Paper IV) were 
approved by REK.  
 
2.4 Response rates 
In all, 508 optometrists (64%) responded to the questionnaire (Papers I and II), of 
whom 212 (42%) also completed the practice registration form (Papers I and II). 
In the VIMOC examination, 112 members of The Norwegian Association of 
Diabetes Eye Care in Norwegian Optometric Practice 
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Optometry (NOF) (11%) volunteered to participate, 101 of them (90%) met the 
inclusion criteria, and 74 (73%) completed the study (Paper V). In total, 1,396 
(74%) of the invited members of the NDA responded to the questionnaire and 
1,352 of them (97%) were included in the analysis (Paper III). For the sample 
invited from the HUNT population, 126 (77%) took part in the clinical examination 
(Paper IV).  
 
2.5 Results 
2.5.1. Optometric practice (Papers I, II and V)  
Patient history of vision and ocular health was always part of the routine eye 
examination. The majority of the optometrists also asked questions about general 
health. In all, 92% of optometrists reported that they undertake ophthalmoscopy 
as part of their routine examination; direct ophthalmoscopy was most frequently 
used (Paper I). One in four of the optometrists who completed the practice 
registration form were qualified to perform dilated fundus examination. Retinal 
examination was reported for 88% of patient encounters, of which 2% were 
performed in mydriasis. In patients with diabetes, ophthalmoscopy was 
performed in 96% of examinations, 2% of which were dilated retinal examinations 
(Paper II). In all, 4,052 patients were described in the practice registration form 
study; 72% were 35 years and older, 4% had a known history of diabetes and 
12% had known ocular disease. The optometrists reported finding cataracts in 
9% of encounters, of which half were found in patients with no previous history of 
cataract. Clinical findings of retinopathy were reported in 3% of patients; two 
thirds had no known history of retinopathy. More than 80% of optometrists 
reported having some form of interaction with general practitioners and/or 
ophthalmologists. In all, 6% of the patients reported in the practice registration 
form study were referred. More than half of the cases of retinopathy were 
considered in need of referral; this occurred more frequently if the patient did not 
have a known history of retinopathy (57%) than if they did (37%). 
 
2.5.2. Visual impairment (Papers I, II, III and IV)  
In all, 2% of the patients encountered in optometric practice were visually 
impaired (best corrected visual acuity [BCVA] <0.5), of whom half (1% overall) 
had low vision (BCVA<0.33) (Paper I). For patients with a known history of 
diabetes, visual impairment and low vision were recorded in 5% and 2% of 
patient encounters, respectively. Among the NDA members who responded to 
the questionnaire, 88% reported using some optical correction (Paper III). Fifteen 
percent reported experiencing visual problems during the previous year and 12% 
reported visual problems related to their diabetes. In the clinical examination, four 
participants (3%) had correctable visual impairment, but none were visually 
impaired (Paper IV); correctable visual impairment was associated with old age.   
 
2.5.3. Diabetic retinopathy (Papers I, II, III and IV)  
In the practice registration form study, suspected diabetic retinopathy was found 
in 10% of patients with known diabetes and 0.2% of patients without an 
established diabetes history (Paper II). Old age (75 years and older), 
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hypertension and diabetes were independent predictors of any retinopathy. 
Diabetes and hypertension were the only independent predictors for vascular 
retinopathies (Paper II). In the questionnaire, 13% of the NDA members who 
responded reported a history of diabetic retinopathy, of which more than half of 
the cases had been laser-treated (Paper III). Disease duration was the only 
variable where an independent association with history of diabetic retinopathy 
was found (Paper III). In the clinical examination of the HUNT-sample, diabetic 
retinopathy was found in 11% of persons with known diabetes and in 4% of 
persons with screen-detected diabetes (Paper IV). Retinopathy consistent with 
diabetic retinopathy was in found 3% of persons with impaired glucose tolerance 
and 10% of people with normal glucose tolerance. Retinopathy was not 
associated with a known history of diabetes or with current glycaemic status, but 
previous non-fasting plasma glucose level was an independent risk factor for 
retinopathy (Paper IV).  
 
2.5.4. Optometrists’ assessment of diabetic retinopathy (Papers II and V)  
In the practice registration form study, optometrists suspected diabetic 
retinopathy in 10% of patients with diabetes. However, for patients with a 
reported history of diabetic retinopathy, half of the cases were not confirmed by 
the optometrist (Paper II). In the VIMOC examination, the sensitivity (95% 
confidence interval) for identifying eyes with any diabetic retinopathy was 67% 
(62% to 72%) (Paper V). The specificity for identifying eyes without diabetic 
retinopathy was 84% (80% to 89%). Four optometrists (5%) met the standard 
required for screening programmes for diabetic retinopathy, i.e. at least 80% 
sensitivity and 95% specificity. Optometrists with a Master of Science in 
optometry had significantly higher sensitivity than optometrists with a basic 
optometric education.  
 
2.5.5. Regular eye examination in patients with diabetes (Papers III and IV)  
Among the members of the NDA who responded to the questionnaire, 87% had 
received information about the importance of regular eye examinations and 78% 
had their eyes examined according to guidelines (Paper III). There was an 
independent association between regular eye examinations and (1) patients with 
disease duration greater than 10 years and (2) patients who had received 
information about eye examinations. In the clinical examination, less than 35% of 
the HUNT-sample had their vision regularly examined (Paper IV). However, 
regular examination was associated with a known history of diabetes, and 80% of 
the participants with known diabetes had regular eye examinations (Paper IV).  
 
2.6 Conclusion  
The clinical study showed that eye examination by optometrists detects visual 
impairment due to refractive error (Paper IV). The practice registration form study 
demonstrated that optometrists frequently examine patients with diabetes 
(Papers I and II). Optometrists take medical history, assess ocular health, and 
contribute to case-finding of ocular disease (Papers I and II). However, both the 
practice registration form study (Papers I and II) and the experimental study 
(Paper V) indicated that diagnostic sensitivity for case-finding and assessment of 
diabetic retinopathy is poor. Further, the results from the practice registration 
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form study raised some concern, as 25% of the patients with suspected vascular 
retinopathy and no history of retinopathy or systemic disease were not referred 
and were only judged to need routine optometric follow-up (Paper II).     
 
The practice registration form study results showed that the prevalence of known 
ocular disease and visual impairment was higher among those with diabetes than 
among those without. Surprisingly, the clinical study showed a lower prevalence 
of diabetic retinopathy compared to previous studies in Norway and other 
Western countries (Paper IV). This finding was supported by the prevalence of 
known history of diabetic retinopathy recorded in the practice registration form 
study (Paper II) and reported by members of the NDA in the questionnaire (Paper 
III). The lack of an association between diabetic retinopathy and a known history 
of diabetes/current glycaemic status, despite the predictive value of non-fasting 
plasma glucose level ten years earlier (Paper IV), indicates how difficult it is to 
predict diabetic retinopathy, and highlights the importance of regular eye 
examinations.  
 
The questionnaire surveys of members of the NDA (Paper III) and the HUNT 
sample (Paper IV) showed that the majority of patients with diabetes have their 
eyes examined according to guidelines. Compliance with guidelines is associated 
with both diabetes duration and receipt of information about potential eye 
complications.  
 
2.7 Inference of results   
The optometric practice is an easily accessible place for primary eye care in the 
Norwegian health care system. The routine optometric examination detects 
correctable visual impairment and undercorrected refractive error, and 
encourages case-finding of ocular disease and retinal manifestations of systemic 
disease. However, the diagnostic sensitivity of the retinal examination appears to 
be low. Measures should be taken to improve diagnostic sensitivity.  
 
Optometrists do probably take on medical responsibilities, and their clinical 
decision making and referral habits should be addressed. Consensus on patient 
management, referral practice and general collaboration with general 
practitioners and ophthalmologists should be established to ensure the best 
possible patient care.  
 
Further research is needed in order to estimate accurately the prevalence of 
diabetic retinopathy and visual impairment among patients with diabetes in 
Norway.  
 
In patients with diabetes, experience of eye examinations in accordance with 
national professional guidelines is associated with diabetes duration and receipt 
of information regarding potential eye complications in diabetes. Most patients 
with diabetes use some optical correction and the number of patients with 
diabetes examined in optometric practices is high. Optometric practices have the 
potential to develop themselves into viable settings for patient education that play 
an important role in screening for diabetic retinopathy. However, for optometrists 
to become part of a screening programme for diabetic retinopathy, targeted 
formal optometric training and mandatory continuing optometric education is 
necessary.  
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3. General background 
3.1 Introduction  
The global prevalence of diabetes is increasing due to an aging world population 
[1]. Patients with diabetes live longer and more people develop diabetes [2, 3]. 
The estimated prevalence of known diabetes in the Norwegian general 
population is 2% [4]. In Western societies, diabetic retinopathy is a leading cause 
of visual impairment and blindness in the working age group [5]. Ophthalmologic 
screening of patients with diabetes has been shown to be more cost-effective 
than many other routine interventions in healthcare [6, 7]. Optometrists are 
providers of eye care, and patients with diabetes are frequently examined in 
optometric practice due to refractive errors and presbyopia. Studies have shown 
that optometrists are able to detect and grade diabetic retinopathy [8]. 
Furthermore, specially trained optometrists perform well when screening for 
diabetic retinopathy [9-11]. However, health services research in the field of 
vision and eye care in Norway is limited.  
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3.2 Optometry 
3.2.1 Definitions  
The term optometry is derived from Greek: optos (visible) and metron (measure). 
Optometry is defined as “the healthcare profession concerned especially with 
examining the eye for defects and faults of refraction, with prescribing 
correctional lenses or eye exercises, with diagnosing diseases of the eye, and 
with treating such diseases or referring them for treatment” [12]; an optometrist is 
defined as “a specialist licensed to practice optometry” [13]. 
3.2.2 Scope of optometry 
The scope of optometry differs worldwide [14], and more specifically in Europe 
[15], ranging from dispensing of optical aids to the diagnosis and treatment of 
certain ocular diseases. The World Council of Optometry (WCO) is an 
international optometric organisation representing over 300,000 optometrists 
from 150 member organisations in 90 countries (including Norway). The WCO 
defines optometry as follows: “Optometry is a healthcare profession that is 
autonomous, educated, and regulated (licensed/registered), and optometrists are 
the primary healthcare practitioners of the eye and visual system who provide 
comprehensive eye and vision care, which includes refraction and dispensing, 
detection/diagnosis and management of disease in the eye, and the rehabilitation 
of conditions of the visual system” [16]. At present, optometry in Norway Includes: 
(1) the examination of vision and ocular health, and (2) the dispensing and 
manufacturing of optical correction devices and low vision aids. NOF‘s vision 
statement is “…first contact for better vision!” [17].   
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3.2.3 Regulation of optometry in Norway 
In Norway, optometry has developed from a craftsmanship to a health profession, 
first secured by the Regulation of Optometrists of 22. April 1988 [18]. 
Furthermore, licensed Norwegian optometrists trained in the use of ocular 
diagnostic drugs were given diagnostic privilege to use certain ocular diagnostic 
drugs in 2004 [19] and in January 2009, optometrists were given the opportunity 
to refer patients directly to an ophthalmologist [20]. Optometry in Norway is 
regulated by the Health Personnel Act [21], which is founded on the principles of 
responsible conduct. In 2005, NOF issued competency standards with clinical 
guidelines [22], and these define the expected standard of Norwegian optometric 
practice.  
3.2.4 Optometric practice in Norway 
The majority of optometrists in Norway are employed in private practice, either in 
independent practices or in national or international companies with multiple 
practices. Optometrists are also represented in hospital eye departments, low 
vision clinics, educational institutions and in the optical industry. Norwegian 
optometrists are a heterogeneous group with regard to academic background. 
They include practitioners with Technical College, University College degrees (2 
to 3 years course duration) and University degrees (Bachelor of Science [BSc] 
/Master of Science [MSc] / Doctor of Philosophy [PhD]). Consequently, the 
content and quality of their eye examinations probably differ according to their 
competency level. The eye examination should include a patient history, 
examination of visual function, refraction, assessment of binocular vision and 
oculomotoric function, as well as examination of the eye and its surrounding 
structures. In cases of suspected eye disease or systemic disease affecting the 
eye or vision, optometrists are obliged to refer the patient to a medical doctor. It 
has been estimated that Norwegian optometrists perform more than one million 
Diabetes Eye Care in Norwegian Optometric Practice 
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eye examinations per year, of which 4% result in referral to other healthcare 
providers [23]. 
3.3 Diabetes 
In Norway, 90,000 to 120,000 people have diabetes. It is likely that as many 
more have undiagnosed diabetes [4], and even more are likely to have impaired 
glucose tolerance and impaired fasting glycaemia [24]  
3.3.1 Diagnostic criteria for diabetes 
The level of fasting plasma glucose employed as a diagnostic criterion for 
diabetes assumes a glycaemic threshold that identifies people at risk of 
microvascular complications [25]. The National professional guidelines: “Diabetes 
- Prevention, diagnostics and treatment” issued in April 2009 [26] uses the 
international diagnostic criteria for diabetes: fasting serum blood glucose 
 7.0 mmol/L and/or 2-hour serum blood glucose  11.1 mmol/L and/or chance 
serum blood glucose  11.1 mmol/L in combination with symptoms. In the 
general population, mild retinopathy is associated with Hemoglobin A1C (HbA1c) -
level, hypertension and abdominal obesity, which may indicate insulin resistance 
or associated factors as part of the pathogenesis of the retinopathy [27]. The 
diagnostic criteria for diabetes have been questioned, because diabetic 
retinopathy can occur in people without diabetes, that is, people with serum blood 
glucose below the diagnostic criteria for diabetes [28, 29]. Moreover, a recent 
study proposed that either the diagnostic level of fasting plasma glucose should 
be lowered to 6.5 mmol/L, or HbA1c of 6.5% should be used as diagnostic 
criterion, based on a threshold for risk of moderate non-proliferative diabetic 
retinopathy or worse, which is specific for diabetes [30].  
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3.3.2 Late complications and practice guidelines 
Diabetes may affect several organs or organ systems, including the eye. Late 
complications in diabetes include both macrovascular and microvascular disease. 
In persons with diabetes, cardiovascular disease is more frequent, has an earlier 
onset, and is more likely to have severe manifestations and complications. The 
triad of microvascular disease, nephropathy, neuropathy and retinopathy, 
however, is specific to diabetes [31]. Population-based studies have shown that 
diabetic retinopathy is related to hyperglycaemia, hypertension, high cholesterol, 
increased microalbumin, increased creatinine, abdominal obesity and increasing 
age [27, 30, 32-35]. Practice guidelines for diabetes state treatment targets 
aimed at preventing and delaying late complications. The National professional 
guidelines: “Diabetes - Prevention, diagnostics and treatment” define treatment 
targets for HbA1c, fasting blood glucose, non-fasting blood glucose, body weight, 
serum low-density lipoprotein (S-LDL) -Cholesterol, blood pressure, physical 
activity, and smoking [26].   
 
Diabetic retinopathy should be treated before symptoms occur [5]. To facilitate 
this, the National professional guidelines recommend regular eye examination 
[26]. Patients diagnosed with type 1 diabetes should have their first eye 
examination 5 years after diagnosis, then yearly thereafter, or every second year 
if plasma blood glucose and blood pressure are stable. Patients diagnosed with 
type 2 diabetes should have their first eye examination at the time of diagnosis, 
then annually thereafter, or biennially if plasma blood glucose and blood pressure 
are stable. If diabetic retinopathy is present, the importance of strict blood 
pressure regulation (blood pressure < 135/80 mmHg) and blood glucose control 
(HbA1c < 7% mmol/l) is emphasised [26]. 
 
Diabetes Eye Care in Norwegian Optometric Practice 
17 
 
3.4 Ocular complications in diabetes 
Diabetic retinopathy is the most feared ocular complication in diabetes. However, 
other aspects of the eye and visual function may also be affected [36-38]. 
Table 3.1 gives an overview of potential ocular complications in diabetes and 
associated ocular conditions. Visual acuity, refractive error, cataract and 
retinopathy are described in more detail below. 
3.4.1 Visual acuity 
In the general population, vision impairment, both correctable and uncorrectable, 
is more common in patients with diabetes [39]. Visual acuity can be affected due 
to the effect of hyperglycaemia on ocular structures. Variable and blurred vision 
can be experienced as a result of transient refractive changes, and reduced 
visual acuity can occur as a result of cataract and/or diabetic retinopathy.  
3.4.2 Refractive error 
Generally, hyperglycaemia does not alter the refractive properties of the healthy 
human eye. However, in patients with diabetes, hyperglycaemia can be 
associated with transient refractive changes, both myopic and hyperopic shifts 
[40]. Transient hyperopia can also occur during intensive glucose reduction, and 
normalisation of refraction may take months after the regulation of blood glucose 
[41]. Suggested causes of these transient refractive shifts are change in lens 
thickness, changes in lens shape and/or changes in refractive index [40, 41]. 
Additionally, permanent refractive change, usually towards myopia, can occur; 
these are likely to be due to increased thickness and curvature of the lens [36]. 
Only marginal changes in refractive error and higher order aberrations have been 
demonstrated in patients complaining of blurred vision. This may indicate that 
blurred vision is also influenced by other factors, such as changes in the retina or 
visual cortex, or it may indicate that changes in refraction, higher order 
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aberrations, and shape of the cornea/lens are related to the severity and duration 
hyperglycaemia [42]. In patients with newly diagnosed diabetes, or with poorly 
controlled diabetes, it is advisable to postpone the issue of a new prescription 
until glycaemic control is well established [37].    
3.4.3 Cataract 
The association between diabetes and cataract has been well documented in 
large cross-sectional and prospective population-based studies [43-46]. Diabetes 
is associated with the prevalence and progression of posterior subcapsular 
cataract and cortical cataract, but not with nuclear cataract [43-46]. Cataract 
occur at a younger age and progress more rapidly in patients with diabetes [47]. 
The risk of cataract increases with increasing duration of disease and severity of 
hyperglycaemia [48]. Impaired glucose tolerance has been shown to be a risk 
factor for development of cortical cataract [49]. The visual outcomes of cataract 
surgery may be poorer in patients with diabetes than in patients without diabetes, 
and adequate laser treatment of retinopathy is required before cataract surgery 
[38]. 
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Table 3.1 Overview of ocular complications and associations of diabetes   
 
OCULAR COMPLICATIONS AND OCULAR ASSOCIATIONS  
Refraction and visual function  Signs and symptoms Possible cause 
Refraction Transient change 
Permanent change 
Refractive index of lens  
Lens curvature and thickness  
Best corrected visual acuity Reduced visual acuity Cataract  
Clinically significant macula oedema  
Vitreous haemorrhage 
Colour vision Tritan colour vision defect  
Contrast sensitivity Reduced contrast sensitivity  
Visual field Metamorphopsia 
Scotoma 
Clinically significant macula oedema 
Vitreous / preretinal haemorrhage 
Vascular occlusion 
Cover test and ocular motility  Diplopia / Tropia III. IV. or IV. cranial nerve palsy 
Ocular structure and function Signs and symptoms Possible cause 
Pupillary reflex Miosis 
Mydriasis 
Relative afferent pupillary 
defect  
Light-near dissociation 
Neuropathy 
Iris rubeosis 
Lids Meibomian gland dysfunction  
Stye  
Blepharitis  
 
Cornea Reduced corneal sensitivity  
Persistent epithelial defects   
Erosions and ulcers 
Infections  
Neuropathy and vasculopathy 
Posttraumatic 
Abnormalities of corneal epithelium  
Iris Neovascularisation  
Lens Cataract  
Vitreous Vitreous haemorrhage 
Posterior vitreous detachment 
 
Optic nerve Diabetic Retinopathy 
Anterior Ischaemic Optic 
Neuropathy  
Diabetic papillopathy 
 
Macula Diabetic retinopathy and 
macular oedema 
 
Retina Diabetic retinopathy 
Retinal detachment 
 
Diabetes is a known risk factor Signs and symptoms Possible cause 
Glaucoma 
Primary open-angle glaucoma 
Neovascular glaucoma  
Angle-closure glaucoma 
Visual field defects Increase susceptibility to nerve 
damage 
 Impaired blood flow / vascular 
perfusion  
Neovascularisation 
Increased lens thickness/autonomic 
dysfunction  
Ocular ischemic syndrome Vision loss Internal carotid/ophthalmic artery 
occlusion 
Diabetes is a possible risk factor   
Retinal vein occlusion  Acute vision loss 
Mimic diabetic retinopathy  
Non-ischaemic (30%) or ischaemic  
Retinal arteriolar embolus Transient ischaemic attack Discrete plaque-like lesions  
Retinal artery occlusion Sudden, unilateral painless 
vision loss 
 
Corneal disease Pain, photophobia, blurred 
vision 
Hyperaemia 
Abnormalities of corneal epithelium 
Reduced corneal sensitivity  
Mimics of diabetic retinopathy   
Age-related macular degeneration  Wet AMD Increased expression of VEGFs 
Chronic inflammation 
Hypertensive retinopathy Severe signs Hypertension 
Radiation retinopathy Delayed onset 
Identical to diabetic 
retinopathy 
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3.4.4 Diabetic retinopathy 
Most patients with diabetes will develop some degree of diabetic retinopathy [50-
53] and around one third will develop some degree of diabetic macular oedema 
[51, 54-56]. The reported prevalence of diabetic retinopathy differs widely [57]. In 
international population-based studies, the prevalence of diabetic retinopathy 
ranges from 24% to 36% in patients with known diabetes [32, 33, 58-62] and 
from 3% to 16% in patients with newly diagnosed diabetes [29, 32, 33, 62, 63]. 
The prevalence of sight-threatening diabetic retinopathy is lower, ranging from 
1% to 13% [33, 58, 60-62, 64, 65]. The general prevalence of diabetic retinopathy 
has decreased in recent years, possibly due to improvements in primary care in 
terms of the use of eye care services, monitoring of glucose levels and blood 
pressure, and treatment of hypertension [66, 67]. In Norway, the prevalence of 
retinopathy is sparsely described. The Eigersund study found a general 
prevalence of diabetic retinopathy of 14% (34% and 10% in type 1 and type 2 
diabetes, respectively) [68]. A recent screening study undertaken in Tønsberg, 
Stavanger and Tromsø found a prevalence of any retinopathy of 28% (66% and 
24% in type 1 and type 2 diabetes, respectively) [64]. The most recent study, the 
Tromso Eye Study reported a prevalence of diabetic retinopathy of 27% and  a 
prevalence of macular oedema of 4% [69] 
 
Early detection and prompt treatment of sight-threatening retinopathy are 
fundamental goals in the prevention of visual impairment in diabetes. An 
international clinical classification system, the “International Clinical Diabetic 
Retinopathy and Diabetic Macular Edema Disease Severity Scale”, has been 
developed to improve screening and communication between healthcare 
providers [70]. A summary of the classification is outlined in Table 3.2. The 
retinopathy grading includes five levels, three with relatively low risk of visual loss 
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and two with relatively high risk of visual loss. The grading of macular oedema 
consists of two steps to accommodate for variation in examiner education and 
available equipment: (1) the presence/absence of retinal thickening in the 
posterior pole, and (2) oedema severity (mild, moderate or severe).  
 
Table 3.2 Classification of diabetic retinopathy and diabetic macular 
oedema  
 
Diabetic Retinopathy Disease Severity Scale 
Severity level Findings on dilated ophthalmoscopy 
No apparent retinopathy No abnormalities 
Non-proliferative diabetic retinopathy Microaneurysms only 
Moderate non-proliferative  diabetic More than just microaneurysms but less than severe non-
Severe non-proliferative  diabetic retinopathy 
(4:2:1) 
 
Any of the following: 
More than 20 intraretinal haemorrhages in each of  4 quadrants 
Definite venous beading in 2+ quadrants 
Prominent intraretinal microvascular abnormalities in 1+ 
quadrant 
And no sign of proliferative retinopathy  
Proliferative diabetic retinopathy 
 
One or more of the following: 
Neovascularisation 
Vitreous/preretinal haemorrhage 
 
Diabetic Macular Edema Disease Severity Scale 
Severity level Findings on dilated ophthalmoscopy* 
Diabetic macular oedema apparently absent No apparent retinal thickening or hard exudates in posterior 
pole 
Diabetic macular oedema apparently present Some apparent retinal thickening or hard exudates in posterior 
pole 
Mild Some retinal thickening or hard exudates in posterior pole but 
distant from the centre of the macula 
Moderate Retinal thickening or hard exudates approaching the centre of 
the macula but not involving the centre 
Severe Retinal thickening or hard exudates involving the centre of the 
macula 
* Hard exudates are a sign of current or previous macular oedema. Diabetic macular oedema is defined as 
retinal thickening, and this requires a three-dimensional assessment that is best performed by dilated 
examination using slit-lamp biomicroscopy and/or stereo fundus photography. (From International Clinical 
Diabetic Retinopathy and Diabetic Macular Edema Disease Severity Scale [70]) 
 
Development and progression of diabetic retinopathy and diabetic macular 
oedema is associated with diabetes duration [51, 54, 71-73], hyperglycaemia [27, 
51, 54-56, 71-74], hypertension [27, 51, 55, 71, 72, 74, 75], and hyperlipidaemia 
[74, 76, 77]. However, epidemiological studies have failed to show a consistent 
association between serum lipid levels and diabetic retinopathy [78]. Current 
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treatment of diabetic retinopathy includes systemic control of diabetes, surgical 
therapy and pharmaceutical therapy [79, 80]. Intervention studies (the UK 
Prospective Diabetes Study, UKPDS, and the Diabetes Control and 
Complications Trial, DCCT) have shown that intensive control of glucose levels 
[81-83] and strict blood pressure control (UKPDS) [84] reduces the risk of the 
occurrence and progression of diabetic retinopathy. The Fenofibrate Intervention 
and Event Lowering in Diabetes study (FIELD) and the Action to Control 
Cardiovascular Risk in Diabetes trial (ACCORD) have shown that lipid lowering 
therapy is protective against the development and progression of diabetic 
retinopathy and the development of macular oedema [78, 85, 86]. Laser 
photocoagulation of proliferative diabetic retinopathy and clinically significant 
macular oedema reduces the risk of visual loss by 50% to 70% [87, 88]. A recent 
review [80] proposed the following clinical recommendations for surgical and 
pharmaceutical interventions for diabetic retinopathy: (1) panretinal 
photocoagulation is indicated in high risk proliferative diabetic retinopathy, and in 
early proliferative retinopathy and severe non-proliferative diabetic retinopathy if 
additional risk factors are present, (2) focal laser photocoagulation is indicated in 
clinical significant macular oedema involving the centre of the macula and 
affecting vision, (3) vitrectomy is (i) recommended in patients with severe vitreous 
haemorrhage and significant diabetic retinopathy, (ii) should be considered in 
eyes with severe proliferative diabetic retinopathy not responding to extensive 
panretinal photocoagulation, and (iii) can be beneficial in patients with diffuse 
macular oedema not responding to other treatments, and (4) intravitreal steroids 
and intravitreal anti-vascular endothelial growth factor agents may have a role in 
reducing macular oedema and reversing neovascularisation.  
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3.5 Visual impairment 
VISION 2020 is a global initiative for the elimination of avoidable blindness, 
defined as “blindness which could be either treated or prevented by known, 
cost-effective means” [89]. The initiative was launched by the World Health 
Organization (WHO) and the International Agency for the Prevention of Blindness 
(IAPB), with international memberships of non-governmental organizations, 
professional associations, eye care institutions and corporations. It is estimated 
that up to 80% of the world's blindness is avoidable [90]; moreover, diabetic 
retinopathy is addressed by VISION 2020 as one of the main causes of avoidable 
blindness [89]. 
3.5.1 Definitions of visual impairment 
Visual impairment is defined by the WHO in the International statistical 
classification of diseases, injuries and causes of death, 10th revision (ICD-10) 
[91]. Low vision is defined as BCVA of at least 0.05 but less than 0.33; blindness 
is defined as BCVA of less than 0.05. However, other terms and other definitions 
of visual impairment are commonly used in clinical practice and in the literature. 
These terms and definitions originate from legal acts and research studies. In the 
United States, the Social Security Act of 1935 defines legal blindness as BCVA of 
less than or equal to 0.1 [92]; in the United Kingdom, the National Assistance Act 
of 1948 defines blindness as BCVA of less than or equal to 0.05 and partial sight 
as BCVA of less than 0.33 [93]. In Norway, the National Insurance Act defines 
low vision as BCVA of less than 0.33 [63]. Population studies have defined visual 
impairment as BCVA of less than 0.5 [94]. This also defines the visual acuity (VA) 
criterion for driving a private car (total weight  3500 kg and up to eight 
passenger seats) in Norway [95]. Correctable visual impairment has been 
defined as VA of less than 0.5 in the better eye before refraction (habitual visual 
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acuity [HVA]) which improves to no visual impairment (that is, BCVA of greater 
than or equal to 0.5) after refraction [96].  
3.5.2 Epidemiology of visual impairment 
The estimated number of visually impaired people in the world (using the WHO 
definition) is 285 million (4.24%), of whom 246 million (3.65%) have low vision 
(0.05<BCVA<0.33) and 39 million (0.58%) are blind (BCVA<0.05) [90]. The world 
leading cause of visual impairment is uncorrected refractive errors (43%) followed 
by cataract (33%), glaucoma (2%), age-related macular degeneration (1%), 
diabetic retinopathy (1%), corneal opacities (1%) and trachoma (1%). The 
leading causes of blindness are cataract (51%), glaucoma (8%), age-related 
macular degeneration (5%), childhood blindness and corneal opacities (4%), 
refractive errors and trachoma (3%) and diabetic retinopathy (1%) [90].  
 
In Western Europe, the prevalence of visual impairment is lower, with 1.3% 
having low vision (0.05<BCVA<0.33) and 0.2% being blind (BCVA<0.05) [97]. 
However, blindness and partial sight registrations due to age-related macular 
degeneration and diabetic retinopathy are increasing [98-100]. The most 
important causes of blindness are age-related macular degeneration (50%), 
glaucoma (18%) and diabetic retinopathy (17%) [97]. In the Nordic countries, the 
reported prevalence of visual impairment (BCVA<0.5) and blindness (BCVA<0.1) 
is 0.7% to 2.0% and 0.5% to 1.0%, respectively. The main causes of visual 
impairment are age-related macular degeneration, cataract, diabetic retinopathy 
and glaucoma [101-103].  
 
The prevalence of visual impairment and eye disease increases with increasing 
age, and the majority of the visually impaired (BCVA<0.5) are 65 years or older 
[101, 104-109]. There is no national register of blind and partially sighted people 
Diabetes Eye Care in Norwegian Optometric Practice 
25 
 
in Norway and no accurate estimate of the prevalence of visual impairment and 
eye disease among the Norwegian population. Population-based studies report 
that 1% to 6% of the general adult population have correctable visual impairment 
[96, 104, 110-112] and the prevalence of correctable visual impairment increases 
with increasing age [104, 113, 114]. Table 3.3 shows estimates of visual 
impairment and eye disease among Norwegians older than 49 years, based on 
estimated data from the Eye Disease Prevalence Research Group for Western-
Europe [115-119].  
 
Table 3.3 Estimated numbers of people older than 49 years with visual 
impairment and eye disease in Norway 
 
  Estimated number of people 
  Estimated prevalence (%)* All Female Male 
Visual impairment (BCVA<0.5)  2.0 33,087 17,312 15,775 
Blindness (BCVA<0.05) 0.5 8,.272 4,328 3,944 
Cataract 25.4 420,207 219,865 200,342 
Diabetic retinopathy 4.0 66,174 34,624 31,550 
Age-related macular degeneration 2.5 41,359 21,640 19,719 
Glaucoma 2.1 34,742 18,178 16,564 
* Based on estimated data from the Eye Disease Prevalence Research Group for Western-Europe [115-119]   
 
3.5.3 Visual impairment in diabetes 
In the general population within Western societies, 5% to 13% of blind and partial 
sight registrations are due to diabetic retinopathy [5, 98, 99, 101, 120, 121]. In 
patients with diabetes, the prevalence of visual impairment due to diabetic 
retinopathy is 0.4% to 1.6% [59-61, 69, 122-125]. However, 3% to 9% of patients 
with diabetes have visual impairment attributable to concurrent ocular disease 
[59, 122].  
 
In patients with type 1 diabetes, the 25-year incidence of proliferative diabetic 
retinopathy is 42% to 43% [53, 67]. Even with screening for diabetic retinopathy 
and laser treatment of sight-threatening retinopathy, blindness is still a serious 
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issue [126]. The 25-year incidence of blindness and visual impairment in patients 
with type 1 diabetes is 3% to 9% [53, 67] and 13% [127], respectively. 
Maculopathy and poor glycaemic control are both risk factors for the 
development of blindness [126]. Improved glycaemic and blood pressure control 
and avoidance of smoking may reduce visual impairment [127]. A lower risk of 
proliferative diabetic retinopathy in recently diagnosed patients may reflect 
improvements in care [67].  
 
Diabetic retinopathy is estimated to occur 4 to 7 years prior to a clinical diagnosis 
of type 2 diabetes [128]. In type 2 diabetes, the reported 10-year incidence of any 
retinopathy is 50% [129] and the reported 4-year incidence of sight-threatening 
retinopathy is 2% [130]. Despite regular eye examinations and laser treatment of 
sight-threatening retinopathy, a small number of older patients with type 2 
diabetes become visually impaired due to unsuccessful photocoagulation of 
macular oedema [131]. The reported five-year incidence of blindness and visual 
impairment is 0.6% and 1.7 %, respectively [132]. Moreover, in patients with 
type 2 diabetes, vision deteriorates significantly during the first six years after 
diagnosis. This is primarily dependent on the age of the patient and the presence 
of age-related macular degeneration, diabetic retinopathy and cataract at the 
time of diagnosis [133].  
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3.6 Eye examination in diabetes 
3.6.1 Definitions 
Screening can be targeted at a population (mass screening), a specific risk group 
(prescriptive screening) or at individuals who for other reasons attend a setting 
where screening may occur (opportunistic screening) [134]. Screening is defined 
as: “Examination of a group of usually asymptomatic individuals to detect those 
with a high probability of having a given disease, typically by means of an 
inexpensive diagnostic test” [135]. In contrast, case-finding is defined as 
“secondary prevention through early detection of cases among persons using 
health services for other reasons, e.g., checking blood pressures of all patients 
who attend a physician’s office” [136]. Optometric practice provides a natural 
setting for case-finding of ocular disease and ocular complications of systemic 
disease, and could be a potential setting for prescriptive screening for diabetic 
retinopathy in patients with diabetes.  
 
Sensitivity and specificity define the ability of a clinical test to correctly identify 
persons with and without disease. Sensitivity and specificity are independent of 
the population examined. However, the positive and negative predictive power of 
a test, that is, the chance that a positive or negative test result will be correct, 
depends on the prevalence of the disease in the examined population. For 
diseases with low prevalence a negative test result is likely to be correct, 
consequently a high specificity is required to avoid large numbers of false 
positives [137]. The British Diabetic Association (now Diabetes UK) has set a 
required screening standard for diabetic retinopathy of at least 80% sensitivity 
and 95% specificity [138].   
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3.6.2 St. Vincent Declaration and screening for diabetic retinopathy 
The St. Vincent Declaration (1989) states general goals for patients with diabetes 
in terms of (1) improvements in health experience and life expectancy, and (2) 
prevention and cure of diabetes and its complications [139]. The statement was 
made after a meeting held in St. Vincent, Italy, between diabetes experts and 
representatives of Government Health Departments and patient organisations 
from all the European countries. The meeting was supported by the WHO and 
the International Diabetes Federation.  
 
The St. Vincent Declaration stated, as a specific goal in plans for prevention, 
identification and treatment of diabetes and its complications, that it would aim to 
“reduce new blindness due to diabetes by one-third or more” [139]. Most cases of 
visual loss can be prevented by regular eye examination and early treatment of 
diabetic retinopathy [6, 124, 140-142]. Screening for diabetic retinopathy is 
shown to be more cost-effective than many other routine interventions for 
detecting and treating disease [7]. Mydriatic retinal photography, with additional 
use of ophthalmoscopy for cases with ungradeable retinal photographs, is the 
most effective method for screening and monitoring diabetic retinopathy [143], in 
terms of sensitivity for detecting sight-threatening retinopathy and likelihood of 
achieving an overall sensitivity greater than 80% within the screening 
programme. The most robust screening method is digital mydriatic retinal 
photography [144], which has the additional advantages of instant viewing and 
repeat photography, the possibility of electronic transfer, and the facility for 
patient education and involvement. The establishment of a robust screening 
programme and training strategy for healthcare professionals requires substantial 
organisation and commitment from all parties involved, as well as good patient 
education [144].  
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Studies have shown that optometrists are able to detect and grade diabetic 
retinopathy. A study, undertaken at Queensland University of Technology 
(Australia), of randomly selected members of the Optometrists Association 
Australia Queensland Division (n=19) showed a sensitivity and specificity of 
94.1% and 97.4%, respectively for detection of diabetic retinopathy based on 
retinal slide assessment. The sensitivity of retinopathy grading was 66.8%. 
Based on ophthalmoscopy, the sensitivity and specificity for detection of 
retinopathy was 93.9% and 92.1%, respectively. Retinopathies were correctly 
classified in 64.5% of cases[8]. A Welsh study showed improved sensitivity for 
detection of any diabetic retinopathy (73.9% versus 88.2%) and sight-threatening 
retinopathy (82.2% versus 91.1%) by community optometrists using 35 mm 
retinal slides compared to dilated direct ophthalmoscopy [145]. Moreover, the 
study showed higher sensitivity for a specially trained optometrist compared to 
the community optometrists (97.2% versus 91.1%). Optometrists (n=13) involved 
in a screening programme in St Helens and Knowsley (UK) using dilated indirect 
ophthalmoscopy, had a sensitivity and specificity for detecting any diabetic 
retinopathy of 72% and 77%, respectively [10]. For UK optometrists (from the 
Wirral, St Helens and Knowsley, and Aberdeen) specially trained to take part in 
screening for diabetic retinopathy, the reported sensitivity and specificity for 
detecting sight-threatening diabetic retinopathy was 73% to 87% and 90% to 
95%, respectively [9-11].  
 
The level of optometric education and scope of optometry in Australia and the UK 
differ from the basic optometric education and scope of optometry in Norway. 
Therefore, Norwegian optometrists may not demonstrate this level of diagnostic 
accuracy when screening for diabetic retinopathy.       
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3.6.3 Knowledge and utilisation of eye care in diabetes  
A study undertaken in 1996 indicated that only 53% of patients with diabetes in 
Norway were referred by general practitioners to an ophthalmologist for an eye 
examination. Furthermore, only 37% had been examined by an ophthalmologist 
during the previous year [146]. Improved eye care in patients with diabetes has 
been reported in the US (1988-2002) [147], Australia (2003-2005) [148] and 
Germany (1999-2008) [149]. Utilisation of eye care services is associated with 
the use of health care services in general and is increased by health promotion 
campaigns [148, 150, 151]. Recent cross-sectional surveys of the general 
diabetic population in Germany, the UK, Australia and the US have shown that 
63% to 77% of patients with diabetes have their eyes examined according to 
existing guidelines [147, 149-152]. Current studies also indicate improved eye 
care in Norway from 1996 to 2005/2007, with 69% to 71% attending regular eye 
examinations by 2005/2007 [64, 153].   
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3.7 Questions unanswered 
The Norwegian health services research in the field of eye and vision care has 
been limited. The prevalence of visual impairment and the prevalence of diabetic 
retinopathy among patients with diabetes in Norway are sparsely described. 
There are limited data regarding factors associated with retinopathy, concurrent 
ocular disease, current eye care and compliance to eye examination guidelines. 
In the Norwegian health care system, optometrists do not have a formal role in 
the care of patients with diabetes and there are no accurate data regarding 
Norwegian optometric practice in terms of the patients examined, the eye 
examinations undertaken, and the optometrists’ referral practice. To my 
knowledge, there have so far been no descriptions of optometric practice based 
on large national studies with representative samples of optometrists and their 
patients. Nor have there been any large national, or international, studies that 
describe the diagnosis, management and referral of retinopathy in optometric 
practice.  
 
It is in the patients’ best interest that their vision and ocular health is managed in 
a safe and proper manner. The lack of an established system for eye 
examination in diabetes and the lack of information about current ocular care in 
patients with diabetes in Norway provides inspiration to explore: (1) optometric 
practice with a focus on the eye examination, visual function and retinopathy of 
the patients examined, and the optometrists’ patient management routine, and 
(2) vision and ocular health in patients with diabetes.  
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4. Aims 
The overall aim of this thesis was to contribute to the existing knowledge of 
Norwegian optometry and the management of vision and ocular health in patients 
with diabetes in Norway in terms of health services research.  
 
The thesis had four main objectives: 
1. to describe Norwegian optometric practice in terms of optometrist and 
patient characteristics, the routine eye examination, and the collaboration 
between optometrists and general practitioners and ophthalmologists 
2. to establish the prevalence of visual impairment and case-finding of 
suspected retinopathies in patients examined in optometric practice, to 
explore the patient-reported prevalence of diabetic retinopathy and visual 
impairment in patients with diabetes, and to analyse predictors of 
retinopathy 
3. to evaluate the optometrists’ retinal assessment and their diagnostic 
quality of assessment of diabetic retinopathy  
4. to assess compliance with recommended eye care guidelines and to 
assess variables associated with regular eye examination, in patients with 
diabetes 
  
In Papers I and II, the aims were: 
1. to describe Norwegian optometric practice and optometrists 
2. to describe characteristics of the patients who are examined Norwegian 
optometric practice 
3. to establish the prevalence of patient-reported diabetes in optometric 
practice 
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4. to explore the prevalence of visual impairment among patients seen for a 
routine eye examination in optometric practice 
5. to explore the rate of case-finding of ocular disease, in particular 
suspected retinopathies, during routine eye examination in optometric 
practice 
6. to analyse associations with suspected retinopathies detected in 
optometric practice 
7. to determine the proportion of previously unobserved signs of ocular and 
systemic disease detected by routine eye examination in optometric 
practice 
8. to assess how optometrists deal with patients who have clinical signs of 
ocular disease and ocular complications of systemic disease 
9. to explore the optometrist’s collaboration with general practitioners and 
ophthalmologists 
 
In Paper III, the aims were: 
1. to describe and analyse eye care among members of the NDA who had 
diabetes 
2. to explore available sources of information regarding eye care among 
patients with diabetes 
3. to assess reported eye care in relation to established practice guidelines 
4. to analyse and identify variables associated with eye care according to 
guidelines in patients with diabetes 
 
In Paper IV, the aims were: 
1. to describe the prevalence of retinopathy consistent with diabetic 
retinopathy in people with diabetes, impaired glucose tolerance and 
normal glucose tolerance 
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2. to describe the prevalence of visual impairment in people with diabetes, 
impaired glucose tolerance and normal glucose tolerance 
3. to investigate predictors of retinopathy consistent with diabetic 
retinopathy 
4. to explore the rate of regular eye examination in people with diabetes, 
impaired glucose tolerance and normal glucose tolerance 
    
In Paper V, the aims were: 
1. to assess the diagnostic sensitivity and specificity of optometrists’ retinal 
image evaluation of diabetic retinopathy  
2. to describe how optometrists would manage and follow-up patients based 
on retinal image evaluation of diabetic retinopathy.   
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5. Methods 
5.1 Definition of terms 
5.1.1 Optometric practice 
In this thesis, optometric practice is limited to private, clinical practice. Optometric 
practice includes the practicing optometrists, their patients, the eye examination, 
and the collaboration with general practitioners and ophthalmologists.  
5.1.2 Visual impairment and correctable visual impairment 
Visual impairment was defined by BCVA in the better eye, as described in 3.5.1: 
(1) visual impairment, BCVA < 0.5, (2) low vision, BCVA < 0.33, (3) blindness, 
BCVA < 0.05 and (4) correctable visual impairment, HVA < 0.5 improving with 
refraction to BCVA  0.5. Furthermore, reduced functional vision was defined as 
BCVA in the better eye < 0.8, corresponding to the visual acuity criteria for driving 
heavy vehicles, trucks and buses in Norway [95].  
5.1.3 Retinopathy and diabetic retinopathy 
Retinopathy was used as label for any disease abnormality affecting the retina 
and was divided into macular disease, diabetic retinopathy and 
hypertensive/vascular retinopathy. Diabetic retinopathy was graded in 
accordance with the International Clinical Diabetic Retinopathy and Diabetic 
Macular Edema Disease Severity Scale, Table 3.2 [70].  
5.1.4 Screening and case-finding  
The terms screening and case-finding are defined in 3.6.1. In this thesis, the term 
screening is used to describe prescriptive screening, that is, regular retinal 
examination for diabetic retinopathy in patients with diabetes. The term case-
finding is used to describe opportunistic screening, in specific retinal examination 
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in patients who attend optometric practice for routine eye examination. The term 
screen-detected diabetes defines diabetes identified by mass screening, 
including an oral glucose tolerance test, in a sample of the general adult 
population.  
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5.2 Study design  
This thesis consists of five studies. All studies had a cross-sectional design. 
Table 5.1 lists the main aims of the thesis, categorised by the Papers (I-V) 
addressing them and the materials and methods used. Figure 5.1 shows the 
study populations and designs used in Papers I-V. 
 
Table 5.1 Aims of the thesis categorised by research method and referring 
Papers (I-V)   
 Methods 
Sample 
size (n) Paper 
Norwegian optometric practice    
Optometrists and routine examination in optometric practice Questionnaire 508 I 
General patients examined in optometric practice PRF 4,052 I 
Patients with diabetes examined in optometric practice PRF 166 II 
Detection and management of suspected retinopathies  PRF 212 II 
    
Visual impairment and retinopathy    
Visual impairment in patients examined in optometric practice    
General patients examined in optometric practice PRF 4,052 I 
    
Visual impairment and visual symptoms in patients with 
diabetes    
Patients examined in optometric practice (visual acuity) PRF 166 II 
Members of a national diabetes organization (visual Questionnaire 1,352 III 
People from the HUNT survey (visual symptoms and visual Questionnaire 20 IV 
    
Diabetic retinopathy and suspected diabetic retinopathy     
Self-reported and suspected retinopathies among patients 
seen in optometric practice  PRF 4,052 II 
Self-reported prevalence among members of a national 
diabetes organisation Questionnaire 1,352 III 
Diabetic retinopathy found in a sample of people from the 
HUNT survey 
Clinical 
examination 
126 
 
IV 
 
    
Optometrists’ retinal assessment and diagnostic quality 
of case-finding of diabetic retinopathy     
Optometrists’ routine examination  Questionnaire 508 I 
Detection of suspected retinopathies  PRF 212 II 
Sensitivity and specificity of optometrists’ image assessment for 
diabetic retinopathy 
VIMOC 
examination 
74 
 
V 
 
    
Management of vision and ocular health in diabetes    
Eye examination in members of a national diabetes organisation Questionnaire 1,352 III 
Eye examination in patients with diabetes in a general Questionnaire 20 IV 
PRF, practice registration form, VIMOC, Visual Identification and Management of Ophthalmological Conditions
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5.3 Study population and study samples 
5.3.1 Papers I and II 
At the time of the studies, 1,454 optometrists were registered with the Norwegian 
Registration Authority for Health Personnel (Norwegian Board of Health, 01.06.2005). 
However, the Norwegian Registration Authority for Health Personnel did not have a 
current address register. Therefore, an address list of members of the NOF (n=1,044) 
was obtained (NOF, 26.10.2004). All members of the Norwegian Association of 
Optometrists working in private optometric practice (n=761) were invited to participate in 
a questionnaire survey. Members working in hospitals, low vision clinics, the educational 
system or industry, as well as members who were retired, unemployed, on leave, not 
practicing optometry, living abroad, or without a known residential address, were 
excluded. In addition, 29 practising, non-association member optometrists, who heard 
about the study and volunteered to participate, were included, giving an eligible sample 
of 790. All questionnaire respondents were asked to complete the practice registration 
form, on which they were asked to record details for 20 consecutive patients seen for a 
full eye examination. Patients seen for contact lens fitting or contact lens follow-up were 
not included in the registration form. There were two reasons for this exclusion. First, 
contact lens fitting is a specialised qualification in Norway. Second, the routine for 
contact lens fitting and follow-up differs from the routine eye examination in terms of 
content and follow-up routines.    
5.3.2 Paper III 
The NDA is a voluntary, independent organisation with the stated objective of serving 
patients with diabetes and others who have an interest in diabetes. At the time of the 
study, the NDA had the only national registry of adults with diabetes in Norway. In 2005, 
it had 35,058 members, consisting mainly of patients with diabetes, but also some of 
their relatives (approximately 900) and some healthcare professionals (approximately 
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3,000). A random sample of members of the NDA aged 18 years and older (n=1,961) 
was invited to participate in the questionnaire survey. People without diabetes, deceased 
members, and members either without a known address or with an overseas address, 
were excluded, leaving an eligible sample of 1,887. 
5.3.3 Paper IV 
A sample from a population-based screening survey undertaken in Verdal, Norway in 
2004-2005 was used. The screening survey investigated the prevalence of undiagnosed 
cases of hyperglycaemia (according to WHO’s criteria [154]) in a general Norwegian 
population. In short, a random sample (n=2,000) of the population aged 20 years and 
older were invited to undertake an oral glucose tolerance test. In total, 1,115 (56%) 
people completed the test. In our study, we invited 163 people from the screening survey 
to a follow-up eye examination in 2005. All available participants with known diabetes 
(n=24) and screen-detected diabetes (n=50) were included. In addition, a random 
sample of participants with impaired glucose tolerance (n=46), and an age- and gender-
matched sample of participants with normoglycaemia (n=43) were invited. Baseline 
information for the participants was accessible through the second Nord-Trøndelag 
Health Study (HUNT2) [155]. 
5.3.4 Paper V 
At the time of the study, 1,835 optometrists were registered with the Norwegian 
Registration Authority for Health Personnel (Norwegian Board of Health, 01.06.2011). 
All full members of the NOF (n=1028) were invited to participate by personal e-mail. 
Optometrists who were currently working in private practice and had worked in private 
practice for the previous 6 months and intended to continue to work in private practice for 
the following 6 months, were eligible for inclusion in the study. In all, 112 (11%) 
optometrists responded positively to the e-mail and volunteered to participate, 11(10%) 
did not meet the inclusion criteria, leaving an eligible sample of 101.  
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5.4 Data collection  
Data for all studies were collected in the period November 2004 to February 2011. The 
information was collected by questionnaires, practice registration forms, clinical 
examination and VIMOC examinations. A VIMOC examination tests clinical competency 
using images with accompanying multiple choice questions. The questionnaires were 
completed by Norwegian optometrists and patients with diabetes in Norway. The practice 
registration form was completed by optometrists in private optometric practice in Norway. 
The clinical examination was undertaken in a sample from the HUNT-study in Verdal, 
Nord-Trøndelag. The VIMOC examination was completed by a sample of optometrists in 
private optometric practice in Norway.  
5.4.1 Papers I and II 
In Papers I and II we used a questionnaire (Appendix 1) and a practice registration form 
(Appendix 2). Both were completed by Norwegian optometrists working in private clinical 
practice. The questionnaire included questions about the nature of the practice, 
education and work experience, practice habits, and opinions on important principles of 
practice. On the practice registration form, optometrists were asked to record details for 
20 consecutive patients seen for a full eye examination. The details recorded were 
patient history, BCVA, ocular health and further patient management. The questionnaire 
and the practice registration form were tested in a pilot study involving twelve 
optometrists, reporting 240 patient encounters, in Kongsberg. The optometrists 
considered the questionnaire and practice registration form, with accompanying 
instructions, to be easy to understand. Only minor adjustments of language style were 
made as a result of the pilot study. The invitation to participate in the survey, including 
the questionnaire and the practice registration form, were sent to the optometrists in 
November 2004. Reminders were sent twice, in December 2004 and January 2005. In 
addition, telephone, e-mail, and the optometrists’ internet discussion forum were used to 
improve the response rate. A final call for responses was made in June 2005. 
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5.4.2 Paper III 
Study three comprised a postal questionnaire (Appendix 3) completed by those 
members of the NDA who had diabetes. The questionnaire included questions about: (1) 
care of vision and ocular health, (2) history of ocular disease and visual symptoms, and 
(3) type of diabetes, year of diagnosis, treatment, blood glucose stability, most recently 
recorded HbA1c and blood pressure levels, details of any antihypertensive and 
cholesterol lowering medication taken, and current and previous smoking habits. The 
patient questionnaire was tested in a pilot-study involving thirty-two patients with 
diabetes in Kongsberg; all were members of the NDA. The pilot study led to the inclusion 
of a question regarding the source of information detailing the importance of regular eye 
examinations. Overall, answers from the pilot-study indicated that the questions were 
regarded as relevant and easy to comprehend. A random sample, computer-drawn from 
the NDA membership registry, was sent a postal invitation to participate in the survey, 
including the questionnaire, in October 2005. Reminders were sent to all invitees in 
December 2005. 
5.4.3 Paper IV 
In Paper IV, we used a questionnaire (Appendix 4), a standardised eye examination and 
registration form (Appendix5), and standardised registration form for analysis of retinal 
photographs (Appendix 6). The questionnaire was completed by patients with diabetes. 
The questionnaire was identical to the questionnaire in Paper III. The clinical 
examination was performed on all participants by two experienced optometrists. The 
clinical examination included a history of visual symptoms, ocular disease, vision and 
eye examination, measurement of HVA and BCVA, assessment of the crystalline lens 
and non-mydriatic fundus photography. The clinical examination was developed from a 
clinical examination undertaken in thirty-two patients with diabetes as part of a bachelors 
student’s project (“Prevalence of ocular changes in patients with type 2 diabetes”) [156]. 
The author initiated the bachelor’s student’s project, planned the design of  the study, 
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and supervised the student during data collection, data analysis and project report 
writing. Analysis of the retinal photographs was performed by two ophthalmologists. The 
images were viewed on a 21” monitor with screen resolution of 1600x1200. The retinal 
photographs were analysed and graded with regard to: (1) presence of retinopathy, (2) 
type of retinopathy and (3) severity of diabetic retinopathy. The severity of diabetic 
retinopathy was graded according to the Diabetic Retinopathy Disease Severity Scale 
[70]. Analysis and grading were undertaken independently by the two ophthalmologists, 
who were blinded to information about the study participants. Baseline information for the 
participants was provided by the Nord-Trøndelag Health Study. The study sample was 
sent an invitation to participate in October 2005. The invitation included information 
about the study, a written consent form, and an appointment time for the clinical 
examination. The appointment time was available for rescheduling on request. 
Reminders were not sent. 
 5.4.4 Paper V 
Paper V employed a web-based VIMOC examination (Appendix 7). The examination 
was completed by members of the NOF. The VIMOC examination had an experimental 
design consisting of 14 retinal images which were to be assessed with respect to: (1) 
presence or absence of diabetic retinopathy, and (2) appropriate patient management. 
No patient information was provided and the optometrists were to assume that the 
patient was not under the care of an ophthalmologist. The optometrists had no 
information about the patient’s visual acuity and they were not provided with patient 
management guidelines. The retinal images were provided from the clinical study in 
Paper IV. Only images with full grading agreement between the two ophthalmologists 
were included. The ophthalmologists’ diagnostic conclusion for each image was then 
used as a diagnostic gold standard. Seven images graded to represent non-proliferative 
diabetic retinopathy and seven images without diabetic retinopathy were randomly 
selected. A 50% occurrence of diabetic retinopathy was used to reduce the possibility of 
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producing false high specificity by chance. The sample size was based on the following 
assumptions to allow maximum variance: a 50% prevalence of diabetic retinopathy, a 
standard deviation of true sensitivity and specificity for the individual optometrists’ image 
evaluation of 0.2, and individual optometrist sensitivity and specificity of 50%. This 
allowed sensitivity and specificity for any diabetic retinopathy to be calculated with a 
confidence interval of < 0.05 with a sample of 100 optometrists. The optometrists were 
not asked to grade the retinopathy and the sensitivity of mild and moderate non-
proliferative diabetic retinopathy was assessed in terms of detection of retinopathy in 
images with mild and moderate non-proliferative diabetic retinopathy respectively. For 
each image, the optometrists were asked three multiple choice questions: (1) in your 
opinion, is this an eye with diabetic retinopathy? (2) what clinical findings gave the 
foundation for your assessment? and (3) based solely on retinal findings, how would you 
manage this patient if they were not under the care of an ophthalmologist? Question one 
had a forced choice answer of either yes or no. For questions two and three, multiple 
responses were possible. Possible answers for question two were: no retinopathy, 
microaneurysms, hard exudates, cotton wool spots, venous beading, intraretinal 
microvascular abnormalities (IRMA), neovascularisation, and other findings/ provisional 
diagnosis. Possible answers for question three were: none/routine follow-up, report to 
general practitioner (GP), referral to GP, and referral to ophthalmologist. The 
optometrists used their own computer with their ordinary screen for viewing. They could 
move back and forth in the VIMOC exam to review the images and to revise their prior 
assessments before admitting their response. In addition, the optometrists were to 
answer questions about which instruments they had available for retinal examination, 
their preferred method of retinal examination, their preferred method of retinal 
examination for patients with diabetes, which instruments they had available for retinal 
imaging, their work experience, their level of optometric education and qualification to 
use diagnostic drugs, and gender. The VIMOC examination was tested in a pilot study by 
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3 academic optometrists, resulting in no changes being made. Data were collected in 
February and March 2011 and one reminder was sent. 
 
5.5 Data entry and verification 
5.5.1 Papers I and II 
The data were entered into the statistical program Statistical Package for the Social 
Sciences (SPSS) by the author. Two databases were generated, one for the 
questionnaire survey and one for the practice registration form study. One optometrist 
had completed the practice registration form incorrectly; this form was therefore 
excluded. All data entries were checked manually for discrepancies by an assistant. The 
error rate was less than 0.25 % in the original files. The errors were corrected and the 
corrected files were used for analysis.    
5.5.2 Paper III 
The data were entered into an Excel spread sheet by a professional data entry service 
(Bredesen Puncheservice as, Lørenskog). Data entries for 200 (14%) questionnaires 
were checked manually for discrepancies by an assistant. The error rate was less than 
0.20 % in the original file. For statistical analyses, the Excel spread sheet was exported 
to SPSS.  
5.5.3 Paper IV 
The data were entered into an Excel spread sheet by the author and a co-worker. Data 
entries for 20 (14%) registration forms were checked manually for discrepancies by the 
co-worker. The error rate was less than 0.40% in the original file. For statistical analysis 
the Excel spread sheet was exported to SPSS.  
Diabetes Eye Care in Norwegian Optometric Practice 
 
46 
 
5.5.4 Paper V 
The data were collected using Question Writer 4. Data entry was made directly by the 
optometrist when submitting their responses in the web-based examination. The 
optometrists’ responses were downloaded as a comma-separated value file. The 
database was then opened and arranged in Excel, and then exported to SPSS.  
 
5.6 Data analysis 
The original questionnaires, practice registration form, clinical examination registration 
form, image analysis form and VIMOC exam are provided in Appendices 1 to 7. The 
variables are defined in detail in the Variable list in Appendix 8.  All statistical methods 
used were standard statistical methods. The data analysis was performed with the 
statistical package SPSS, version 12.0.2 -17.0. Specific variables and statistical methods 
used in Papers (I-V) are described below.  
5.6.1. Main variables 
Vision and eye examination 
Eye examination was defined as an ocular examination including a retinal examination. 
Vision examination was defined as an examination of eyesight. Regular examination was 
defined as examination at regular intervals, e.g. yearly, every six months or monthly. In 
the questionnaire completed by patients with diabetes (Paper III and IV), the specific 
questions about eye examination were: “Do you have your eyes regularly examined due 
to your diabetes?“, “In general, how long is it between the eye examinations?”, “Do you 
have your vision regularly examined?“, and “How long time is it between the vision 
examinations?”.  
 
Diabetes Eye Care in Norwegian Optometric Practice 
47 
 
Ocular disease 
History of ocular disease was defined by patient-reported history of cataract, glaucoma, 
age related macular degeneration, and/or diabetic retinopathy (Papers I, II, III and IV). A 
clinical finding of ocular disease was defined by an optometrist’s reported finding of 
cataract and/or any retinopathy (Papers I, II and IV) and an ophthalmologist’s diagnosis 
of diabetic retinopathy (Paper IV).  
 
Visual impairment 
Visual impairment was defined as reduced functional vision, visual impairment, low 
vision, blindness and correctable visual impairment (Papers I and IV), as defined in 
5.1.2.   
 
Retinopathy 
Retinopathy was defined as any disease abnormality affecting the retina identified by: (1) 
patient-reported history of retinopathy (Papers I, II, and III), (2) optometrist’s finding of 
suspected retinopathy (Papers I and II) and (3) ophthalmologist’s diagnosis of diabetic 
retinopathy (Papers IV and V). The classifications of retinopathy and diabetic retinopathy 
are given in 5.1.3 and Table 3.2.  
 
Diagnostic sensitivity and specificity  
Diagnostic sensitivity and specificity of diabetic retinopathy were estimated based on the 
practice registration form findings and calculated from the results of the VIMOC 
examination. The screening standard was defined according to the screening standard 
established by the British Diabetic Association (Diabetes UK) [138] of at least 80% 
sensitivity and 95% specificity. 
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Patient management 
Patient management in optometric practice was defined as subsequent handling of the 
patients seen for full eye examination (Papers I and II) and subsequent patient 
management based on retinal image evaluation (Paper V). Patient management was 
divided into: (1) no further action/routine optometric follow-up, (2) patient requested to 
contact GP and/or ophthalmologist (not defined in Paper V), (3) report to GP and/or 
ophthalmologist, and (4) referral to GP and/or ophthalmologist.  
 
Collaboration in optometric practice 
Collaboration in optometric practice was defined as an interaction between the 
optometrist and GP and/or ophthalmologist. Collaboration was divided into: (1) telephone 
referral/consultation, (2) remitting reports and/or referrals, (3) receiving reports and/or 
referrals, and (4) joint practice.  
 
5.6.2 Statistical methods Papers I and II 
In Papers I and II, the data were analysed in frequency and summation tables. 
Differences between proportions were analysed using chi-square tests. A p-value < 0.05 
was considered statistically significant. Variables associated with retinopathy were 
analysed using bivariate and multivariate logistic regression analysis. Variables with 
p 0.25 from the bivariate analyses were entered into the logistic regression models. A 
list of optometrists registered in Norway at the time of the study was obtained for 
analysis of gender, age and health region of practice for the non-respondents. 
5.6.3 Statistical methods Paper III 
Questionnaires with missing data for gender, age or type of diabetes, or diabetes other 
than type 1 and type 2 (3 %) were excluded from analysis. The data were analysed in 
frequency and summation tables. Group differences were analysed using the Student’s-t, 
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chi-square and Fisher’s exact tests. Due to the large size of the data, a p-value < 0.01 
was considered statistically significant. Variables associated with a known history of 
diabetic retinopathy, visual symptoms, regular follow-up and lack of eye examination 
were analysed using bivariate and multiple logistic regression. Variables with p 0.25 
from the bivariate analyses were entered into the logistic regression models. In addition 
to prevalence odds ratios (PORs), prevalence ratios (PRs) were calculated for variables 
associated with a history of diabetic retinopathy and regular eye examination. The POR 
estimates the incidence rate ratio (risk factors/predictors) with fewer assumptions than 
the PR [157]. However, the PR is considered by many to be easier to interpret, and is a 
better measure of public health burden of a disease [157].  
5.6.4 Statistical methods Paper IV 
In Paper IV, data were analysed using standard parametric and non-parametric 
statistical methods. The inter-grader agreement for the retinal photographs was 
measured by Cohen’s kappa coefficient (ț); a ț-value >0.60 was considered to represent 
substantial inter-grader agreement and a ț-value >0.80 was considered to represent 
almost perfect agreement [158]. Group differences in presenting VA, BCVA, visual 
impairment and prevalence of retinopathy were analysed at an individual level using the 
two-tailed independent Student’s t-test and the Pearson Chi-square test. The 95% 
confidence interval for prevalence was calculated by an exact method because of the 
small sample sizes. Vision and eye examination were analysed by Pearson’s chi-square 
test. The general relationship between VA and other variables was analysed for the right 
eye by rank correlation tests, Spearman’s rho and Kendall’s tau. A p-value < 0.05 was 
considered statistically significant. Predictors of retinopathy were analysed by bivariate 
and multivariate logistic regression. Baseline risk factor variables with missing data for 
more than 20% of the participants were excluded from analysis. Variables with p-values 
 0.25 from the bivariate analyses were entered into the logistic regression model.  
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5.6.5 Statistical method Paper V 
In Paper V, the data were analysed in frequency and summation tables; group 
differences were analysed by chi-square tests. Diagnostic sensitivity and specificity with 
95% confidence intervals were calculated for any retinopathy, and for mild and moderate 
non-proliferative retinopathy. Associations between diagnostic quality and formal 
education were analysed using the Pearson Chi-square and Student’s-t tests. A p-value 
0.05 was regarded as significant.  
 
5.7 Formal approvals and ethics  
All parts of this study followed the tenets of the Declaration of Helsinki for research 
involving humans. The studies in Papers I and II were presented to the REK. The studies 
were not regarded subject to specific evaluation and approval. The Norwegian Social 
Science Data Services were notified before study commencement. Information about the 
study, the voluntary nature of participation and confidentiality was provided in the 
invitation sent to the optometrists. A notice was posted in each participating consulting 
room/practice notifying patients of the on-going practice registration form study. Patient 
data were anonymised before being passed to the research team and the responding 
optometrists were anonymous to the researchers. The study in Paper III was approved 
(May 12. 2005) by the REK. Data were collected anonymously. Information about the 
study, the voluntary nature of participation, confidentiality and study approval was given 
on the front page of the questionnaire. The return of a completed questionnaire was 
regarded as written consent. In Paper IV, the questionnaire was approved (May 12. 
2005) by the REK. Information about the study, the voluntary nature of participation and 
confidentiality was provided in the invitation, along with an informed consent form 
(Appendix 8). The REK approved (January 19. 2009) the planned analyses of the data 
from the clinical study and baseline information from the HUNT 2 -study. Patient data 
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were anonymised before statistical analysis. The study in Paper V was not regarded 
subject to evaluation and approval by the REK. 
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6. Results   
6.1 Response rate 
In Papers I and II, 508 (64%) optometrists responded to the questionnaire survey, of 
these 212 (42%) completed the practice registration form, reporting 4,052 patient 
encounters. In Paper III, 1,396 (74%) of the invited members of the NDA, responded to 
the questionnaire survey. Forty-four of the completed questionnaires had missing 
information regarding, for age, gender, or type of diabetes; in some cases, the 
respondent had diabetes other than type 1 or type 2. Questionnaire analysis was based 
on the remaining 1,352 cases. In Paper IV, 126 of the 163 (77%) invited people 
participated in the clinical examination: 20 (83%) of the patients with known diabetes, 36 
(68%) of the patients with screen-detected diabetes, 38 (83%) of the people with 
impaired glucose tolerance and 32 (74%) of the people with normal glucose tolerance. In 
Paper V, 112 (11%) optometrists agreed to participate in the study; of these, 101 (90%) 
met the inclusion criteria and 74 (73%) completed the VIMOC examination. 
 
6.2 Optometric practice 
6.2.1 Optometrists 
The characteristics of the optometrists who either responded or did not respond to the 
questionnaire (2005, Papers I and II), the participating and non-participating optometrists 
in the practice registration form study (2005, Papers I and II), and the participating and 
non-participating optometrists in the VIMOC examination (2011, Paper V) are shown in 
Table 6.1. In 2005, participating optometrists reported that they performed, on average, 
21 routine optometric examinations per week (standard deviation [SD] ± 11, range 0-70). 
However, the reported total number of patient examinations (including contact lens 
fittings and follow-ups) was, on average, 40 per week (SD ± 19, range 0-150).  
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national health region n (%
) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
East 
73 
(35) 
97 
(33) 
170 
(34) 
104 
(37) 
 
261 
(34) 
 
21 
(28) 
317 
(33) 
 
338 
(33) 
South 
51 
(24) 
66 
(23) 
117 
(23) 
60 
(21) 
 
171 
(23) 
 
20 
(27) 
276 
(29) 
 
293 
(29) 
W
est 
44 
(21) 
62 
(21) 
106 
(21) 
54 
(19) 
 
156 
(21) 
 
11 
(15) 
165 
(17) 
 
176 
(17) 
M
iddle 
15 
(7) 
46 
(16) 
61 
(12) 
35 
(13) 
 
94 
(12) 
 
16 
(22) 
119 
(12) 
 
135 
(13) 
N
orth 
27 
(13) 
22 
(8) 
49 
(10) 
27 
(10) 
 
76 
(10) 
 
6 
(8) 
77 
(8) 
 
83 
(8) 
H
igh
er edu
cation
 an
d  
special trainin
g n (%
) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M
aster of Science in optom
etry
  
44 
(21) 
50 
(17) 
94 
(19) 
 
 
 
92 
(12) 
 
22 
(30) 
133 
(14) 
 
196 
(19) 
Right to em
ploy diagnostic drugs 
50 
(24) 
53 
(18) 
103 
(20) 
 
 
 
101 
(13) 
 
63 
(85) 
520 
(55) 
 
583 
(57) 
N
um
ber of years in
 
optom
etric practice n
 (%
) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 5 years 
75 
(36) 
77 
(26) 
152 
(30) 
 
 
 
 
 
 
21 
(28) 
 
 
 
 
 
6-10 years 
47 
(22) 
62 
(21) 
109 
(22) 
 
 
 
 
 
 
17 
(23) 
 
 
 
 
 
11-20 years 
54 
(26) 
94 
(32) 
148 
(30) 
 
 
 
 
 
 
27 
(36) 
 
 
 
 
 

 21 
34 
(16) 
60 
(21) 
94 
(19) 
 
 
 
 
 
 
9 
(12) 
 
 
 
 
 
O
phthalm
oscopy  
part of routine exam
 n (%
)  
201 
(96) 
266 
(90) 
467 
(92) 
 
 
 
 
 
 
 
 
 
 
 
 
 
M
ethod of  
retin
al exam
in
ation
 n
 (%
) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D
irect ophthalm
oscopy 
116 
(56) 
175 
(61) 
291 
(59) 
 
 
 
 
 
 
9 
(12) 
 
 
 
 
 
Indirect ophthalm
oscopy 
54 
(26) 
44 
(15) 
98 
(20) 
 
 
 
 
 
 
35 
(47) 
 
 
 
 
 
Both direct and indirect 
ophthalm
oscopy 
21 
(10) 
23 
(8) 
44 
(9) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Retinal fundus photography 
1 
(0.5) 
7 
(2) 
8 
(2) 
 
 
 
 
 
 
25 
(34) 
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Optometrists who held an MSc in clinical optometry examined the retina more frequently 
during their routine examinations than those with a basic optometric education (94% 
versus 87%, p<0.001) and more frequently performed dilated retinal examinations (5% 
versus 1%, p<0.001). Furthermore, they reported detecting a higher prevalence of 
retinopathy than optometrists with a basic optometric education (8% versus 3%, 
p<0.001). 
6.2.2 Patients examined in optometric practice 
The mean (SD) number of patients encountered by each optometrist in the practice 
registration form was 19 (±3), the range was 2 to 20 patients. In total, 4,052 patient 
encounters were recorded (Table 6.2). The majority of patients were 35 years or older. In 
all, 24% of the patients were known to have ocular disease or systemic disease of ocular 
relevance, and 12% had known ocular disease. Two percent of patients were visually 
impaired (BCVA<0.5), of these more than half had low vision (BCVA < 0.33). In general, 
VA was poorer among the elderly (Figure 6.1). 
 
Figure 6.1 Best corrected visual acuity of the patients (n=4,025) examined in optometric 
practice during the practice registration form study in 2004-2005 (Paper I)  
  
 
Table 6.2 C
haracteristics of patients exam
ined in optom
etric practice during the practice registration study in 2004-2005, Papers I 
and II 
  
P
atients exam
in
ed by optom
etrists 
 
A
ll groups 
0-15 years 
16-34 years 
35-44 years 
45-54 years 
55-64 years 
65-74 years 

 75 years 
 
 
 
A
ge distribu
tion
a n (%
) 
4,041 (99.7) 
326 (8.1) 
792 (19.6) 
543 (13.4) 
874 (21.6) 
661 (16.4) 
426 (10.5) 
419 (10.4) 
G
ender distribution
b n (%
) 
 
 
M
ale 
1,699 (43.3) 
150 (47.6) 
307 (40.1) 
222 (42.2) 
382 (45.3) 
283 (44.1) 
179 (43.9) 
170 (41.5) 
Fem
ale 
2,216 (56.7) 
165 (52.3) 
457 (59.8) 
304 (57.8) 
461 (54.7) 
356 (55.7) 
229 (56.1) 
240 (58.5) 
O
cu
lar an
d m
edical h
istory n (%
) 
 
 
Cataract 
371 (9.2) 
1 (0.3) 
8 (1.0) 
7 (1.3) 
26 (3.0) 
46 (7.0) 
91 (21.4) 
188 (44.9) 
G
laucom
a 
109 (2.7) 
0 (0.0) 
1 (0.1) 
6 (1.1) 
22 (2.5) 
19 (2.9) 
25 (5.9) 
36 (8.6) 
Age related m
acular degeneration 
99 (2.4) 
0 (0.0) 
1 (0.1) 
1 (0.2) 
3 (0.3) 
11 (1.7) 
18 (4.2) 
63 (15.0) 
H
ypertension 
439 (10.8) 
0 (0.0) 
6 (0.8) 
17 (3.1) 
65 (7.4) 
123 (18.6) 
113 (26.5) 
110 (26.3) 
Cardio-vascular disease 
238 (5.9) 
2 (0.6) 
4 (0.5) 
5 (0.9) 
15 (1.7) 
44 (6.7) 
63 (14.8) 
105 (25.1) 
D
iabetes 
166 (4.1) 
4 (1.2) 
16 (2.0) 
16 (2.9) 
22 (2.5) 
39 (5.9) 
34 (8.0) 
35 (8.4) 
Fam
ily history of diabetes 
302 (7.5) 
20 (6.1) 
42 (5.3) 
41 (7.6) 
74 (8.5) 
63 (9.5) 
36 (8.5) 
25 (6.0) 
V
isual im
pairm
ent n (%
) 
 
 
 
 
 
 
 
 
Visually im
paired (BCVA
c <
 0.5)   
99 (2.4) 
3 (0.9) 
9 (1.2) 
3 (0.6) 
8 (0.9) 
11 (1.7) 
7 (1.7) 
57 (13.7) 
Low
 vision (BCVA
c <
 0.33)   
54 (1.3) 
3 (0.9) 
6 (0.8) 
1 (0.2) 
5 (0.5) 
8 (1.2) 
3 (0.7) 
28 (6.7) 
Blind (BCVA
c  <
0.05)   
4 (0.1) 
0 (0.0) 
2 (0.3) 
0 (0.0) 
2 (0.2) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
R
etin
al exam
in
ation
  
3576 (88.3) 
245 (75.2) 
600 (75.8) 
486 (86.2) 
819 (93.7) 
630 (95.3) 
406 (95.3) 
398 (95.0) 
D
ilated retinal exam
ination
d 
78 (2.2) 
7 (2.9) 
3 (0.5) 
6 (1.3) 
21 (2.6) 
13 (2.1) 
8 (2.0) 
20 (5.0) 
C
linical findings of ocular disease n (%
) 
 
 
 
 
 
 
 
 
Cataract 
442 (10.9) 
1 (0.3) 
4 (0.5) 
3 (0.6) 
24 (2.7) 
70 (10.6) 
119 (27.9) 
218 (52.0) 
Retinopathy
e 
116 (3.2) 
0 (0.0) 
2 (0.3) 
3 (0.6) 
13 (1.6) 
20 (3.2) 
22 (5.4) 
56 (14.0) 
M
acular disease 
56 (1.6) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
4 (0.5) 
3 (0.5) 
12 (3.0) 
37 (9.3) 
H
ypertensive/vascular retinopathy 
27 (0.8) 
0 (0.0) 
1 (0.2) 
0 (0.0) 
6 (0.7) 
9 (1.4) 
5 (1.2) 
6 (1.5) 
D
iabetic retinopathy 
23 (0.6) 
0 (0.0) 
1 (0.2) 
3 (0.6) 
2 (0.2) 
4 (0.6) 
4 (1.0) 
9 (2.3) 
N
o tentative diagnosis  
10 (0.3) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
1 (0.1) 
4 (0.6) 
1 (0.2) 
4 (1.0) 
 
 
 
 
 
 
 
 
 
R
eferred for m
edical assessm
ent 
258 (6.4) 
8 (2.5) 
20 (2.5) 
13 (2.4) 
33 (3.8) 
40 (6.1) 
54 (12.7) 
86 (20.6) 
BCVA, best corrected visual acuity.  
D
ata m
issing for a11, b137, c45, d10 and e488 patients
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In total, 166 (4%) patients had a known history of diabetes, of whom 61 (37%) had some 
known ocular disease, 34 (20%) had a known history of hypertension, and 14 (8%) had a 
known history of cardiovascular disease other than hypertension.  
 
History of retinopathy, findings of cataract, age greater than 75 years, and female gender 
were all associated with reduced functional visual acuity. The BCVA was poorer among 
patients with diabetes than those without (Figure 6.2a and Figure 6.2b).   
 
In all, 11% of patients were considered to be in need of further medical attention. A 
referral or report to a GP or ophthalmologist was sent in 6% and 3% of patient 
encounters, respectively. Another 2% of patients were orally requested to contact their 
GP (Table 6.3).  
 
 
 
Diabetes Eye Care in Norwegian Optometric Practice 
57 
 
Figure 6.2 Best corrected visual acuity of patients with and without diabetes 
examined in optometric practice during the practice registration study in 2004-
2005, Paper I 
 
 
Figure 6.2a Best corrected visual acuity (BCVA) for patients with diabetes (n=166)  
 
 
 
 
Figure 6.2b Best corrected visual acuity (BCVA) for patients without diabetes (n=3886) 
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6.3 Patients with diabetes 
This thesis includes information from three different samples of patients with known diabetes 
(n=1,538) (Table 6.4). Patients from the HUNT sample (Paper IV) were older than either the 
patients seen in optometric practice (Paper I and II) or the NDA members (Paper III). There 
were no significant differences between the groups with respect to the reported type of 
diabetes, self-reported history of diabetic retinopathy, laser-treated diabetes-related ocular 
disease, cataract or age-related macular degeneration. The reported frequency of a known 
history of glaucoma was significantly higher for members of the NDA than for the other two 
groups.  
 
In the practice registration study (Paper I and II), 34 (20%) of the 166 patients with a self-
reported history of diabetes had reduced functional vision (BCVA<0.8) and nine (5%) were 
visually impaired (BCVA 0.5), of which four had low vision (BCVA < 0.33). In the clinical 
study (Paper V) none of the participants with known or screen-detected diabetes were 
visually impaired (BCVA<0.5), but 2 (4%) had reduced functional vision and 2(4%) had a 
correctable visual impairment.  
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Table 6.4 Characteristics of patients with known diabetes: members of the Norwegian 
Diabetes Association responding to the questionnaire (2005), patients examined in 
optometric practice during the practice registration study (2004-2005), and patients 
from the HUNT sample taking part in the clinical examination study (2005), Papers I-IV  
 
 
 
Norwegian 
Diabetes 
Association 
(n=1,352) 
Norwegian 
optometric 
practice 
(n=166) 
The HUNT 
study 
(n=20) 
Gender n (%) (n=1,352/157/20)       
Female 699 (51.7) 83 (52.9) 9 (45.0) 
Male 653 (48.3) 74 (47.1) 11 (55.0) 
Age distribution n (%) (n=1,352/166/20)***       
0-15  4 (2.4)  
16-34 100 (7.4) 16 (9.6) 0 (0.0) 
35-44 130 (9.6) 16 (9.6) 1 (5.0) 
45-54 216 (16.0) 22 (13.3) 0 (0.0) 
55-64 397 (29.4) 39 (23.5) 9 (45.0) 
65-74 301 (22.3) 34 (20.5) 8 (40.0) 
75+ 208 (15.4) 35 (21.5) 2 (10.0) 
Duration of diabetes mean (SD)  (n=1,321/126/12) 14 (±12) 9 (±11) 11 (±15) 
Type of diabetes n (%) (n=1,352/128/19)       
Type 1 451 (33.4) 32 (25.0) 2 (10.5) 
Type 2 901 (66.6) 94 (73.4) 17 (89.5) 
Other  2 (1.6) 0 (0.0) 
Regular vision examination n (%) (n=1,336/18) 1,161 (85.9)  13 (68.4) 
Regular eye examination n (%) (n=1,336/20) 1,141 (85.4)  16 (80.0) 
Known history of ocular disease n (%)       
Cataract (n=1,019/166/20) 261 (25.6) 34 (20.5) 6 (30.0) 
Diabetic retinopathy (n=1,058/131/20) 182 (17.2) 18 (13.7) 1 (5.0) 
Glaucoma (n=905/166/20)* 93 (10.3) 6 (3.6) 1 (5.0) 
Age-related macular degeneration (n=857/166/20) 35 (4.1) 3 (1.8) 0 (0.0) 
Laser treated diabetic ocular disease n (%) (n=1,052/128/18) 124 (11.8) 13 (10.2) 1 (5.6) 
History of diabetic retinopathy reported 105 (10.0) 11 (8.6) 0 (0.0) 
History of diabetic retinopathy not reported 19 (1.8) 2 (1.6) 1 (5.6) 
Informed about importance of eye examination n (%) 1,169 (86.8)  15 (75.0) 
Source of information (not mutually exclusive) n (%)       
General practitioner 678 (50.3)  12 (80.0) 
Ophthalmologist 515 (38.2)  5 (33.3) 
Hospital 338 (25.1)  3 (20.0) 
Other medical practitioner 114 (8.5)  2 (13.3) 
Optometrist 93 (6.9)  1 (6.7) 
Leaflets/Journal of the Norwegian Diabetes Association  298 (22.1)  1 (6.7) 
Diabetes patient education course 218 (16.2)  2 (13.3) 
Media 68 (5.0)  1 (6.7) 
Other patients with diabetes 94 (7.0)  0 (0.0) 
*p< 0.05 Fisher’s exact test  
***p<0.001 Pearson chi-square  
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6.4 Paper I 
In the questionnaire, all optometrists (n=508) reported that taking a patient history of vision 
and ocular health was part of their routine consultation. Fifty-five percent of optometrists 
established the general health history of all patients, and 42% established diabetes history in 
particular. Refraction was always part of the routine examination, and the majority of 
optometrists performed ophthalmoscopy, binocular examination and tonometry as part of 
their routine examination. Less than half reported including slit lamp examination of the 
anterior segment and visual field examination in their routine examinations. Optometrists 
(n=212) who completed the practice registration form reported more frequently that they 
included ophthalmoscopy as part of their routine examination than non-participating 
optometrists, that is, the optometrists who completed the questionnaire, but not the practice 
registration form (96% versus 90%, p<0.01), and graded their fundus evaluation skills more 
highly. More than 80% of optometrists reported collaborating with GPs and ophthalmologists. 
Written reports were more frequently sent to GPs than to ophthalmologists (48% versus 
39%, p<0.01), as were referrals (83% versus 66%, p<0.001), whereas telephone 
contact/referral was more commonly made to ophthalmologists than to GPs (54% versus 
20%, p<0.001). Patient reports were more often received from ophthalmologists than from 
GPs (65% versus 24%, p<0.001). Optometrists participating in the practice registration study 
reported more frequently that they: (1) sent reports to GPs (55% versus 44%, p<0.05) and 
received referrals from GPs (30% vs. 22%, p<0.05) GPs, and (2) received patient reports 
from ophthalmologists (68% versus 56%, p<0.01) than the non-participating optometrists. 
Clinical findings of cataract and retinopathy were reported in, respectively 11% and 3% of 
the patients examined (n=4,052). In all, 6% of patients were referred. In half of the referrals, 
the receiver of the referral was accounted for; 72% of these referrals were made to a GP, 
25% to an ophthalmologist and 3% to a casualty department. 
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6.5 Paper II 
The majority of optometrists (96%) participating in the practice registration study (n=212) 
reported performing ophthalmoscopy as part of their routine examination; 24% were qualified 
to undertake dilated retinal examination. Direct ophthalmoscopy was the most frequently 
used method of retinal examination; it was reported as preferred method of examination by 
59% of optometrists (Table 6.1). Ophthalmoscopy was performed in 3,576 out of 4,052 
(88%) patient encounters; of these, 78 (2%) were dilated retinal examinations. 
Ophthalmoscopy was performed significantly more often in the 166 patients with known 
diabetes (in 96% of examinations), than in the 3,886 patients without diabetes (in 88% of 
examinations). A tentative diagnosis of retinopathy was made for 106 (3%) patients, of 
whom two thirds had no previous history of retinopathy (Table 6.2). Diabetic retinopathy was 
suspected in 23 patients, of whom 14 had no history of retinopathy and 6 had no history of 
diabetes. In patients with suspected hypertensive/vascular retinopathy, 10 out of 27 had no 
history of hypertension and/or cardiovascular disease, and none had a known history of 
diabetes.  
 
Diabetic retinopathy was detected in 17 out of 159 (11%) of patients with diabetes, 9 of 
whom had a reported history of diabetic retinopathy. In 9 of the 18 patients (50%) with a 
reported history of diabetic retinopathy, the retinopathy was not detected by the optometrist. 
Seven of these patients had undergone laser treatment. In 9 of the 18 patients (50%) with a 
reported history of diabetic retinopathy, the retinopathy was not detected by the optometrist. 
Seven of these patients had undergone had undergone laser treatment. Multivariate logistic 
regression analysis showed that old age (75 years or older), hypertension and diabetes were 
independent predictors for any retinopathy, with odds ratios (ORs) (95% CI) of 6.4 (4.2 to 
9.9), 3.8 (2.4 to 6.0) and 2.5 (1.4 to 4.7), respectively. For vascular retinopathy, only 
diabetes and hypertension were independent predictors, with ORs (95% CI) of 7.2 (3.7 to 
14.1) and 4.9 (2.6 to 9.3), respectively. In total, the optometrists judged 439 of the 3,576 
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(12%) retinally-examined patients to be in need of some medical follow-up of ocular findings. 
Among the 106 patients with suspected retinopathies, 54 (51%) were considered to be in 
need of some further management (Table 6.3). Patients with retinopathy were significantly 
(p<0.01) more frequently urged to see a physician if the retinopathy was previously unknown 
(41 out of 71 patients) than if it was known (13 out of 35 patients). 
 
6.6 Paper III 
In all, 1,141 (85%) of the NDA questionnaire respondents reported to have regular eye 
examinations. Of these, 1,052 (92%) were examined according to the recommended follow-
up schedule. Only 6% reported never having had their eyes examined. The initial 
examination was in accordance with guidelines in 31% of respondents with type 1 diabetes, 
and in 47% of respondents with type 2 diabetes. The median interval between eye 
examinations was 12 months; this accounted for 65% of respondents, 18% were examined 
more frequently. In patients with type 1 diabetes, 88% (358/407) were examined annually or 
more frequently, with a follow-up interval of: 1 to 3 months in 2%, 4 to 6 months in 15%, 7 to 
9 months in 3%, and 10 to 12 months in 69%. In patients with type 2 diabetes, 98% 
(694/711) were examined biannually or more frequently, with a follow-up interval of: 1 to 3 
months in 2%, 4 to 6 months in 13%, 7 to 9 months in 1%, 10 to 12 months in 63%, and 12 
to 24 months in 18%. In all, 1,169 (87%) respondents confirmed that they had received 
information about the importance of having regular eye examinations because of their 
diabetes. Respondents who had their eyes examined according to the guidelines were more 
likely to have received such information than respondents who did not have regular eye 
examinations (95% versus 42%, p<0.001). The factors of having received information about 
the importance of eye examinations, and diabetes duration of more than 10 years, were both 
independently associated with the performance of regular eye examinations. Spectacles 
and/or contact lenses were used by 1,188 (88%) of the respondents. Patients who used 
optical correction were more likely to have their vision regularly examined than respondents 
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who did not use optical correction (88% versus 71%, p<0.001). Visual problems related to 
diabetes were reported by 156 (12%) respondents. Among patients who reported visual 
problems and who also had a known history of diabetic retinopathy, 81% reported a history 
of laser treatment for ocular disease related to diabetes. In total, 178 (13%) respondents 
reported a history of diabetic retinopathy, of whom 101 (57%) also had a history of laser 
treatment. A reported history of diabetic retinopathy was more frequent in patients with a 
diabetes duration of more than ten years than in patients with shorter disease duration; the 
prevalence ratio (95% CI) was 3.5 (2.5 to 5). A history of diabetic retinopathy was more 
frequently reported by respondents who had their eyes regularly examined than by 
respondents who did not undergo regular eye examinations (19% versus 5%). A reported 
history of diabetic retinopathy was associated with type 2 diabetes, a diabetes duration of 
more than 10 years, use of oral anti-diabetic agents, use of insulin, HbA1c levels above 7%, 
unstable blood glucose levels and the use of anti-hypertensive medication. In a multivariate 
logistic regression analysis, diabetes duration was the only variable that was independently 
associated with a history of diabetic retinopathy.  
 
6.7 Paper IV 
In total, 126 people from the HUNT population underwent clinical examination; 20 of these 
had known diabetes (Table 6.5). In all, 23 [18%, 95%CI (12, 26)] had a known history of one 
or more ocular disease. The reported history of cataract was significantly higher among 
participants with diabetes or screen-detected diabetes, than among people with impaired 
glucose tolerance or normal glucose tolerance. Previously undiagnosed ocular disease was 
found in 25% [95% CI (18, 33)] of people. Retinopathy consistent with diabetic retinopathy 
was present in seven participants [6%, 95% CI (3, 13)], two of whom had a known history of 
diabetes. Six people [6%, 95% CI (2, 12)] had mild non-proliferative retinopathy and one 
[1%, 95% CI (0, 5)] had moderate non-proliferative diabetic retinopathy. Neither a known 
history of diabetes, nor current glycaemic status, was associated with findings of retinopathy. 
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There was no significant difference in baseline body mass index, hip-waist-ratio, non-fasting 
plasma blood glucose, cholesterol, high density lipoprotein (HDL)-cholesterol or blood 
pressure, between people with and without diabetic retinopathy. In a multivariate logistic 
regression analysis, non-fasting plasma glucose levels 10 years previously was an 
independent risk factor for developing retinopathy [OR 1.5, 95% CI (1.01, 2.13), p=0.046]. In 
total, 108 participants [86%, 95% CI (79, 91)] used optical correction. Of all the participants, 
19 [15%, 95%CI (9, 23)] had reduced functional vision (VA < 0.8) with their presenting 
correction and 4 [3%, 95%CI (1, 8)] were visually impaired (VA < 0.5). With the best optical 
correction, 3 [2%, 95%CI (1, 7)] people had reduced functional vision (BCVA < 0.8), but 
none were visually impaired (Figure 6.3). In bivariate analyses of BCVA, VA was negatively 
correlated with increasing age and findings of cataract. Correctable visual impairment [3%, 
95%CI (1, 8)] was associated with old age, but not with hyperglycaemic category group, 
gender, history of ocular disease, history of diabetes, regular vision examination or regular 
eye examination. 
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Figure 6.3 Visual acuity of the sample from the HUNT population examined in the 
clinical study (2005), Paper IV 
 
 
 
 
Figure 6.3a Presenting (habitual) visual acuity 
BCVA, best corrected visual acuity; HVA, habitual visual acuity; IGT, impaired glucose tolerance; KDM, known diabetes 
mellitus; NGT, normal glucose tolerance; SDM, screen-detected diabetes  
 
 
 
 
 
Figure 6.3b Best corrected visual acuity 
BCVA, best corrected visual acuity; HVA, habitual visual acuity; IGT, impaired glucose tolerance; KDM, known diabetes 
mellitus; NGT, normal glucose tolerance; SDM, screen-detected diabetes  
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6.8 Paper V 
In all, 74 of the 101 eligible optometrists completed the VIMOC examination study. The 
participants were significantly more highly educated than the average Norwegian 
optometrist (Table 6.1). The two most common preferred methods of retinal examination 
were undilated indirect ophthalmoscopy (in 47% % of participants), and undilated retinal 
fundus photography (in 34% of participants). Multiple examination methods were 
reported for patients with diabetes. Twenty-three percent of optometrists reported 
undertaking dilated retinal examinations in patients with diabetes. The optometrists’ 
assessment of diabetic retinopathy for all 14 retinal images is shown in Table 6.6, The 
images are shown in Figure 6.4. The overall sensitivity and specificity for detecting any 
retinopathy was 67% [95%CI (62, 72)] and 84% [95%CI (80, 89)], respectively. 
Optometrists with an MSc in clinical optometry had significantly higher sensitivity than 
optometrists with only a basic optometric education, 77% [95%CI (71, 84)] versus 63% 
[95%CI (56, 69)]. There was no association between either sensitivity or specificity and 
(1) the number of years the optometrist had been in practice, or (2) the optometrist’s 
preferred method of retinal examination. The requirement for sensitivity of at least 80% 
and specificity of at least 95% was met by 24 (32%) and 31 (42%) of the optometrists, 
respectively.  Of the optometrists with an MSc, 50% met the requirement for sensitivity 
and 45% met the requirement for specificity. For those optometrists with only a basic 
optometric education, the requirements for sensitivity and specificity were met by 25% 
and 39%, respectively. Only four optometrists (5%) met the required standard for both 
sensitivity and specificity. Patient management was dependent on retinal findings (Table 
6.7). Report or referral to a GP or/and to an ophthalmologist was regarded appropriate 
for 99% of cases with true positive findings and 96% of cases with false positive findings. 
The referral rate to ophthalmologists was higher for moderate (92%) than for mild (62%) 
non-proliferative diabetic retinopathy. No further management was considered 
appropriate in 68% of cases with true negative findings and 66% of cases with false 
negative findings. 
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Figure 6.4 Retinal images assessed by optometrists in the VIMOC examination 
according to image presentation sequence, Paper V  
 
 
 
Top row from left to right; image 1-3, second row from left to right; image 4-6, third row from left to 
right; image 7-9, fourth row from left to right; image 10-12, and bottom row from left to right; image 
13-14  
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7. Discussion 
7.1 Introduction 
This is, to the best of my knowledge, the first national cross sectional description of 
optometric practice, and the first national study to estimate the prevalence of retinopathy 
among patients examined in optometric practice. This is also the first Norwegian study to 
describe the prevalence of retinopathy consistent with diabetic retinopathy in people 
without diabetes. The research contributes to the knowledge of utilization of eye care 
services in general, and to the knowledge of compliance with eye care guidelines among 
patients with diabetes in particular.     
 
7.2 Reliability and validity 
Reliability will be described in terms of the measures that have been made to assess 
reliability. Validity will be discussed in terms of: (1) internal validity, that is to what extent 
the findings and causes can be inferred from the sample population, and (2) external 
validity, that is to what extent the results can be applied beyond the sample population. 
7.2.1 Reliability  
In order to increase confidence in the data, and to provide a comprehensive 
understanding, this study applied and combined different research methods and 
collected data from different and independent population samples. This is referred to as 
triangulation. The following considerations of reliability should be kept in mind: (1) all 
questionnaires (Papers I, II, III, and IV), the practice registration form (Papers I and II), 
the clinical examination (Paper IV) and the VIMOC examination (Paper V) were 
assessed in pilot studies before study commencement, but reliability was not measured 
by test-retest, (2) the grading of diabetic retinopathy in the clinical study (Paper IV) was 
evaluated in terms of kappa analysis and the inter-rater reliability was very good 
(ț=0.75), (3) the optometrists’ assessment of diabetic retinopathy, sensitivity and 
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specificity (Paper V), was evaluated against a “gold-standard” of 14 retinal images 
selected from images with 100% diagnostic agreement between two ophthalmologists in 
the clinical study (paper IV), and (4) the reported history of ocular disease (Papers I, II, III 
and IV), systemic disease (Papers I, II and III) and the optometrists’ clinical findings and 
ocular diagnosis (Papers I and II) were not verified against patient medical records.  
 
7.2.2 Internal validity of the studies of optometric practice (Papers I, II and V) 
A majority of the optometrists invited to participate in the questionnaire survey (65%) 
responded to the questionnaire and 42% of the questionnaire respondents participated in 
the practice registration study (Papers I and II). Questionnaire respondents were 
younger and more likely to be female than non-respondents. The practice registration 
form participants had more often had 3 years or more formal optometric education and 
worked in smaller communities than non-participants. In the VIMOC study, 112 (11%) 
optometrists participated in the study, of these 101 (90%) met the inclusion criteria and 
74 (73%) completed the VIMOC examination (Paper V). Participants in the VIMOC 
examination more had often an MSc in clinical optometry and the right to employ 
diagnostic drugs for clinical evaluation, than non-participants. The questionnaire, practice 
registration form and VIMOC examination was completed by the optometrists in a 
consistent manner. Only one participant completed the practice registration form 
incorrectly; this form was excluded from analysis. The questionnaire and VIMOC 
examination were fully completed by the majority of the optometrists, and the practice 
registration form was fully completed for the majority of patient encounters. Respectively, 
100%, 99.6% and 100% of the questionnaires were complete for the main variables of 
refraction, retinal examination and patient management. The optometrists recorded 19 
(±3) of the 20 requested patient encounters. For the main variables of visual impairment, 
retinopathy, retinal examination and patient management, the forms were complete for 
98.9%, 88%, 99.8% and 100% of the patient encounters, respectively. The main 
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variables in the VIMOC examination (diabetic retinopathy and patient management) were 
completed for all the image assessments.  
 
Retinal examination, retinopathy and patient management  
Retinal examination, detection of retinopathy and further patient management were not 
associated with either optometrist gender or practice community size. Although the 
frequency of retinal examination, detection of retinopathy, and referral patterns were 
associated with optometric education level (Technical College, 2 years at University 
College, 3 years at University College and MSc), the frequency of retinal examinations 
and detection of retinopathy was not significantly higher among optometrists with 3 years 
of University College education or an MSc (that is, 3 years of optometric education) 
than among optometrists with a Technical College education or 2 years of University 
College education (that is, < 3 years of optometric education. Further, there was no 
significant difference between optometrists with 3 years or more of optometric education 
and optometrists with less than 3 years of optometric education with regard to the 
number of patients considered to be in need of further medical management and referral 
pattern. The questionnaire results could have been affected by information bias, due to 
the optometrists’ perception of expected standards and scope of clinical practice, that is, 
the optometrists may have reported what they believed to be the expected standard, 
rather than what they actually do in practice. In all, 88% of patients encountered had a 
retinal examination, as opposed to the expected level of 95%, based on the optometrists’ 
responses to the questionnaire. However, this may reflect a tailoring of the routine 
examination according to patient age and the probability of having an ocular disease 
[159], as 95% of the patients who were examined were aged 55 years or older. In the 
practice registration study, 96% of patients with a known history of diabetes had their 
retina examined, whereas the majority of the participating optometrists (62%) reported in 
the questionnaire that they never undertake retinal examination in patients with known 
diabetes. This may reflect an expectation that this is beyond the scope of optometric 
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practice. However, it could also be that optometrists tailored their routine to facilitate 
case-finding of diabetic retinopathy as a consequence of the practice registration form 
increasing their awareness regarding retinal examination in general. It is unlikely that the 
difference in educational level between participating and non-participating optometrists in 
the practice registration study would result in overestimation or underestimation of the 
frequency of retinal examination, detection of retinopathy and patient referral for the 
sample. The difference between the reported frequency of retinal examination in the 
questionnaire and practice registration form is probably a result of tailoring the routine to 
the patient’s age and the likelihood of ocular disease. Therefore, the frequency of retinal 
examinations, the age distribution of patients who have a retinal examination, the rate of 
detected retinopathy and the number of patient referrals and referral pattern are probably 
representative for the sample.  
 
The quality of retinal assessment for diabetic retinopathy 
Participants in the VIMOC examination (Paper V) were more likely to have an MSc in 
clinical optometry and the right to employ diagnostic drugs for clinical evaluation than 
non-participants. The main outcome variable of sensitivity was associated with formal 
education, while specificity was not. Optometrists with an MSc had a significantly higher 
sensitivity than optometrist with only a basic optometric education. Since optometrists 
with an MSc are more frequently represented in this study, and they have a higher 
sensitivity than optometrist with a basic optometric education, it is likely that the study 
overestimated sensitivity for the sample. However, the specificity of the optometrists’ 
retinal image evaluation for diabetic retinopathy is likely to be representative, as 
specificity was not related to formal education.   
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7.2.3 External validity of the studies of optometric practice (Papers I, II and V) 
How representative were the participating optometrists? 
At the time of the questionnaire survey and practice registration study (2004-2005), 
1,454 optometrists were registered with the Norwegian Registration Authority for Health 
Personnel; of these, 1,044 (72%) were members of the NOF. Mean age and gender 
distribution were similar for Norwegian Association of Optometrists members and non-
members (Papers I and II). At the time of the VIMOC examination study (2011), 1,850 
optometrists were registered with the Norwegian Registration Authority for Health 
Personnel; of these, 1,028 (56%) were active, full members of the NOF (Paper V). The 
difference in the proportion of optometrist being members of the NOF in 2004/2005 and 
2011 reflects the fact that optometrists working in one of the large national private owned 
chains were not members in 2011, due to business policy relating to membership fees. 
Further, the number for 2011 excludes members who are registered on leave, which is 
mainly maternity leave / leave to care for children. The optometrists invited to participate 
in 2004/2005 (Papers I and II) and 2011(Paper V) were, at the time, representative of 
Norwegian optometrists in general.  
 
The questionnaire respondents (Paper I) were younger and more frequently female than 
non-respondents, and optometrists who participated in the practice registration study 
(Papers I and II) also more frequently had 3 years or more formal optometric education. 
This is in a reflection of: (1) the development of Norwegian optometry education from 
Technical College to University College, (2) a shift from male to female dominance 
among students undertaking optometry education, and (3) an increase in the number of 
students studying optometry (from approximately 20 graduates per year prior to 1990, to 
approximately 40 per year between 1990 and 1999, and approximately 60 per year since 
2000). The results found in the questionnaire survey and practice registration study 
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(Paper I and II) are likely to be representative for the invited sample, as discussed in 
7.2.2. 
 
The optometrists taking part in the VIMOC examination (Paper V) more frequently had 
an MSc and/or the right to use diagnostic ocular drugs than participants in the 
questionnaire survey and the practice registration study. This is partly explained by 
recent changes in the regulation of optometric practice and the availability of 
postgraduate optometric education in Norway. Norwegian optometrists were given the 
right to the requisition and use of certain ocular diagnostic drugs in 2004; postgraduate 
education in optometry has been available in Norway since 1998. In 2004, 132 
optometrists had an MSc in clinical optometry; by 2011 this number had increased to 
208. This selection bias could be a result of the specific nature of the study. First, highly 
educated optometrists with a special interest in diabetes and diabetic retinopathy were 
probably motivated to take part in the study. Second, the study may have intimidated 
optometrists with only a basic optometric education and those with modest knowledge of 
diabetes and diabetic retinopathy, and this may have prevented them from participating.  
For these reasons, the results observed in the VIMOC examination probably 
overestimated the diagnostic sensitivity of the invited sample, as discussed in 7.2.2.       
 
How representative were the patients examined in optometric practice? 
Patients examined in Norwegian optometric practice were not representative for the 
general Norwegian population. At the time of the study, 40% of the general Norwegian 
population were 45 years and older, whereas the majority (60%) of the patients in the 
practice registration study were over 45 years. The sample was, however, likely to be 
representative of patients seen for routine eye examinations in optometric practice. The 
scope for International extrapolation is limited, as the extent of optometric practice and 
organisation of eye care services differ worldwide, and patient characteristics may vary 
accordingly.  
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Retinal examination, retinopathy and patient management  
The internal validity for the findings of the main outcome variables in the practice 
registration study was good, as discussed in 7.2.2. The selection bias does not appear to 
limit generalisation of the results (regarding retinal examination, detection of retinopathy, 
number of patient referrals and referral pattern) to general Norwegian optometric 
practice. International extrapolation of the findings cannot be claimed, as the scope of 
optometric practice differs in Europe [15] and worldwide [14].   
 
The quality of retinal assessment for diabetic retinopathy 
As discussed in 7.2.2, the internal validity of the findings for sensitivity was limited, and it 
is likely that sensitivity for detection of diabetic retinopathy was overestimated. Specificity 
was, however, representative for the sample. The results for diagnostic sensitivity for 
detecting diabetic retinopathy should not be generalised to Norwegian optometric 
practice. It is likely that sensitivity in general optometric practice is lower. However, 
specificity of the sample is likely to be representative of Norwegian optometric practice.  
 
7.2.4 Internal validity of the studies of patients with diabetes (Papers II, III and IV) 
Response rate in the questionnaire studies (Papers III and IV) was high, and the findings 
are probably representative for members of the NDA (Paper III) and the HUNT study 
sample (Paper IV). The analysed questionnaires were complete for age, gender and type 
of diabetes, and the internal validity of the questionnaire survey results are likely to be 
good. Some limitations should be considered, as the results were based on patients’ 
self-reported answers. Recall bias can underestimate the prevalence of retinal 
examination and the time of the first eye examination, as insignificant events, such as 
examinations with no findings of retinopathy, can be forgotten [160]. On the other hand, 
social acceptance can lead to the prevalence of retinal examination being overestimated, 
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as respondents may perceive regular eye examinations as the expected, and most 
acceptable, form of healthcare [160]. Frequency of eye examinations can be 
overestimated due to the effect of telescoping, that is, the likelihood of remembering an 
event as being more recent than it actually is [160]. In contrast, the frequency of receipt 
of information about the importance of eye examination can be underestimated, due to 
recall-bias and social acceptance, as people may forget the information received, and in 
the case of non-compliance to recommended care, patients may deny having received 
such information. It has been shown that patients over-report eye examination twice as 
frequently as they under-report eye examination; in contrast, self-reported treatment of 
diabetes is more valid [160]. In conclusion, the results in this study could have 
overestimated the frequency of retinal examination in the samples. The rate of retinal 
examination in patients with diabetes was high in both the practice registration study 
(Papers I and II) and the clinical study (Paper IV). Some limitations should be considered 
with respect to the observed prevalence of diabetic retinopathy: (1) the sensitivity and 
specificity of the methods used for retinal examination, and (2) the formal optometric 
education of the optometrist participating in the practice registration study. The sensitivity 
and specificity of screening for diabetic retinopathy has been found to be lower using 
undilated direct ophthalmoscopy (Paper I and II) compared to dilated slit lamp 
examination, and lower using single-field, non-mydriatic photography (Paper IV) 
compared to multiple-field, mydriatic photography [143]. This could have contributed to 
an underestimated prevalence of retinopathy, both in the patients encountered in 
optometric practice and in the HUNT sample. Further, the prevalence of diabetic 
retinopathy among patients with diabetes examined in optometric practice (Papers I and 
II) is likely to have been underestimated as a result of the lower diagnostic sensitivity of 
the methods used, as well as the low diagnostic sensitivity of the optometrists’ 
assessment of diabetic retinopathy (Papers II and V). This is particularly true for mild 
non-proliferative diabetic retinopathy. The reported history of retinopathy by members of 
the NDA (Paper III) could have underestimated the prevalence of diabetic retinopathy 
Diabetes Eye Care in Norwegian Optometric Practice 
 
80 
 
because of unawareness of existing retinopathy as well as undiagnosed diabetic 
retinopathy. In conclusion, the actual prevalence of diabetic retinopathy could be higher 
than was found in all three of our studies.  
 
7.2.5 External validity of the studies of patients with diabetes (Papers II, III and IV) 
The prevalence of diabetes among patients attending Norwegian optometric practice is 
nearly twice the estimated prevalence of diabetes in the general Norwegian population 
[4], primarily due to a higher prevalence of diabetes among the patients under 75 years 
of age compared to the general population [4]. The members of the NDA represent a 
selected group of patients with diabetes, where patients with type 1 diabetes and 
patients with a long duration of diabetes are overrepresented. In addition, it is likely that 
members of patient organizations are self-selected in terms of other characteristics, for 
instance they may have a general interest in health, which is not reported in our study. In 
the sample from the Nord-Trøndelag Health Study, only a limited number of patients with 
diabetes were included. The external validity of the findings of diabetic retinopathy and 
eye care is limited because of selection bias. Furthermore, the methods used may have 
underestimated the prevalence of retinopathy in the samples, as discussed in 7.2.4. This 
limits the generalisation of the results to the general diabetic population.  
 
7.3 Interpretation of the main findings 
7.3.1 Patients encountered in Norwegian optometric practice 
The majority of the patients seen in Norwegian optometric practice are 45 years or older, 
and women are more frequently examined than men. This is consistent with international 
studies of optometric and medical practice [161, 162]. The age distribution can be 
explained by the onset of presbyopia and probably reflects recommended follow-up 
intervals for different age groups [22]. Population studies in Australia and the US have 
shown that the prevalence of correctable visual impairment increases with increasing 
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age [104, 113, 114]. The clinical study (Paper IV) showed that 3% of adults have a 
correctable visual impairment and 6% have under-corrected refractive error. The rate of 
correctable visual impairment and under-corrected refractive error in the sample from the 
HUNT population is consistent both with international population-based studies and a 
small Norwegian population study. These studies, found that 1 to 6% of people have a 
correctable visual impairment [96, 104, 110-112] and 6 to 10% have under-corrected 
refractive error [112, 113]. Unfortunately, habitual visual acuity was not recorded in the 
practice registration study (Paper I), and the prevalence of a correctable visual 
impairment among patients examined in optometric practice could not be estimated. 
 
7.3.1 The role of the Norwegian optometrist 
Papers I, II and IV have shown that the routine optometric examination detects refractive 
error and correctable visual impairments, as well as cases of ocular disease. 
Furthermore, examinations undertaken in optometric practice include examination of 
visually impaired patients and patients with diagnosed ocular disease (Papers I and II). 
The prevalence of visual impairment among patients examined in optometric practice is 
similar, or higher, than both the reported prevalence in the Scandinavian general 
population and the estimated prevalence for Western Europe [101, 115, 163]. This 
reflects the role of the optometrist in examination, and probably rehabilitation, of the 
visually impaired. The higher rate of known history of glaucoma and age-related macular 
disease among patients examined in optometric practice (Paper I) compared to the 
prevalence reported in large population-based studies [117, 118], suggests a role for 
optometrists in the vision and eye care of patients with known ocular disease. Moreover, 
nearly half of the findings of cataracts and more than half of the findings of retinopathies 
in the practice registration study were detected in patients with no reported history of 
ocular or systemic disease (Papers I and II). This illustrates the role of the optometrists in 
case-finding of ocular disease. However, the diagnostic sensitivity of the retinal 
Diabetes Eye Care in Norwegian Optometric Practice 
 
82 
 
examination undertaken in optometric practice is likely to be low, as the rate of vascular 
retinopathy in patients without diabetes and the rate of diabetic retinopathy in patients 
with diabetes were lower than previously found in international population studies [57, 
164]. The incidence of known retinopathies missed during the routine optometric practice 
examination supports this view (Paper II). This low diagnostic sensitivity could be related 
to the investigative methods used and/or the optometrists’ diagnostic skills. Undilated 
direct ophthalmoscopy has a lower diagnostic sensitivity and specificity for detection of 
retinal abnormalities than dilated indirect ophthalmoscopy and photographic grading 
[143, 165]. The low frequency of dilated fundus examinations in the practice registration 
study (Papers I and II) can be explained by the recent introduction of the right to employ 
diagnostic drugs for clinical evaluation and the fact that only a small number of 
optometrists were qualified to perform dilated ophthalmoscopy at the time of the study. 
Based on the results of the retinal examination undertaken as part of the routine 
optometric examination and a reported prevalence of retinopathy in Norway of 13.8 to 
28% [64, 68], case-finding of diabetic retinopathy in optometric practice probably has an 
acceptable diagnostic specificity (Paper II). However, the diagnostic sensitivity is too low. 
This is supported by the findings in the VIMOC study (Paper V), where the sensitivity for 
detecting any diabetic retinopathy was low (67%) and the specificity was moderate 
(84%). A previous UK study of community optometrists showed a higher sensitivity 
(88%), but lower a specificity (69%) for retinal image assessment of any diabetic 
retinopathy; whereas a specially trained optometrist in the same study had a sensitivity 
of 86% and a specificity of 89% [145].  
 
In conclusion, the routine optometric examination appears to be an unreliable method of 
screening for diabetic retinopathy, as it does not meet international screening criteria 
[138, 144]. The VIMOC examination study showed that only 5% of the participating 
optometrists satisfied the screening standard established by the British Diabetic 
Association of at least 80% sensitivity and 95% specificity [138]. It is important to bear in 
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mind, however, that the participating optometrists did not have specific training in 
screening for diabetic retinopathy, nor were they provided with a diabetic retinopathy 
grading scale or specific computer screens facilitating classification of diabetic 
retinopathy. The results indicate that formal training in screening for diabetic retinopathy 
is needed, in order to improve diagnostic accuracy. The current guidelines for optometric 
practice recommend retinal examination methods with high diagnostic sensitivity and 
specificity for the examination of patients with diabetes. These are either dilated slit lamp 
examination or dilated retinal photography [22]. This, along with improved formal training 
could establish optometric practice as a setting for screening for diabetic retinopathy. 
However, further research is needed to evaluate the effects of formal training and 
improved diagnostic techniques on diagnostic accuracy.  
 
Based on our results (Papers I and II), we estimate that Norwegian optometrists 
undertake more than one million routine eye examinations per year, generating more 
than 60,000 referrals, 30,000 patient reports and 20,000 patient contacts to the GP. The 
rate of referrals is higher than previously reported [23]. This could be explained by 
discrepancies in the patient samples, as the previous study also included contact lens 
examinations and follow-ups, which are usually scheduled, even in healthy individuals, 
more frequently than routine eye examinations to prevent ocular complications 
associated with contact lens wear. The main causes of referral in Norwegian optometric 
practice (visual acuity, cataract, intraocular pressure, maculopathy and retinopathy) 
(Paper I), correspond with findings in the UK [166]. Our results suggest that optometrists 
make medical judgements, and that patient management depends on the optometrists’ 
evaluation of ocular findings (Paper II). This observation should raise some concern. 
Retinal microvascular changes can be related to long-term hypertension, type 2 
diabetes, impaired glucose metabolism, obesity, dyslipidemia, stroke and increased 
cardiovascular mortality [167]. Among patients with findings of vascular retinopathy and 
no known history of retinopathy or related systemic disease, one quarter of the patients 
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examined were not considered to be in need of further medical attention. This 
interpretation should, however, be treated with caution as the number of non-referrals 
were low and reasons for non-referral were not recorded. It is possible, for example, that 
a patient was not referred because they already had an upcoming medical appointment 
booked. If optometrists are taking on inappropriate medical responsibility, one possible 
explanation for it could be the lack of an established collaboration with medical 
practitioners and inadequate report and referral routines. Another explanation could be 
the lack of formal integration within the healthcare system. The reported collaboration 
with other healthcare professionals varied, with nearly one out of five optometrists stating 
that they have no collaboration with either GPs or ophthalmologists. The Norwegian 
Association of Optometrists has issued guidelines for clinical practice [22] which include 
guidelines for referral. In general, a referral should be made if the routine examination 
reveals findings which indicate that the expertise of other healthcare professionals is 
necessary to ensure best possible healthcare. Future research should address the 
awareness of, and the adherence to, these guidelines by Norwegian optometrists. 
Historically, Norwegian optometrists have referred patients directly to ophthalmologists. 
In our study (Papers I and II), the majority of referrals were to a GP. This could be 
explained by the implementation of the list system in Norwegian general practice in 
2001, which at the time of the study required referral to an ophthalmologist to be made 
by the patient’s GP. Paper I concluded that a direct referral route from optometrist to 
ophthalmologist should be established, and as of January 2009, Norwegian optometrists 
have been given the opportunity to refer directly to ophthalmologists [20]. In the hearing 
procedure of this regulation there were arguments both for and against the regulation. 
The effect of this regulation should be addressed in future health services research.  
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7.3.2 Eye examination, diabetic retinopathy and visual impairment in diabetes 
In our study (Paper III), the vast majority of patients with diabetes (78%) had their eyes 
examined according to current guidelines. Diabetes duration and having received 
information about potential eye complications were independently associated with eye 
care according to the guidelines. The proportion of patients who had been examined 
according to guidelines was significantly higher than had been previously reported in 
Norway [146], and similar or higher than found in international cross-sectional surveys of 
the general diabetic population [146, 147, 149-152]. This may reflect an actual 
improvement in the management of ocular health in patients with diabetes, in 
accordance with findings reported in studies of eye care in patients with diabetes in the 
US between 1988 and 2002 [147], in Australia between 2003 and 2005 [148] and in 
Germany between 1999 and 2008 [149]. Other current studies undertaken in Norway 
also indicate improved eye care [64, 153], although reported follow-up according to 
guidelines was lower than found in our study. This discrepancy could be explained by 
selection bias, as discussed in 7.3.5. Half of the NDA questionnaire respondents had not 
received information about the importance of regular eye examinations from their GP 
(Paper III). The vast majority of the respondents used some form of optical correction. 
Patients with diabetes are frequently examined in Norwegian optometric practice and 
case-finding of diabetic retinopathy does occur in optometric practice. Studies have 
shown that the use of eye care services in diabetes is associated with the use of health 
services in general and with health promotion campaigns [148, 150, 151]. On the one 
hand, this suggests a role for optometrists in promoting regular eye examination and 
providing education to patients with diabetes. On the other hand, the promotion of 
regular eye examination could raise questions about the motives and integrity of 
optometrists, as they have a financial interest in patients having regular eye 
examinations.  
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Our study showed a prevalence of diabetic retinopathy of 11 to 17% among patients with 
diabetes (Papers II, III and IV). This corresponds with the total prevalence of diabetic 
retinopathy reported in a small Norwegian community [68]. However, it is lower than the 
reported prevalence in population-based studies from the US, UK, Denmark and 
Australia [33, 59-62, 65] and a recent Norwegian population-based screening study 
(28%) [64]. The prevalence of diabetic retinopathy in our study is likely to have been 
underestimated as a result of bias, as described in section 7.2. Therefore, estimation of 
the prevalence of diabetic retinopathy in the general diabetic population in Norway, 
based on this study, is questionable.  
 
In general, the prevalence of visual impairment was higher among patients examined in 
optometric practice than among the sample for the HUNT study (Papers I and IV). This 
could have been a result of people who experience visual problems being more likely to 
see an optometrist than people who do not experience any symptoms and people who 
have visual problems being less likely to participate in a population study if they are 
already under the care of an ophthalmologist or optometrist. The prevalence of visual 
impairment in our study was higher in patients with diabetes than in patients without 
diabetes (Paper I). The prevalence of visual impairment and low vision is consistent with 
the lower end of population-based reported prevalences of 3.8 to 13.1% and 2.9 to 6.2%, 
respectively [59-61, 122, 125, 168]. However, we did not explore the reasons for the 
visual impairment; visual impairment caused by diabetic retinopathy in our study could 
be even lower because our findings may have included visual impairment related to 
concurrent ocular disease [59, 122]. However, the low prevalence of low vision may also 
suggest good compliance with recommended eye care among patients with diabetes in 
our study.  
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8. Implications 
Optometric practice is an easily accessible place for primary eye care in the Norwegian 
healthcare system. The routine optometric examination detects correctable visual 
impairment and under-corrected refractive error and may promote case-finding of ocular 
disease and retinal manifestations of systemic disease. However, the diagnostic 
sensitivity of the retinal examination appears to be low. Measures should be taken to 
improve diagnostic sensitivity.  
 
Optometrists probably do take on medical responsibilities, and their clinical decision 
making and referral habits should be addressed. Consensus on patient management, 
referral practice and general collaboration with GPs and ophthalmologists should be 
established to ensure best possible patient care.  
 
Further research is needed to provide estimates of the prevalence of diabetic retinopathy 
and visual impairment among patients with diabetes in Norway.  
 
In patients with diabetes, eye examination in accordance with national professional 
guidelines is associated with diabetes duration and having received information about 
potential eye complications in diabetes. Most patients with diabetes use some optical 
correction and the number of patients with diabetes examined in optometric practice is 
high. Optometric practice has the potential to develop itself into a viable setting for 
patient education and to play an important role in screening for diabetic retinopathy. 
However, for optometrists to become part of a screening programme for diabetic 
retinopathy, targeted formal optometric training and mandatory continuing optometric 
education in screening for diabetic retinopathy is required.  
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Postscript 
 
Since I began my research, the NOF has issued its clinical guidelines for optometric 
practice (2005), Norwegian optometrists have been given the opportunity to refer directly 
to an ophthalmologist (2009), and the first national professional guidelines for diabetes 
have been issued (2009). 
 
As the population grows older and the prevalence of systemic disease affecting the eye 
increases, the demand for eye care services will grow. Optometrists could provide a key 
function in primary eye care in Norway. Higher education and research are the 
foundations of professional development. The educational system must adapt to meet 
the future demands of the profession, the health authorities and the general public, as 
the scope of optometry in Norway is likely to change. The Norwegian Health Authorities, 
the optometry profession (NOF) and optometry educational establishments (such as 
Buskerud University College) have a responsibility to ensure that the competency of 
optometrists and the quality of optometric practice meet the high standards required and 
provide the necessary eye care for specific groups in the population. In the UK, where 
optometrists are a formal part of the National Health Service, specialisation and 
accreditation have been implemented for specific areas such as shared care in diabetes. 
Further optometric research should address vision and eye care in the general 
population, the quality of Norwegian optometric practice, and models for eye care in 
community health services.   
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Abstract
Background: The scope of optometry differs worldwide. In Norway the vast majority of optometrists perform
ophthalmoscopy as part of their routine examinations. The aim of this study was to describe the frequency of
suspected retinopathies in patients seen for routine optometric examination and to determine how optometrists
deal with these patients.
Methods: 212 optometrists participated in a questionnaire survey and a practice registration during November
2004 – May 2005. In the practice registration, details for 20 consecutive patient encounters were recorded. Data
were analysed by chi-square tests and multiple logistic regression.
Results: All optometrist stated that ocular history taking was an integrated part of their routine examination,
while general health and diabetes history were routinely addressed by 59% and 42% of the optometrists,
respectively. During the practice registration 4,052 patient encounters were recorded. Ophthalmoscopy was
performed in 88% of the patients, of which 2% were dilated fundus examinations. Retinopathy was suspected in
106 patients, of whom 31 did not report a previous history of ocular or systemic disease. Old age (75+),
hypertension and diabetes strongly predicted retinopathy with odds ratio (95% CI) of 6.4 (4.2 to 9.9), 3.8 (2.4 to
6.0) and 2.5 (1.4 to 4.7), respectively. Diabetic retinopathy was seen in 10% of diabetic patients and suspected in
0.2% of patients with no established history of diabetes. Retinopathy was not confirmed in 9 out 18 patients with
a history of diabetic retinopathy; seven of these had undergone laser treatment. Out of the 106 patients with
findings of retinopathy, 28 were referred to an ophthalmologist or a general practitioner (GP), written reports
were sent to a GP in 16 cases, ten patients were urged to contact their GP for further follow up, while 52 were
considered in need of routine optometric follow up only.
Conclusion: Optometric practice provides a low threshold setting for detecting cases of ocular disease and
retinal manifestations of systemic disease in the population. At present diagnosis of retinopathy in Norwegian
optometric practice is unreliable. There are potentials for improving the optometrists' routine examination, their
patient management patterns and collaboration routines with medical doctors.
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Background
The scope of optometry differs worldwide [1] and, more
specifically, in Europe [2] ranging from dispensing of
optical aids to the diagnosis and treatment of certain ocu-
lar diseases. In various countries, there is disparity in the
legal recognition of optometry as a health care profession.
Since 1988 Norwegian optometric practice has been regu-
lated by The Health Personnel Act, which is founded on
the principles of responsible conduct.
In the Scandinavian population, retinal disorders are the
most common reason for visual impairment (66%), and
in the working age population, diabetes represents a lead-
ing cause (13%) [3]. The reported prevalence of diabetic
retinopathy differs widely [4]. Most people with diabetes
will develop some degree of retinopathy, and 11–30%
will develop sight threatening retinopathy during the
course of their illness [5-9].
Studies have shown optometrists are able to detect and
grade diabetic retinopathy[10] and specially trained
optometrist perform well when screening for diabetic
retinopathy using dilated, indirect ophthalmoscopy [11-
13]. The vast majority of Norwegian optometrists perform
ophthalmoscopy as part of their routine examinations
[14], and dilated fundus examination can be undertaken
by optometrists certified to use ocular diagnostic drugs.
Norwegian optometrists with specific certification were
given the privilege to acquire and use ocular diagnostic
drugs in 2004. At the time of the study 9% of Norwegian
optometrists had this privilege, which requires approved
education in the use of ocular diagnostic drugs.
There are few studies describing diagnosis and manage-
ment of retinopathy in routine optometric practice. The
aim of this study was to establish the prevalence of possi-
ble retinopathy in diabetic and non-diabetic individuals
seen in routine optometric practice, to determine the pro-
portion of previously unknown ocular and systemic dis-
ease and, finally, to explore how optometrists deal with
such patients during everyday practice. The study did not
assess or validate the optometrists' findings.
Methods
All members of the Norwegian Association of Optome-
trists (NAO) working in optometric practice in the com-
munity were invited to participate in a questionnaire
survey. In addition, 29 practicing non-member optome-
trists who heard about the study volunteered to partici-
pate, making the total sample 790, figure 1. All
Selection of optometrists in the studyFigure 1
Selection of optometrists in the study.
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questionnaire responders (n = 508) were also asked to
take part in a practice registration. During November
2004 – May 2005, 212 Norwegian optometrists partici-
pated in both the questionnaire survey and the practice
registration. The survey has been described elsewhere
[14].
In the questionnaire, the optometrists were asked about
their education and work experience, practice habits (his-
tory taking and examination), opinions on important
principles of practice and their collaboration with general
practitioners (GPs) and ophthalmologists. In the practice
registration, each optometrist recorded the following data
for 20 consecutive patients seen for a full eye examination:
demographics, patient's history, best corrected visual acu-
ity, intra-ocular pressure, ocular diseases, and how the
patients were dealt with (e.g. referral, written report to
physicians). Data were reported by the optometrists on a
registration form. Recorded ocular diseases were: patient-
reported history of cataract, glaucoma and/or age related
macular degeneration (AMD) and suspected cataract and/
or suspected retinopathy. In Norway diagnosis of ocular
disease is not in the scope of optometric practice and the
terms suspected or possible retinopathy are used to reflect
that these are tentative diagnosis as reported by the
optometrists. Additionally patient reported history of:
hypertension, cardiovascular disease and diabetes were
recorded. In patients with history of diabetes were also
asked about type of diabetes, illness duration, treatment,
HbA1c-values, blood pressure, diabetic retinopathy, and
laser treatment.
The study was presented to Regional Committee for Med-
ical Research Ethics; the study was not regarded subject to
specific evaluation and approval. The Norwegian Social
Science Data Services were notified prior to commence-
ment of the study. A notice was posted in the consulting
room/practice notifying patients of the ongoing practice
registration. Patient data was unidentified before it was
passed on to the research team and the responding
optometrists were anonymous to the researchers.
Differences between proportions were analysed using chi-
square tests. Features associated with suspected retinopa-
thy were analysed by univariate and multiple logistic
regression. The statistical package SPSS version 12.0.2 was
used.
Results
All optometrists reported that a history of vision and ocu-
lar health was part of their routine examination. Respec-
tively, 59% and 42% of the optometrists also addressed
general health and diabetes in the patient history taking
for all patients. Ophthalmoscopy was part of the routine
examination for the majority of optometrists (96%). One
out of four optometrists was qualified to perform dilated
fundus examination. Direct ophthalmoscopy was most
frequently used (60%). One out of four reported slit lamp
indirect ophthalmoscopy as the most frequent method
and one out of ten used both direct and indirect ophthal-
moscopy in most patients.
During the practice registration, 4,052 patient encounters
were recorded, 2,216 (57%) with females. The patients'
age distribution is shown in figure 2. Among the patients,
166 had a known history of diabetes, 439 had known
hypertension, while 125 had some other known cardio-
vascular disease (hypertension excluded). In patients with
a history of diabetes, 34 reported a known history of
hypertension and 14 reported a known history of other
cardio-vascular disease (hypertension excluded).
Ophthalmoscopy was performed in 3,576 (88%) of the
patients, of which 78 (2%) were dilated fundus examina-
tions. In patients with known diabetes, ophthalmoscopy
was performed significantly more often than in non-dia-
betics (96% vs 88%, p = 0.002). Tentative retinopathy was
found in 106 (3%) patients, of whom 57 (59%) were
females. Almost half of these patients were 75 years or
older, and none were younger than 16 years. In patients
with diabetes, 35% of the possible retinopathies were
found in the age group 16–64 years. There were no statis-
tically significant differences with regard to gender, age,
and known history of hypertension and/or cardiovascular
disease between diabetic and non-diabetic patients with
findings of retinopathy.
The most common tentative diagnosis made during fun-
dus examination was macular disease (Table 1). More
than half of the patients had no previous history of AMD.
Diabetic retinopathy was suspected in 23 patients, among
whom six had no established history of diabetes and 14
had no previous history of retinopathy. In patients with
suspected hypertensive/vascular retinopathy, 10 out of 27
had no history of hypertension and/or cardiovascular dis-
ease and none had a history of diabetes.
Multiple logistic regression analysis showed that old age
(75+), hypertension and diabetes were independent pre-
dictors of retinopathy (all kinds), with odds ratio (95%
CI) of 6.4 (4.2 to 9.9), 3.8 (2.4 to 6.0) and 2.5 (1.4 to 4.7),
respectively. For vascular retinopathy only diabetes and
hypertension were independent predictors with odds
ratio (95% CI) of 7.2 (3.7 to 14.1) and 4.9 (2.6 to 9.3),
respectively.
Diabetic retinopathy was seen in 17 (10%) of the diabetic
patients, of these nine had reported history of diabetic
retinopathy. However, retinopathy was not described by
the optometrists in 9 out of 18 patients with reported his-
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Age distribution of diabetic and non-diabetic patients seen in Norwegian optometric practice compared to the age distribution of the Norwegian populationFigure 2
Age distribution of diabetic and non-diabetic patients seen in Norwegian optometric practice compared to the age distribution 
of the Norwegian population.  Diabetic patients seen in optometric practice,  Non-diabetic patients seen in optometric 
practice,  The Norwegian population.
Table 1: Clinical findings in 3,576 fundus examined encounters and management* by tentative diagnosis and history.
Optometrists' tentative diagnosis and 
patients' history
n Referral/report/patient
urged to contact doctor
No/routine optometric follow up
Diabetic retinopathy 23 12 11
No history of retinopathy 14 8 6
History of retinopathy 9 4 5
Hypertensive/vascular retinopathy 27 16 11
No history of retinopathy 26 15 11
History of retinopathy 1 1
Macular disease† 56 26 30
No history of retinopathy 31 18 13
History of retinopathy 25 8 17
All retinopathies 106 54 52
No retinopathy 3,470 385 3,085
* Fisher's Exact Test p < 0.001 between patients with findings of retinopathy and patients with no findings of retinopathy
† Fisher's Exact Test p = 0.003 between patients with retinopathy findings and known history of retinopathy and patients with retinopathy findings 
and no history of retinopathy.
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tory of diabetic retinopathy. Seven of these nine patients
reported to have undergone laser treatment. There were
no significant differences with regard to gender, age, type
of diabetes, diabetes treatment, history of hypertension or
cardiovascular disease between diabetic patients with
findings of retinopathy (n = 17) and diabetic patients with
no retinopathy (n = 147).
In total, 439 of the 3,576 (12%) fundus examined
patients were judged by the optometrists to be in need of
some medical follow up (referral, report or patient consul-
tation) of the ocular findings (Table 1).
Retinopathy was suspected in 3% of the patients seen in
optometric practice; of whom two thirds had no previous
history of retinopathy. More than half of the suspected
retinopathies were considered to be in need of some fur-
ther management by a medical practitioner. Patients with
retinopathy were more frequently prompted to contact a
physician if the retinopathy was previously unknown (41/
71 vs. 13/35, p = 0.003). The reason for non-referral of
patients with findings of retinopathies was not explored.
Discussion
In our study population, the proportion of vascular retin-
opathy seen in non-diabetics was lower than expected
according to figures reported in epidemiological studies
[15]. This could be due to the low frequency of dilated
fundus examinations in our study. Dilated indirect oph-
thalmoscopy and photographic grading have a higher sen-
sitivity than direct ophthalmoscopy in detection of retinal
abnormalities[16,17]. The low frequency of dilated fun-
dus examinations in our study can be explained by the
small number of optometrist qualified to perform dilated
ophthalmoscopy and the recent introduction of the privi-
lege to acquire and use ocular diagnostic drugs.
Reported prevalence of diabetic retinopathy varies widely.
In Scandinavia, prevalence between 13.8 and 75.1% have
been reported in people with diabetes [4], this is higher
than the proportion detected by Norwegian optometrists
in their practice. However, we do not know how well dia-
betic patients seen in optometric practice correspond with
the diabetic population in the community. The lower
number of retinopathies among diabetics seen in opto-
metric practice may reflect a selection bias; diabetic
patients should have their retinas regularly examined by
an ophthalmologist according to guidelines [18]. Diabetic
patients with retinopathies may therefore be less likely to
go to an optometrist.
Nine reported cases of retinopathy were not described by
the optometrists; however, most of these patients had
undergone laser treatment. A possible explanation may be
that scarring from laser treatment has not been regarded
as retinopathy by the optometrists. However, the retin-
opathies not detected by the optometrists and the overall
low numbers of retinopathies observed among both non-
diabetics and diabetics may also represent a poor diagnos-
tic sensitivity. Unfortunately, our data did not permit us to
validate the quality of the optometrists' diagnostic work.
The optometrists' follow-up decisions in patients with
findings of retinopathy should raise some concern. Only
one quarter of the patients with suspected vascular retinop-
athy and no known history of retinopathy or related sys-
temic disease were only considered to be in need of
optometric routine follow up. This practice is probably
not acceptable. In general, these patients should be seen
by a physician as retinal microvascular changes are related
to long-term hypertension, type 2 diabetes, impaired glu-
cose metabolism, obesity, dyslipidemia, stroke and an
increased cardiovascular mortality [19]. This may suggest
that optometrists make medical judgements and that
patient management depends on their evaluation of the
ocular findings, not solely on the patient's history. How-
ever, our numbers are low and the reason for non-referral
has not been recorded in the study, the interpretation
should therefore be considered with caution. If some
optometrists do take inappropriate medical responsibil-
ity, one possible explanation could be inadequate report
and referral routines and lack of established collaboration
with medical practitioners.
Previous studies of optometrist's effectiveness in screening
for diabetic retinopathy have revealed a specificity ranging
from 62 to 95% and a sensitivity of 70 to 87% [11-13,17]
Based on the reported prevalence of diabetic retinopathy
in the Norwegian diabetic population (13.8%) [20] and
the number of retinopathies missed (n = 9) and detected
(n = 17) by the optometrists in this study, we propose that
the diagnostic specificity must be high. It is unlikely that
report/referral of cases of suspected retinopathy will
impose undue pressure on the health care services. This is
supported by a previous study by Riise et al [21] which
concluded that 94% of referrals form Norwegian optome-
trists were clinically relevant. However, taking the low
diagnostic sensitivity into consideration suggests that the
routine examination as currently undertaken by Norwe-
gian optometrists is an unreliable method of screening for
diabetic retinopathy. Moreover, the study illustrates the
disparity of optometric practice in Europe and worldwide
with regard to training and the role in the health care sys-
tem, emphasizing the importance that health policies
decisions are founded on the practice in the community
were the policy will be employed.
Some limitations of the study should be taken into con-
sideration. First, as compared to the non-participants, the
optometrists who took part in this study tended to be
BMC Health Services Research 2008, 8:38 http://www.biomedcentral.com/1472-6963/8/38
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younger, more were females, and they had in general
higher education and worked in smaller communi-
ties[14]. Hence their frequency of retinal examinations,
method of ophthalmoscopy and collaboration habits
may differ from that of the non-participants. Second,
practice registration data was recorded for consecutive
patients to avoid selection bias, however, the reported
patient histories relied on patients' self-report and mem-
ory recall. Third, the practice registration may have influ-
enced the way the optometrists performed their routine
examination. Finally, we did not observe the optometrists'
work and their conclusions were not verified.
Conclusion
Optometric practice is a low threshold setting for case-
finding of ocular pathology and retinal manifestations of
systemic disease in the population. At present, the diagno-
sis of retinopathies in Norwegian optometric practice is
unreliable. There are potentials for improving the optom-
etrists' routine examination, their patient management
patterns and collaboration routines with medical doctors.
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Abstract
Background: Regular examination and early treatment of diabetic retinopathy can prevent visual
loss. The aim of the study was to describe the care of vision and ocular health in people with
diabetes in Norway.
Methods: A cross-sectional questionnaire survey of a random sample (n = 1,887) of the
Norwegian Diabetic Associations' (NDA) members was carried out in 2005. Questions were asked
about care of vision and ocular health, history of ocular disease and visual symptoms, general
medical history and diabetes management. The study was approved by the Regional Committee for
Medical Research Ethics.
Results: The response rate was 74%. Forty-four questionnaires with incomplete data regarding
gender, age or type of diabetes were excluded, leaving 1352 cases (52% females) for analysis. 451
(33%) had type 1 and 901 (67%) had type 2 diabetes, the mean duration of diabetes was
respectively, 22 (sd ± 14) and 10 (sd ± 9) years. In all 1,052 (78%) had their eyes examined
according to guidelines and 1,169 (87%) confirmed to have received information about regular eye
examinations. One in two recalled to have received such information from their general
practitioner. To have received information about the importance of eye examinations (PR 3.1, 95%
CI 2.4 to 4.0), and diabetes duration > 10 years (PR 1.2, 95% CI 1.2 to 1.3), were independently
associated with reporting regular eye examinations. A history of diabetic retinopathy was reported
by 178 (13%) responders, of which 101 (57%) reported a history of laser treatment. Responders
who had regular eye examinations reported more frequently a history of diabetic retinopathy (19%
vs. 5%, p < 0.001). The frequency of retinopathy was significantly higher in responders with
reported HbA1c values above treatment target (23% vs. 13%, p = 0.001). However, in responders
who were not regularly examined, there was no difference in reported frequency of retinopathy
with regard to HbA1c level.
Conclusion: Eight out of ten diabetic members of the NDA had their eyes examined according to
current guidelines and the majority was well informed about the risk of vision loss due to diabetes.
The results indicate that the reported history of diabetic retinopathy likely underestimates the
prevalence of retinopathy.
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Background
In Western societies, diabetic retinopathy is one of the
leading causes of visual impairment and blindness in the
working age group [1-3]. The prevalence of diabetic retin-
opathy in Norway is sparsely described in the literature
[4,5]. It is estimated that 90–120,000 Norwegians have
known diabetes and that probably just as many have
undiagnosed diabetes [6]. Most diabetic patients will
develop some degree of retinopathy. Studies indicate that
between 6% and 30% will develop sight threatening retin-
opathy during the course of their illness [7-14]. In West-
ern Europe, diabetic retinopathy accounts for 4.7–13.3%
of the blind and partial sight registrations [3,15-17]. Reg-
ular examination of ocular health and early treatment of
diabetic retinopathy can prevent most cases of visual loss
[18-22], and ophthalmologic screening of patients with
diabetes is more cost-effective than many other health
interventions for detecting and treating disease [21,23].
The Norwegian College of General Practitioners has pub-
lished guidelines for examination of ocular health in
patients with diabetes, first issued in 1988 [24]. Table 1
shows the Norwegian practice guidelines compared to
practice guidelines in the United Kingdom, USA and Aus-
tralia. In 1996 only 53% of diabetic patients seen in gen-
eral practice were managed according to these guidelines
[25,26].
The aim of this study was to describe and analyse the care
of vision and ocular health among people with diabetes in
Norway. Secondly, we wanted to explore their sources of
information regarding ocular care. Finally we liked to
assess the reported care in relation to established practice
guidelines and to identify features associated with good
practice.
Methods
The study had a cross-sectional design. A random sample
of persons with diabetes, drawn from the member list of
the Norwegian Diabetes Association (NDA), was invited
to participate in a questionnaire survey. At the time of the
study, NDA was the only national registry of adults with
diabetes. NDA is a voluntary, independent organization
with the objective of serving people with diabetes and
others who have an interest in diabetes. In 2005 NDA had
35,058 members, including mainly people with diabetes,
some of their relatives (about 900), and around 3,000
health care professionals. The type of diabetes was not
recorded in the NDA membership registry. A random
sample comprising about 6% of NDA members 18 years
and older was drawn by computer from the NDA mem-
bership registry. They were subsequently sent a postal
questionnaire in October-December 2005. Non-diabetics,
deceased members and members with unknown address
or living abroad were excluded, leaving an eligible sample
of 1,887. Information about the study, the voluntary
nature of participation, confidentiality and study
approval were given on the front page of the question-
naire and the return of a completed questionnaire was
regarded as written consent. Reminders were sent once to
all participants. The questionnaire had been assessed in a
pilot survey. This pilot survey led to the inclusion of a
question regarding source of information about the
importance of regular eye examinations. The question-
naire included questions about care of vision and ocular
health, history of ocular disease and visual symptoms, as
well as details about type of diabetes, year of diagnosis,
treatment, blood glucose stability, most recently recorded
HbA1c and blood pressure, antihypertensive and choles-
terol lowering medication, and current and previous
Table 1: Practice guidelines for HbA1c treatment target and management of ocular health in patients with diabetes.
Norway* United Kingdom† USA‡ Australia§
HbA1c treatment target
Children/Type 1 < 18 years < 7.5% < 7%
Type 1 > 18 years < 7.5% < 7%
Type 2 6.5–7.5% < 7%
Younger (<80 years) < 7% < 7%
Older (>80 years) < 9% < 7%
Screening for diabetic retinopathy
First examination
Children/Type 1<18 years At age 12 years At puberty
< 30 years/Type 1 5 years after diagnosis At diagnosis 5 years after diagnosis At diagnosis
> 30 years/Type 2 At diagnosis At diagnosis At diagnosis At diagnosis
Follow-up in absence of retinopathy
Children/Type 1 < 18 years Annually Annually At least biannually
< 30 years/Type 1 Annually Annually Annually At least biannually
> 30 years/Type 2 Annually/Biannually Annually Annually At least biannually
Follow-up in retinopathy Individual Individual Individual Individual
Norwegian practice guidelines compared to practice guidelines in the United Kingdom, USA and Australia at the time (2005) of the study.
*The Norwegian College of General Practitioners, †National Institute for Clinical Excellence, ‡American Diabetes Association, §National Health and 
Medical Research Council
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smoking. In the questionnaire, regular examination was
defined as examination at regular intervals, e.g. yearly,
every six months or monthly. Furthermore, eye examina-
tion and vision examination was defined as examination
of the back of the eye/retina and examination of sight,
respectively. The specific questions on eye examination
were: "Do you have your eyes regularly examined due to
your diabetes?" and "In general, how long time is it
between the eye examinations?".
In 2001 a list system was implemented in Norwegian gen-
eral medical practice, implying that all citizens were listed
with one particular general practitioner (GP). In this sys-
tem the GP has the primary responsibility for the manage-
ment and follow-up of patients with diabetes. Referral to
a specialist (ophthalmologist) must be made by a GP. The
Norwegian College of General Practitioners guidelines
[26] were used as standard of patient care for comparison
with reported care (Table 1).
Data analysis was performed with the statistical package
SPSS version 13.0. Questionnaires with missing data for
gender, age or type of diabetes, or diabetes other than type
1 and type 2 (3%) were excluded from analysis. The data
were analysed in frequency and summation tables; group
differences were analysed using student-t, chi-square and
Fisher's exact tests. A p-value < 0.01 was considered statis-
tically significant. Features associated with known history
of diabetic retinopathy, visual symptoms, regular follow
up and lack of eye examination were analysed by univari-
ate and multiple logistic regression. Variables with p 
0.25 from the univariate analyses were entered into the
logistic regression models. Additionally, the prevalence
rate ratios (PR) were calculated for features associated
with regular eye examination and history of diabetic retin-
opathy to provide a natural intelligible effect measure and
to allow for comparison to the prevalence odds ratios
(POR).
Data were collected anonymously and the study was
approved by the Regional Committee for Medical
Research Ethics.
Results
The total number of responders was 1,396 (74%). Forty-
four questionnaires had missing information regarding
either age, gender, type of diabetes or diabetes other than
type 1 and type 2. The study is based on the remaining
1,352 cases, 699 (52%) were females. In all, 451 (33%)
responders had type 1 diabetes and 901 (67%) had type 2
diabetes. Table 2 shows basic demographic and medical
data of the responders.
In all, 1,141 (85%) of the responders had their eyes regu-
larly examined. Of these 1,052 (92%) were examined
according to recommended follow up schedule. Only 6%
reported never to have had their eyes examined. In per-
sons with type 1 diabetes, 88% (358/407) were examined
annually or more frequently: respectively 2%, 15%, 3%
and 69% were examined every 1–3 months, 4–6 months,
7–9 months and 10–12 months. In persons with type 2
diabetes, 98% (694/711) were examined biannually or
more frequently: respectively 2%, 13%, 1%, 63% and
18% were examined every 1–3 months, 4–6 months, 7–9
months, 10–12 months and 12–24 months. The time of
the first examination was in accordance to guidelines in
31% of responders with type 1 diabetes and in 47% of
responders with type 2 diabetes (Table 3). For all respond-
ers, the median interval between eye examinations was 12
months (65%). Eight-teen percent were regularly exam-
ined more frequently. In total, 1,169 (87%) responders
confirmed to have received some information about the
importance of having their eyes regularly examined due to
their diabetes. Responders who had their eyes examined
according to guidelines were more than twice as likely to
have received such information than responders who did
not undergo regular eye examinations (95% vs. 42%, p <
0.001). Having received information about the impor-
tance of eye examinations, and diabetes duration of more
than 10 years, were both independently associated with
regular eye examinations (Table 4).
Spectacles and/or contact lenses were used by 1,188
(88%) of the responders. The vision was regularly exam-
ined in 1,045 of the responders who used optical correc-
tion. This was significantly more frequent than among
responders who did not use optical correction (88% vs.
71%, p < 0.001). However, there was no significant differ-
ence in the frequency of eye examinations between the
groups. During the previous year, 611 (45%) of the
responders had experienced some kind of visual prob-
lems. Nearly two in five reported to be helped by optical
correction.
Visual problems due to diabetes were reported by 156
(12%) responders. A history of laser treatment of ocular
disease related to diabetes was reported by 81% of the
responders with visual problems related to diabetes and
known history of diabetic retinopathy. In all, 178 (13%)
reported a history of diabetic retinopathy, of these 101
(57%) also reported a history of laser treatment. Diabetic
retinopathy was associated with type 2 diabetes, diabetes
duration >10 years, use of oral anti-diabetic agents, use of
insulin, HbA1c above 7%, unstable blood glucose levels
and the use of anti-hypertensive medication. In a multi-
variate logistic regression analysis diabetes duration was
the only reported factor independently associated with a
history of diabetic retinopathy. The prevalence of diabetic
retinopathy was higher in patients with diabetes duration
longer than 10 years, than in patients with shorter disease
BMC Health Services Research 2008, 8:159 http://www.biomedcentral.com/1472-6963/8/159
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duration prevalence ratio (95% CI) of 3.5 (2.5 to 5).
Moreover, a history of diabetic retinopathy was more fre-
quently reported by responders who had their eyes regu-
larly examined (Table 5).
Discussion
The vast majority of persons with diabetes responding to
this survey had their eyes examined according to guide-
lines advised by the Norwegian College of General Practi-
tioners [26], Table 1. Diabetes duration and having
received information about potential eye complications
were independently associated with eye care management
according to the guidelines.
Compared to cross-sectional surveys of the general dia-
betic population in UK, Australia and the United States
[27-30] the number of persons with diabetes who had
their eyes examined according to guidelines was equal or
higher in our study. Furthermore, the proportion who had
been examined according to guidelines (78%) were
noticeably higher than (53%) reported in a previous Nor-
wegian survey from 1996 [25]. Our study may reflect an
actual improvement in the management of ocular care in
Table 2: Demographic and medical characteristics of responders with type 1 and type 2 diabetes (n = 1,352), n (%)
All patients 
(n = 1,352)
Type 1 
(n = 451)
Type 2 
(n = 901)
Sex distribution
Female 699 (51.7) 247 (54.8) 452 (50.2)
Male 653 (48.3) 204 (45.2) 449 (49.8)
Age distribution*
< 20 years 7 (0.5) 6 (1.3) 1 (0.1)
21–30 years 55 (4.1) 54 (12.0) 1 (0.1)
31–40 years 108 (8.0) 87 (19.3) 21 (2.3)
41–50 years 185 (13.7) 106 (23.5) 79 (8.8)
51–60 years 315 (23.3) 91 (20.2) 224 (24.9)
61–70 years 349 (25.8) 71 (15.7) 278 (30.9)
71–80 years 261 (19.3) 30 (6.7) 231 (25.6)
81–90 years 72 (5.3) 6 (1.3) 66 (7.3)
Mean age (sd) 59 (± 15) 48 (± 15) 64 (± 11)
Mean duration of diabetes (sd)‡ 14 (± 12) 22 (± 14) 10 (± 9)
Mean HbA1c at last diabetes follow up (sd)§ 7.3 (± 1.2) 7.5 (± 1.0) 7.1 (± 1.3)
HbA1c within guideline treatment target*,§
All patients (HbA1c <7%/<9% depending on age) 461 (41.2) 107 (26.4) 354 (49.6)
Patients = 80 years (HbA1c <7%) 420 (39.1) 103 (25.6) 317 (47.2)
Patients > 80 years (HbA1c <9%) 41 (87.2) 4 (100) 37 (86.0)
Stable blood glucose level previous year&#x2225; 845 (63.9) 258 (58.6) 587 (66.6)
Diabetes treatment*
Diet (n = 757) 668 (88.2) 129 (66.2) 539 (95.9)
Exercise (n = 657) 536 (81.6) 112 (59.6) 424 (90.4)
Weight reduction (n = 430) 197 (45.8) 16 (10.4) 181 (65.6)
Oral medication (n = 771) 564 (73.2) 16 (10.3) 548 (89.1)
Insulin (n = 896) 742 (82.8) 443 (99.8) 299 (66.2)
Blood pressure and cholesterol medication*
Blood pressure (n = 1,337) 687 (51.4) 142 (31.6) 545 (61.4)
Cholesterol (n = 1,324) 591 (44.6) 123 (27.7) 468 (53.2)
Smoking
Present smoker† (n = 1,345) 203 (15.1) 88 (19.6) 115 (12.8)
Previous smoker (n = 1,306) 716 (54.8) 216 (50.2) 500 (57.1)
Known history of ocular disease
Cataract* (n = 1,019) 261 (25.6) 63 (17.2) 198 (30.4)
Diabetic retinopathy* (n = 1,058) 182 (17.2) 91 (23.3) 91 (13.6)
Glaucoma* (n = 905) 93 (10.3) 14 (4.2) 79 (13.8)
Age-related macula degeneration† (n = 857) 35 (4.1) 6 (1.9) 29 (5.4)
Hypertensive/occlusive vascular retinopathy (n = 851) 19 (2.2) 3 (0.9) 16 (3.0)
Laser treated diabetes related ocular disease¶
History of diabetic retinopathy reported 105 (10.0) 57 (14.7) 48 (7.2)
History of diabetic retinopathy not reported* 19 (1.8) 7 (1.8) 12 (1.8)
Pearson chi-square *p < 0.001 and †p < 0.01 between type 1 and type 2 diabetics.
Data missing for ‡31,§ 232, &#x2225;30 and ¶300 responders
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people with diabetes in Norway. Improved eye care in
people with diabetes has also been reported in the United
States (1988–2002) and Australia (2003–2005) [28,31].
Unpublished data from a study undertaken in Norwegian
general practice in 1999/2000 revealed that three out of
four patients with diabetes were managed according to
current guidelines (Tor Claudi 2007, personal communi-
cation), indicating an improvement of care compared to
1996 [25]. The improved care could be explained by
increased focus on diabetes as a modern epidemic,
Table 3: Information about eye examination and frequency of eye and vision examination (n = 1,352), n (%)
All patients 
(n = 1,352)
Type 1
 (n = 451)
Type 2
 (n = 901)
Informed about the importance of eye examination*/‡,§ 1,169 (86.8) 433 (96.2) 736 (82.1)
Source of information not mutually exclusive*
General practitioner§ 678 (58.0) 205 (47.3) 473 (64.3)
Ophthalmologist 515 (44.1) 202 (46.7) 313 (42.5)
Hospital§ 338 (28.9) 224 (51.7) 114 (15.5)
Other medical practitioner§ 114 (9.8) 95 (21.9) 19 (2.6)
Optometrist 93 (8.0) 41 (9.5) 52 (7.1)
Leaflets/Journal of the Norwegian Diabetes Association&#x2225;,§ 298 (25.5) 136 (31.4) 162 (22.0)
Diabetes patient education course 218 (18.6) 77 (17.8) 218 (18.6)
Media 68 (5.8) 24 (5.5) 44 (6.0)
Other persons with diabetes§ 94 (8.0) 47 (10.9) 47 (6.4)
First eye examination after diagnosis†,§
Within 1 year 538 (40.3) 121 (26.9) 417 (47.1)
Within 1–5 years 433 (32.5) 138 (30.7) 295 (33.3)
After more than 5 years 221 (16.6) 140 (31.2) 81 (9.2)
Never examined 74 (5.5) 6 (1.3) 68 (7.7)
Unsure 68 (5.1) 44 (9.8) 24 (2.7)
Regular eye examination reported by one or more methods‡,§
Eye examination by one or more methods 1,141 (85.4) 416 (92.7) 725 (81.7)
Examination by ophthalmologist 965 (84.6) 339 (81.5) 626 (86.3)
Fundusphotography 443 (38.8) 202 (48.6) 241 (33.2)
Examination by optometrist 90 (7.9) 30 (7.2) 60 (8.3)
Examination by general practitioner 21 (1.8) 6 (1.4) 15 (2.1)
Regular vision examination reported by one or more methods
by one or more methods 1,161 (85.9) 386 (85.6) 775 (86.0)
by ophthalmologist 979 (84.3) 330 (85.5) 649 (83.7)
by optometrist 252 (21.7) 84 (21.8) 168 (21.7)
by other health care provider 33 (2.8) 18 (4.7) 15 (1.9)
by medical doctor 29 (2.5) 8 (2.1) 21 (2.7)
Missing data for *5,†18, ‡16 responders.
Pearson chi-square § p < 0.001 between type 1 and type 2 diabetics.
&#x2225; Journal of the Norwegian Diabetes Association
Table 4: Characteristics associated with regular eye examination in patients with diabetes
Characteristic 
(association)
Eye exam (%) in 
group with 
characteristic
Eye exam (%) in 
group without 
characteristic
Crude 
prevalence ratio 
(95% CI)
Crude odds 
ratio (95% CI)
Adjusted* odds 
ratio (95% CI)
P value*
Information on eye 
examination
93.0 29.7 3.1 (2.4 to 4.0) 31.5 
(20.7 to 48.1)
27.4 (16.7 to 44.8) <0.001
Diabetes duration > 
10 years
93.5 75.0 1.2 (1.2 to 1.3) 4.8 (3.4 to 6.8) 3.1 (2.0 to 5.1) <0.001
Visual problems 
related to diabetes
97.4 84.5 1.6 (1.1 to 1.2) 6.9 (2.5 to 19.1) 3.6 (1.2 to 10.6) 0.024
Using one or more 
optical corrections
85.9 81.5 1.1 (1.0 to 1.1) 1.4 (0.5 to 1.1) 1.5 (0.8 to 2.9) 0.234
Type of diabetes 
(Type 1)
92.7 81.7 1.1 (1.1 to 1.2) 0.3 (0.2 to 0.5) 0.9 (0.5 to 1.7) 0.842
*Multivariate logistic regression analysis
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increased professional knowledge about clinical guide-
lines, increased patient knowledge, and the coverage of
diabetes in mass media. However, the observation may
also to some extent reflect selection; the responders in our
study were members of the NDA and their rate of regular
eye examination is probably higher than in the general
diabetic population due to a higher interest in own health
and more exposure to patient education materials. More-
over, the overrepresentation of persons with type 1 diabe-
tes and persons with long term illness are probably other
important explanations for the high compliance with the
screening programme. Additionally, self-reports may
overestimate the frequency of eye examinations due to
recall bias, telescoping and social acceptance[32].
Utilization of eye care services is associated with the uses
of health services in general, and with health promotion
campaigns [27,29,31]. The fact that half of the patients
had not received information about the importance of
regular eye examinations by their GP and that not all
patients had their eyes examined according to practice
guidelines, suggest that there are still potentials for
improving the quality of care. Almost 90% of the respond-
ers in our study used some form of optical correction and
diabetic patients are frequently seen in Norwegian opto-
metric practice [33]. This suggests a role for optometrists
in promoting regular eye examinations in diabetes
patients. Moreover, the quality of ocular care can proba-
bly be improved by strengthening the optometrist-GP
communication ensuring that optometrists regularly
inform the GP about significant ocular findings (e.g. retin-
opathy in patients with diabetes) and also about patients
who are not regularly examined. This could be achieved
through continuing education of Norwegian optometrists
and professional awareness campaigns.
The prevalence of known history of diabetic retinopathy
among the responders corresponds with the total preva-
lence of diabetic retinopathy reported in a small Norwe-
gian community, the Eigersund study [4]. However, it is
lower than the reported prevalence in recent Danish stud-
ies [34,35]. On the other hand, the rate of responders with
a history of laser treatment of ocular complications due to
diabetes (three out of five) corresponds well with the fig-
ures in the Danish studies. The Danish studies are based
on clinical examination rather than on self-reports. If we
assume corresponding criteria for laser treatment in Nor-
way and Denmark, this suggests an underestimation of
the prevalence of diabetic retinopathy in our sample,
maybe due to lack of knowledge about the presence of
non-sight-threatening diabetic retinopathy among
responders.
Tight control of blood glucose and blood pressure reduces
the risk of progression towards sight threatening disease
[36] and visual outcome in patients with diabetes is
related to regular eye examination [22]. In our study, the
rate of established diabetic retinopathy was four times
higher in responders who had their eyes regularly exam-
ined as compared to those who did not attend regular eye
examinations. Among responders who had their eyes reg-
ularly examined, the frequency of retinopathy was nearly
twice as high among those who reported HbA1c values
above treatment target. In responders who did not have
their eyes regularly examined, however, the reported fre-
quency of retinopathy was the same for both patients with
HbA1c above and within treatment target. This further
adds to the assumption of a probable underestimation of
diabetic retinopathy in our population, not only due to
lack of patient knowledge, but also due to lack of regular
eye examinations.
The relatively high response rate implies that our findings
are representative for diabetes members of the NDA. An
important limitation is that the findings from this NDA
membership survey cannot be directly extrapolated to the
general diabetes population in Norway. The probable
underestimation of diabetic retinopathy prevalence even
in this patient group, may suggest that the underrecogni-
tion may be even larger in the general diabetes popula-
tion. However, we did not verify whether the reported eye
examination and medical history corresponded with
medical records.
Conclusion
The majority of diabetic members of NDA has their eyes
examined according to existing guidelines and are well
aware of the risk of vision loss due to diabetes. The
Table 5: History of diabetic retinopathy as reported by diabetic patients (n = 900) by blood glucose level* and eye examination, n (%)
Known history of diabetic retinopathy No history of diabetic retinopathy
Regular eye examination†
HbA1c within treatment target 39 (12.9) 264 (87.1)
HbA1c above treatment target 113 (23.3) 371 (76.7)
No regular eye examination
HbA1c within treatment target 3 (5.5) 52 (94.5)
HbA1c above treatment target 3 (5.3) 54 (94.7)
*HbA1c in accordance with treatment target level given in the Norwegian College of General Practitioners' guidelines.
† Pearson chi-square p = 0.001 between persons with HbA1c within and person with HbA1c above treatment target.
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reported prevalence of diabetic retinopathy is probably
underestimated due to lack of knowledge about estab-
lished retinopathy and undiagnosed diabetic retinopathy
among the responders indicating a potential for improve-
ment in care.
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Abstract  
Background 
In the working age group, diabetic retinopathy is a leading cause of visual 
impairment. Regular eye examinations and early treatment of retinopathy can prevent 
visual loss, so screening for diabetic retinopathy is cost-effective. Dilated retinal 
digital photography with the additional use of ophthalmoscopy is the most effective 
and robust method of diabetic retinopathy screening. The aim of this study was to 
estimate the sensitivity and specificity of diabetic retinopathy screening when 
performed by Norwegian optometrists.  
Methods 
This study employed a cross-sectional experimental design. Seventy-four optometrists 
working in private optometric practice were asked to screen 14 single-field retinal 
images for possible diabetic retinopathy. The screening was undertaken using a web-
based visual identification and management of ophthalmological conditions (VIMOC) 
examination. The images used in the VIMOC examination were selected from a 
population survey and had been previously examined by two independent 
ophthalmologists. In order to establish a “gold standard”, images were only chosen for 
use in the VIMOC examination if they had elicited diagnostic agreement between the 
two independent ophthalmologists. To reduce the possibility of falsely high 
specificity occurring by chance, half the presented images were of retinas that were 
not affected by diabetic retinopathy. Sensitivity and specificity for diabetic 
retinopathy was calculated with 95% confidence intervals (CIs). 
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Results 
The mean (95% CI) sensitivity for identifying eyes with any diabetic retinopathy was 
67% (62% to 72%). The mean (95% CI) specificity for identifying eyes without 
diabetic retinopathy was 84% (80% to 89%). The mean (95% CI) sensitivity for 
identifying eyes with mild non-proliferative diabetic retinopathy or moderate non-
proliferative diabetes was 54% (47% to 61%) and 100%, respectively. Only four 
optometrists (5%) met the required standard of at least 80% sensitivity and 95% 
specificity that has been previously set for diabetic retinopathy screening 
programmes. 
Conclusions 
The evaluation of retinal images for diabetic retinopathy by Norwegian optometrists 
does not meet the required screening standard of at least 80% sensitivity and 95% 
specificity. The introduction of measures to improve this situation could have 
implications for both formal optometric training and continuing optometric 
professional education. 
Keywords 
Diabetic retinopathy, optometrist, sensitivity, specificity, retinal images, case finding, 
screening 
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Background  
Approximately 90,000 to 120,000 Norwegians have known diabetes [1], among 
whom reported prevalence of diabetic retinopathy (DR) ranges from 11% to 28% [2-
5]. In the working age group, DR is a leading cause of visual impairment [6]. Among 
people with diabetes, 1% to 13% develop sight-threatening diabetic retinopathy 
(STDR) and 0.4% to 1.3% are visually impaired because of DR [7-13]. Regular eye 
examinations and early treatment of retinopathy can prevent visual loss [9, 14-16], so 
screening for DR is cost-effective [17]. Dilated retinal digital photography with the 
additional use of ophthalmoscopy is the most effective and robust method of DR 
screening [18, 19]. In Norway, the national guidelines for diabetes [20] and The 
Norwegian College of General Practitioners [21] recommend either regular eye 
examinations by an ophthalmologist or the use of retinal photography., The 
Norwegian Association of Optometry has issued clinical guidelines for optometric 
practice [22] which include guidelines for the examination and management of 
patients with diabetes. 
 
People with diabetes are commonly examined in optometric practice due to having 
refractive errors. Norwegian optometric practice may represent a low threshold setting 
for case-finding of DR [23]. Studies in other countries have shown that optometrists 
are able to detect and grade DR [24] and specially trained optometrists perform well 
when screening for STDR (sensitivity 73%-97% and specificity 83%-99%) [25-29]. 
Since 1988, the profession in Norway has developed from being populated by 
opticians to being an approved healthcare profession, populated by optometrists. 
Consequently, Norwegian optometrists are a heterogeneous group with regard to 
formal education [30]. In 2004, optometrists were granted the right to prescribe 
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diagnostic ocular drugs and since 2009 they have been able to refer patients directly to 
an ophthalmologist, without the patient first seeing a gate-keeping general practitioner 
(GP). These two responsibilities warrant a high standard of performance on the part of 
the optometrist.  
 
Sensitivity and specificity define the ability of a clinical test to correctly identify 
people with and without a specific disease. For low prevalence diseases, a high 
specificity is required to avoid large numbers of false positive results. The British 
Diabetic Association (now Diabetes UK) has set a required screening standard for DR 
of at least 80% sensitivity and 95% specificity [31]. The aims of the current study 
were to assess the sensitivity and specificity of the optometrists’ diagnosis of DR and 
to assess sensitivity and specificity with respect to the optometrists’ formal education. 
Furthermore, we wanted to investigate how the optometrists intended to follow up 
their cases.   
  
Methods 
A cross-sectional experimental design was employed. The study population, from 
which study participants were drawn, comprised authorized optometrists in Norway 
(n≈1850). Members of the Norwegian Association of Optometry (NOF) (n=1028) 
were invited to participate by e-mail. Only those optometrists who were currently 
working in private practice, who had worked in private practice for the previous 6 
months and who intended to continue working in private practice for the following 6 
months were eligible for inclusion in the study.  
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Those optometrists who responded positively to our e-mail and were subsequently 
accepted for inclusion in the study were sent an interactive web-based visual 
identification and management of ophthalmological conditions (VIMOC) examination 
that used Question Writer 4 software. A VIMOC examination tests clinical 
competency using cases and/or images with accompanying multiple choice questions 
[32]. The examination consisted of 14 retinal images which the optometrists were to 
assess with respect to the presence or absence of DR, without grading severity. 
Additionally, they were to decide on patient management, based solely on retinal 
findings and making the assumption that the patient had never been examined by an 
ophthalmologist. No grading scales or patient management guidelines were provided 
and the optometrists were not given any patient information, such as visual acuity 
data. It was possible to move back and forth in the VIMOC exam to review the 
images and revise prior assessments before submitting a final response. In addition, a 
questionnaire was included to gather information regarding the participants’ work 
experience, education, preferred method of retinal examination, methods used for 
retinal examination in patients with diabetes, and methods available to them for 
retinal examination and imaging. Optometrists used their own computers with screen 
resolution and colour set to maximum. Screen resolution ranged from 1024x600 to 
2560x1440 pixels.  
 
The study followed the tenets of the Declaration of Helsinki for research involving 
humans and was approved by the Regional Committee for Medical Research Ethics. 
The VIMOC retinal images were obtained from a previous Norwegian population 
survey [2]. Blinded to patient information, all images had been independently 
assessed by two ophthalmologists who graded the presence of retinopathy according 
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to the Diabetic Retinopathy Disease Severity Scale [33]. The ophthalmologists 
viewed the images on a 21” monitor with screen resolution of 1600x1200 pixels. 
From a total of 239 images, only those that had been graded with full agreement 
between the two ophthalmologists (n=217) were considered for inclusion in our study. 
Seven images of retinas affected by non-proliferative diabetic retinopathy (NPDR) 
and seven images of retinas unaffected by DR were randomly selected. The DR 
images included five examples of mild NPDR (Figure 1) and two examples of 
moderate, potentially sight threatening NPDR (Figure 2). To reduce the possibility of 
falsely high specificity occurring by chance, half of the presented images were of 
retinas that were not affected by DR. The diagnoses of the two ophthalmologists for 
each image were used as a “gold standard” against which the performance of the 
study participants was assessed. 
 
The required sample size of participants was calculated based on the following: 50% 
prevalence of DR in the image sample, a standard deviation of true sensitivity and 
specificity for individual optometrists’ image evaluation of 0.2, and 50% sensitivity 
and specificity for detecting DR by individual optometrists to allow maximum 
variance. It was calculated that a CI < 0.05 for sensitivity and specificity for any 
diabetic retinopathy (ADR) could be achieved with 100 study participants, meaning 
that sensitivity and specificity was calculated with 95% confidence interval for any 
retinopathy. Study participants were not asked to grade DR; the sensitivity of mild 
and moderate NPDR was assessed in terms of detection of retinopathy in images with 
mild and moderate NPDR, respectively. The screening standard established by the 
British Diabetic Association (Diabetes UK) of at least 80% sensitivity and 95% 
specificity for ADR [31] was used as the screening standard in our study. Potential 
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associations between test performance and formal education were investigated and 
analysed using Pearson Chi-square and student-t tests; a p-value ≤ 0.05 was regarded 
as significant.  
 
Data were collected in the period between 28th February and 14th March 2011; 
reminders requesting participants to complete the test were sent once. 
 
Results  
In all, 112 (11%) members of NOF responded positively to the e-mail and volunteered 
to participate in this study. Of these 112, 101 (90%) met the inclusion criteria, and 74 
(73%) completed the study. Participants were generally educated to a higher level 
than the average for Norwegian optometrists (Table 1).  
 
The optometrists’ preferred methods of retinal examination were reported to include 
undilated indirect ophthalmoscopy (47% of participants) and undilated retinal fundus 
photography (34% of participants). Multiple examination methods were reported for 
patients with diabetes (Table 2). Twenty-three percent of participants reported that 
they undertook dilated retinal examinations in patients with diabetes. 
 
The optometrists’ assessments of each of the 14 VIMOC images are presented in 
Table 3. Optometrists with higher optometric education (a Master of Science in 
clinical optometry [MSc]) demonstrated significantly higher sensitivity than those 
who had a basic optometric education (Table 4). The specificity was not influenced by 
the optometrist education level. 
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No association was found either between sensitivity or specificity and the number of 
years of experience in optometric practice, or between sensitivity or specificity and 
the participants’ preferred method of retinal examination. The screening standard for 
sensitivity of at least 80% and specificity of at least 95%, for ADR, was met by 24 
(32%) and 31 (42%) optometrists, respectively, overall. The standards for sensitivity 
and specificity were met by 50% and 45%, respectively, of optometrists who held an 
MSc and by 25% and 39%, respectively, who had a basic optometric education. Only 
four optometrists (5%) met the required standard for both sensitivity and specificity. 
 
Patient management decisions were dependent on retinal findings (Table 5). 
Report/referral to a GP and/or an ophthalmologist was regarded as appropriate for 
99% and 96% of true- and false-positive findings, respectively. The rate of referral to 
an ophthalmologist was higher for moderate than for mild NPDR (92% vs. 62%). No 
further management was considered appropriate in 68% and 66% of cases of true- and 
false-negative findings, respectively.  
 
Discussion  
Only 5% of the responding optometrists satisfied the screening standard established 
by the British Diabetic Association of at least 80% sensitivity and 95% specificity 
[31]. Overall, sensitivity for detecting ADR was low and specificity was moderate. 
Sensitivity for detecting potential STDR was, however, high. This suggests that the 
optometrists’ assessment of retinal images is an unreliable method of screening for 
DR. The sensitivity and specificity of detection of DR in the current study and 
previous studies is presented in Table 6. It is not possible to make a direct comparison 
between the current study and previous studies that involved community optometrists 
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[28, 34], as those studies did not report sensitivity and specificity levels for individual 
optometrists. However, based on the reported mean levels of sensitivity and 
specificity, it is unlikely that individual optometrists in those studies would have met 
the British Diabetic Association screening criteria. The sensitivity for detecting ADR 
in our study (67%) was lower than that reported by Gibbins et al. (86-88%) [28]. 
However, the sensitivity for detecting STDR was higher in our study than in either the 
Gibbins et al. or Buxton et al studies (100% vs. 47-97%) [28, 34] and the specificity 
was similar (84% vs. 83-95%). The greater sensitivity for detecting STDR in the 
current study could have been a result of the higher prevalence of STDR in our 
VIMOC sample compared with these earlier studies, which may have inflated 
sensitivity by chance. The prevalence of ADR in our study was comparable with the 
prevalence of ADR in the study by Gibbins et al. [28]. In that study, optometrists had 
received special training in the identification and grading of DR, which could explain 
the relatively high sensitivity levels observed.  
 
We have found that sensitivity, but not specificity, was influenced by the level of 
formal education the participants had received. Optometrists with an MSc had a 
significantly higher sensitivity than optometrist with a basic optometric education. 
This suggests that our results give a better estimate of sensitivity and specificity in 
general optometric practice, as our study included optometrists who had not had any 
special training in screening for DR.  
 
The sensitivity observed in this study is in line with that observed in a previous study 
we undertook to investigate Norwegian general optometric practice [23], where 
sensitivity ranged from 61% to 65%, based on an assumption of 14% prevalence of 
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DR among patients with diabetes [3]. Specificity in the current study was, however, 
lower than in our previous study (84% vs. 98-100%), which could be explained by the 
difference in prevalence between the two studies. In the current study, 98% of 
findings of DR (both true- and false-positives) were considered to warrant a 
report/referral to a physician. This is higher than the rate of 57% reported in a national 
practice registration in Norway [23]. The experimental design in our study, where 
optometrists were blinded to patient information but assumed that the patient had 
never been examined by an ophthalmologist, may have led to an increased tendency 
to recommend referral to a physician.   
 
Assuming the prevalence of DR is 14% [3], the negative and positive predictive 
values of the optometrists’ evaluation of DR in our study would be 94% and 41%, 
respectively. Based on this and on the fact that Norwegian optometrists undertake 
approximately 1 million eye examinations per year (of which approximately 4% are in 
patients with diabetes [30]), our findings suggest that each year approximately 5500 
patients without DR are referred based on a false positive result, while in 
approximately 1300 patients with DR, no further action is taken. However, if the 
British Diabetic Association screening criteria were met in Norwegian optometric 
practice, these figures would be 1700 and 800, respectively. Our results suggest that 
an excessive workload is being placed on healthcare services by inaccurate referral 
practices. However, the national guidelines recommend eye examination by 
ophthalmologists [20, 21], thus the report/referral of a patient who has not previously 
been seen by an ophthalmologist should not be discouraged. Of greater concern is the 
false security given to those patients with DR who are not referred to an 
ophthalmologist.  
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The strengths of this study are the use of standardised images in the VIMOC exam 
and the use of a diagnostic “gold standard” based on 100% agreement between two 
independent ophthalmologists. The experimental design allowed the calculation of 
sensitivity and specificity with acceptable precision in a relatively large nationwide 
sample of optometrists, something that was not achieved in previous studies [25-28, 
34]. In terms of gender, number of years in practice and geographical location, our 
sample of optometrists is representative of members of the NOF and of optometrists 
who participated in a previous study of Norwegian optometric practice [23, 30]. The 
potential for knowledge bias and overestimation of sensitivity and specificity for 
general optometric practice was reduced in the current study because the optometrists 
were not provided with grading scales, nor were they given specific training prior to 
the study.  
 
One potential limitation of the study was the possibility of selection bias, as 
optometrists with a specific interest in diabetes may have been more likely to accept 
the invitation to participate and hence may have been overrepresented in the study. 
This could have inflated the sensitivity levels observed, compared with general 
optometric practice. On the other hand, participating optometrists did not have 
specific training in screening for DR, nor were they provided with a DR grading scale 
or a computer screen that would facilitate classification of DR. Variable viewing 
conditions may have influenced the detection rate of DR. Small screen size, low 
screen resolution and inadequate colour setting may have led to lower sensitivity for 
detecting mild DR. On the other hand, the optometrists’ use of their own facilities 
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simulated real practice, something that the use of perfect viewing conditions could not 
have done.    
 
Conclusions  
Our study is likely to have given a better representation of general optometric practice 
than previous studies [25-28, 34]. However, our findings indicate that at present case-
finding of DR in Norwegian optometric practice is unreliable. Formal optometric 
training in screening for DR and continuing education may improve diagnostic 
sensitivity. Further research will be needed to evaluate the effectiveness of measures 
undertaken to improve optometrists’ diagnostic accuracy for case-finding of DR.  
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Figures 
Figure 1 Mild non-proliferative diabetic retinopathy 
Figure 2 Moderate non-proliferative diabetic retinopathy 
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Tables 
Table 1 Characteristics of Norwegian optometrists 
Information as registered by the Norwegian Association of Optometry (NOF) and 
reported by the participating optometrists. 
 
Table 2 Characteristics of participating optometrists by formal education 
Gender, work experience, available and preferred methods of retinal examination 
presented by whether or not optometrists had obtained the formal education of Master 
of Science. 
 
Table 3 Optometrists’ VIMOC evaluations of retinal images and corresponding 
ophthalmologist grading and patient glucose status 
 
Table 4 Optometrists’ sensitivity and specificity for identifying diabetic 
retinopathy, presented by formal education level 
 
Table 5 Individual image evaluation and suggested follow-up  
The 74 optometrists’ evaluation of the 14 retinal images (1036 evaluations) and 
suggested interactions as part of follow-up, presented by true- and false-positive and -
negative ratings, respectively  
 
Table 6 Optometrists’ sensitivity and specificity for identifying diabetic 
retinopathy as reported in the current study and previous studies  
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al education 
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able 4 O
ptom
etrists’ sensitivity and specificity for identifying diabetic retinopathy, presented by form
al education level 
 
Sensitivity  
Specificity 
A
ny D
R
 (n=7) 
M
ild D
R
 (n=5) 
M
oderate D
R
 (n=2) 
N
o D
R
 (n=7) 
%
  (95%
C
I) 
%
  (95%
C
I) 
%
  (95%
C
I) 
%
  (95%
C
I) 
A
ll optom
etrists (n=74) 
67 (62 to 72) 
54 (47 to 61) 
100   
84 (80 to 89) 
Form
al education
 a , ** 
B
Sc or low
er (n=51) 
63 (56 to 69) 
48 (39 to 57) 
100   
84 (78 to 89) 
M
Sc (n= 22) 
77 (71 to 84) 
68 (59 to 77) 
100   
85 (77 to 93) 
B
Sc, B
achelor of science; C
I, confidence interval; D
R
, diabetic retinopathy; M
Sc, m
aster of science. 
a M
issing data for 1 optom
etrist.  
Student t-test P**<0.01 statistically significant difference in sensitivity betw
een optom
etrists w
ith M
Sc and optom
etrists w
ith B
Sc or even low
er form
al education 
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T
able 6 O
ptom
etrists’ sensitivity and specificity for identifying diabetic retinopathy as reported in the current study and previous 
studies 
 
Sensitivity (95%
C
I) 
Specificity (95%
C
I) 
Study 
R
etinal exam
ination m
ethod 
 
A
D
R
 
STD
R 
A
D
R
 
STD
R 
 
O
ur study (2011) 
 
C
om
m
unity optom
etrists 
Im
age evaluation of digital im
ages 
 
67 (62 to 72) 
84 (80 to 89) 
H
arvey et al (2006)  
 
O
ptom
etrists in a screening program
 
N
ot available 
 
80 (71 to 89) 
99 (98 to 100) 
O
lson et al (2003) 
 
Specially trained optom
etrists  
D
ilated slit-lam
p exam
ination 
 
73 (52 to 88) 
90 (87 to 93) 
Schm
id et al (2002) 
 
C
om
m
unity optom
etrists 
O
phthalm
oscopy (free choice) 
 
92 (84 to 100) 
94 (90 to 98) 
Im
age evaluation of retinal slides 
 
94 (90 to 98) 
97 (92 to 100) 
H
ulm
e et al (2001) 
 
Specially trained optom
etrists  
D
ilated slit-lam
p exam
ination  
 
72 
87 
77 
91 
Prasad et al (2001) 
 
Specially trained optom
etrists  
D
ilated slit-lam
p exam
ination 
 
66 (65 to 67) 
76 (70 to 81) 
97 (97 to 98) 
95 (95 to 96) 
G
ibbins et al (1998) 
 
C
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m
unity optom
etrists 
Im
age evaluation of 35 m
m
 slides 
 
88 (83 to 93) 
91 (79 to 98) 
68 (58 to 68) 
83 (79 to 87) 
Specially trained optom
etrist  
Im
age evaluation of 35 m
m
 slides 
 
86 (81 to 91) 
97 (90 to 100) 
89 (85 to 93) 
87 (84 to 91) 
B
uxton et al (1991) 
 
C
om
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unity optom
etrists 
Im
age evaluation of Polaroid im
ages 
 
48 (26 to 69) 
94 (92 to 97) 
  
  
 
A
D
R
, any diabetic retinopathy, STD
R
, sight-threatening diabetic retinopathy 
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Appendix 1 

          HVA GJØR DU?
                    DIABETES I OPTOMETRISK PRAKSIS - 1
Dette spørreskjemaet vil bli benyttet til å kartlegge optometrisk praksis i Norge ved 
synsundersøkelse av pasienter med diabetes.
Kartleggingen er en del av doktorgradsprosjektet:
DIABETES, SYN OG ØYEHELSE
Har du spørsmål angående undersøkelsen kontakt:
Vibeke Sundling, Institutt for optometri og synsvitenskap, HiBu, Pb 251, 3601 Kongsberg
Telefon 32 86 97 59, mobil: 924 24 360, e-post: vibeke.sundling@hibu.no
Bruk penn ved utfylling av skjemaet, og returner det i vedlagte svarkonvolutt. 
All informasjon vil bli behandlet konfidensielt. Prosjektet er meldt til 
Personvernombudet for forskning, Norsk samfunnsvitenskapelig datatjeneste AS.
Deltagelse i undersøkelsene er frivillig. Du kan på et hvilket som helst tidspunkt før 
prosjektslutt (31.12.2007) trekke samtykket (svaret på undersøkelsen) tilbake og få 
opplysningene du har oppgitt makulert uten å oppgi grunn. Datamaterialet vil bli anonymisert 
innen 31.12.2007. Du vil ikke kunne identifiseres i publikasjoner fra studiet.
Dersom du ikke ønsker å besvare spørreskjemaet, sett kryss her og returner skjemaet!
Jeg ønsker ikke å besvare spørreskjemaet 
Årsak (frivillig):  Jobber ikke klinisk
 Jobber ikke som optiker
 Pensjonist
 I permisjon / sykemeldt / arbeidsledig
 Har ikke tid
 Svarer ikke på spørreundersøkelser
 Annet
IDNR: 
1. Kjønn  Mann  Kvinne
2. Alder år
3. Optisk / optometrisk utdanning (høyeste utdanning)
 Yrkesfaglig 
 2årig høgskole 
 3-årig høgskole 
 Bachelor grad
 Mastergrad
4. Optisk/optometrisk yrkeserfaring år
5. Stillingsstørrelse nå:  timer/uke 
6. Kurs / spesialistkompetanse (sett gjerne flere kryss)
 Diagnostiske medikamenter 
 Kontaktlinser
 ORAS (optometrisk rehabilitering av synshemmede) 
 Arbeidsplassoptometri
 Fremre segment 
 Adferdsoptometri
 Annet
7. Arbeidssted (sett flere kryss dersom relevant)
 By > 50 000 innbyggere
 By < 50 000 innbyggere
 Tettsted
8. Type praksis
 Kjedeuavhengig
 Medlemseiet kjede
 Sentraleiet kjede
 Annet
9. I hvilken helseregion arbeider du?
 Øst (Østfold, Akerhus, Oslo, Hedmark, Oppland)
 Sør (Vestfold, Buskerud, Telemark, Aust-Agder, Vest-Agder)
 Vest (Rogaland, Hordaland, Sogn og Fjordane)
 Midt-Norge (Møre og Romsdal, Sør-Trøndelag, Nord-Trøndelag)
 Nord-Norge (Nordland, Troms, Finnmark)
De neste spørsmålene, spørsmål 10-15, er relatert til synsundersøkelse generelt.
10. Hvilke av følgende undersøkelser har du vanligvis med i synsundersøkelsen din?
(sett flere kryss)
 Anamnese
 Covertest
 Motilitet
 Donders / konfrontasjonstest 
 Refraksjon (subjektiv/objektiv)
 Spaltelampeundersøkelse (fremre segment)
 Oftalmoskopi (direkte/indirekte)
 Tonometri hos alle 
 Tonometri hos alle over  år
 Amsler grid
 Synsfeltsscreening hos alle
 Synsfeltsscreening hos alle over       år 
 Synsfeltsscreening kun ved mistanke om synsfeltutfall
11. Hvor mange synsundersøkelser utfører du vanligvis  pr. uke?
Eksl. kontaktlinser: stk Inkl. kontaktlinser: stk
For spørsmål 12 og 13; angi på en skala hvor 0% = aldri og 100%= alltid. Sett kun 1 kryss!
12. Hvor ofte spør du om pasientens generelle helsetilstand?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
13. Hvor ofte spør du om pasienten har diabetes?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
14. Hvor stor andel av de som kommer til synsundersøkelse, anslår du, har kjent diabetes?
                   %
15. Dersom pasienten har diabetes foretar du flere / andre undersøkelser enn du normalt gjør?
 Ja  Nei
De neste spørsmålene, spørsmål 16-35 omhandler hva du vanligvis foretar deg dersom den 
som kommer til synsundersøkelse oppgir å ha diabetes. Alle undersøkelsene er ikke 
nødvendigvis like viktige.
Angi på en skala hvor 0% = aldri og 100%= alltid. Sett kun 1 kryss!
Dersom pasienten har diabetes; hvor ofte spør du om: 
16. Hvilken type diabetes pasienten har?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 %
17. Hvor lenge pasienten har hatt diabetes?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
18. Hvor godt blodsukkernivået er regulert?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
19. Hvor høyt blodtrykket er?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
20. Hvilken type diabetesbehandling (kost, tabletter, insulin) pasienten får?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
21. Hvordan pasientens øyehelse følges opp?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
22. Hva slags øyebehandling pasienten har fått?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
23. Pasienten opplever/har opplevd at visus varierer?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
24. Pasienten har opplevd dobbeltsyn?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
25. Pasienten har opplevd TIA (forbigående synstap)?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
Angi på en skala hvor 0% = aldri og 100%= alltid. Sett kun 1 kryss!
Dersom pasienten har diabetes; hvor ofte foretar du følgende undersøkelser? 
26. Vurderer om refraksjonen er stabil?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
27. Cover- og motilitetstest?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
28. Fargesynstest?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
29. Tonometri (trykkmåling)?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
30. På hvilken indikasjon blir tonometri (trykkmåling) foretatt?
31. Synsfeltundersøkelse (inkl. Donders og/eller Amsler) ?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
32. På hvilken indikasjon foretar du synsfeltundersøkelse?
33. Spaltelampeundersøkelse av fremre segment?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
34. Fundusundersøkelse?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
35. Fundusfotografering?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
De neste spørsmålene, spørsmål 36-45 , er relatert til fundusundersøkelse generelt og hvordan du 
vurderer dine egen evne til å utføre undersøkelsene.
Angi på en skala hvor 0% = aldri og 100%= alltid. Sett kun 1 kryss!
Hvor ofte benytter du følgende teknikker for fundusundersøkelse?
36. Dilatert fundus undersøkelse?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
37. Direkte oftalmoskopi? (vanlig oftalmoskopi)
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
38. Spaltelampe (binokulær) indirekte oftalmoskopi? (Volk linse)
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
39. Monokulær indirekte oftalmoskopi?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
40. Binokulær indirekte oftalmoskopi?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
41. Fundusfotografering?
      
0% < 25% 25-49 % 50 % 51-75 % > 75 % 100 % 
Hvordan anser du din evne til å utføre fundusundersøkelse og vurdere fundus?
42. Direkte oftalmoskopi (vanlig oftalmoskopi)
     
Svært dårlig Dårlig Middels God Svært god Har ikke utstyr
43. Spaltelampe (binokulær) indirekte oftalmoskopi (Volk linse)
     
Svært dårlig Dårlig Middels God Svært god Har ikke utstyr
44. Fundusfotografering
     
Svært dårlig Dårlig Middels God Svært god Har ikke utstyr
45. Vurdering av fundus
    
Svært dårlig Dårlig Middels God Svært god
De siste spørsmålene, spørsmål 46-51, omfatter samarbeid med annet helsepersonell og 
rapporterings- og henvisningsrutiner
46. Dersom du har foretatt en synsundersøkelse av en pasient med diabetes, i hvilke tilfeller sender du 
rapport til pasientens fastlege?
    
Aldri Ved okulære funn
som skyldes diabetes
Avhenger av grad 
av okulære funn
Alltid Dersom pasient / fastlege
ber om det
47. I hvilke tilfeller henviser du pasienter med diabetes retinopati til øyelege (via fastlege)?
  
Alltid Dersom pasienten følges opp av øyelege,
avhenger det av grad av diabetes retinopati
Avhenger av grad av 
diabetes retinopati
48. Hva slags samarbeid har du med fastlegene? (sett gjerne flere kryss)
 Har ikke samarbeid
 Henviser / konfererer per telefon
 Sender rapporter 
 Sender henvisinger 
 Mottar epikriser 
 Mottar henvisninger
 Arbeider i praksis sammen med fastleger
49. Hva slags samarbeid har du med øyeleger? (sett gjerne flere kryss)
 Har ikke samarbeid
 Henviser / konfererer per telefon
 Sender rapporter 
 Sender henvisinger 
 Mottar epikriser 
 Mottar henvisninger
 Arbeider i praksis sammen med øyeleger
50. Hvor mange pasienter med ikke kjent diabetes har du henvist med mistanke om diabetes 
retinopati i løpet av de siste 12 måneder? Antall: 
51. Hvor mange pasienter med ikke kjent diabetes har du henvist med mistanke om diabetes i løpet av 
de siste 12 måneder? Antall: 
KOMMENTARER:
 JA, jeg ønsker også å delta i del 2 av undersøkelsen.
Vennligst kontroller at du har besvart alle spørsmålene. 
Postlegg spørreskjemaet i vedlagte returkonvolutt, porto er betalt.
Tusen takk for at du tok deg tid til å svare på undersøkelsen!
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 2 

         DIABETES, SYN OG ØYEHELSE
            DIABETES I OPTOMETRISK PRAKSIS - 2
Denne undersøkelsen vil kartlegge forekomsten av diabetes, diabetes retinopati og 
synshemming i optometrisk praksis, samt omfang av rapporter og henvisning til annet 
helsepersonell. Kartleggingen vil kunne bli benyttet i utviklingen av diabetesomsorgen i
Norge med hensyn til oppfølging av syn og øyehelse.
Kartleggingen er del av doktorgradsprosjektet: DIABETES, SYN OG ØYEHELSE
Undersøkelsen innebærer: 
1. å registrere enkelte opplysninger og funn fra de første 20 påfølgende 
synsundersøkelsene du gjennomfører, del 1 av skjemaet.
2. å registrere enkelte tilleggsopplysninger dersom pasienten har diabetes, eller det sendes 
rapport eller henvisning til annet helsepersonell, del 2 av skjemaet.
Svarene vil bli behandlet konfidensielt. Undersøkelsen er meldt til 
Personvernombudet for forskning, Norsk samfunnsvitenskapelig datatjeneste AS 
Pasientinformasjonsskriv til oppslag i praksisen er vedlagt.
Jeg håper du finner tid til å delta i undersøkelsen, nettopp ditt svar er viktig!
Har du spørsmål angående undersøkelsen kontakt:
Vibeke Sundling, Institutt for optometri og synsvitenskap, HiBu, Pb 251, 3601 Kongsberg 
Telefon 32 86 97 59, mobil: 924 24 360, e-post: vibeke.sundling@hibu.no
Vennligst returner skjemaet i vedlagte svarkonvolutt innen 17. desember 2004, også 
dersom skjemaet er utfylt for færre enn 20 synsundersøkelser.
På forhånd takk for hjelpen!
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Appendix 3 

            DIABETES, SYN OG ØYEHELSE
Du er blitt spurt om å delta i denne spørreundersøkelsen fordi du har diabetes 
(sukkersyke). Diabetes kan, som du kanskje vet, skade øynene og synet. Denne 
undersøkelsen vil kartlegge syn og helse hos pasienter med diabetes. Kartleggingen 
kan bli benyttet som grunnlag for å bedre diabetesomsorgen i Norge.
Kartleggingen er en del av doktorgradsprosjektet: DIABETES, SYN OG ØYEHELSE
Har du spørsmål angående undersøkelsen kontakt:
Stipendiat Vibeke Sundling
Institutt for optometri og synsvitenskap, Høgskolen i Buskerud
Telefon 32 86 97 59, mobil: 924 24 360, e-post: vibeke.sundling@hibu.no
All informasjon vil bli behandlet konfidensielt. 
Prosjektet er tilråd av den regionale komité for medisinsk forskningsetikk.
Deltagelse i undersøkelsen er frivillig.
Du vil ikke kunne identifiseres i publikasjoner fra studiet.
Det tar kun noen minutter å fylle ut skjemaet. 
Det utfylte spørreskjemaet returneres i vedlagte frankerte svarkonvolutt. 
1. Kjønn
Kvinne 
Mann 
2. Fødselsår
1 9
3. Bostedfylke
4. Hvilken type diabetes har du? 
Type 1 
Type 2 
Annen 
Usikker 
5. Hvilket årstall fikk du diabetes? 
1 9
Spørsmål 5 – 13  omhandler undersøkelse av 
øyehelse og syn. Når vi spør om du regelmessig
går til undersøkelse, mener vi om du undersøkes 
jevnlig f.eks. årlig, halvårlig, eller månedlig.  I
spørsmålene skiller vi også mellom:
1. Øyeundersøkelse -
Undersøkelse av øyebunn / netthinne 
2. Synsundersøkelse –
Undersøkelse av hvor godt du ser  
5. Når ble den første øyeundersøkelsen
foretatt etter at du fikk diagnosen 
diabetes?
Innen 1 år 
I løpet av 1- 5 år  
Etter mer enn  5 år 
Ikke undersøkt 
Usikker 
6. Går du til regelmessig øyeundersøkelse
på grunn av din diabetes?
Ja 
Nei 
7. Blir det foretatt øyeundersøkelse ved 
kontroll hos fastlege?
Ja 
Nei 
8. Går du regelmessig til synsundersøkelse
hos: 
JA NEI
Optiker  
Øyelege  
Annen lege  
Annet helsepersonell  
Synsundersøkes ikke 
Dersom du går regelmessig til øyeundersøkelse ber 
vi deg om å besvare spørsmål 9- 11. Hvis du ikke 
går til regelmessig øyeundersøkelse gå videre til 
spørsmål 12.
9. Hvor lenge er det vanligvis mellom hver 
gang du er til øyeundersøkelse?
måneder
år
10. Hvordan blir øyeundersøkelsen foretatt? 
JA NEI
Fotografering  
Undersøkelse av øyelege  
Undersøkelse av fastlege  
Undersøkelse av optiker  
Usikker / vet ikke 
11. Hvor fornøyd er du med 
øyeundersøkelsen / oppfølgingen av 
øynene? 
Svært godt fornøyd 
Godt fornøyd 
Middels fornøyd 
Lite fornøyd 
Svært lite fornøyd 
Dersom du går til regelmessig synsundersøkelse 
hos optiker ber vi deg om å besvare spørsmål 12-
13. Hvis du ikke går til regelmessig
synsundersøkelse hos optiker gå videre til spørsmål 
14. 
12. Hvor lenge er det vanligvis mellom hver 
gang du er til synsundersøkelse?
måneder
år
13. Hvor fornøyd er du med 
synsundersøkelsen / oppfølgingen av 
synet? 
Svært godt fornøyd 
Godt fornøyd 
Middels fornøyd 
Lite fornøyd 
Svært lite fornøyd 
Spørsmål 14 –21 omhandler synshjelpemidler, syn 
og øyehelse.
14. Bruker du følgende synshjelpemidler ?
JA NEI
Avstandsbriller / Gåbriller  
Lesebriller / Databriller  
Bifokale / Progressive briller  
Kontaktlinser  
Lupe / lupebrille / lese-TV  
15. Har du problemer med synet, som lege 
har sagt skyldes diabetes?
Ja 
Nei 
Usikker 
16. Har du fått behandling av øynene som 
følge av øyeforandringer som skyldes 
diabetes?
Ja 
Nei 
Usikker 
17. Har du noen kjent øyesykdom? 
JA NEI
Øyeforandring pga diabetes  
Øyeforandring pga 
blodpropp / høyt blodtrykk  
Forkalkning på netthinnen  
Grønn stær / høyt øyetrykk  
Grå stær  
Annen øyesykdom  
18. Har du i løpet av det siste året opplevd 
synsforstyrrelser som:
JA NEI
Uklart syn  
Variabelt syn  
Flekker i synsfeltet  
Deler i synsfeltet forsvinner  
Dobbelt syn  
Rette linjer er bølgede  
Andre symptomer  
19. Dersom du har opplevd synsforstyrrelser, 
forsvinner disse ved bruk av
briller eller kontaktlinser?
Ja 
Nei 
20. Hvem ville du oppsøke først dersom du 
merket forandringer med synet?
Sett ev. flere kryss
21. Har du fått informasjon om å undersøke 
synet og øynene regelmessig fordi du har 
diabetes? 
Ja 
Nei 
Usikker 
Lege 
Optiker 
Øyelege / øyeavd. sykehus 
Usikker 
KOMMENTARER:
Vennligst kontroller at du har besvart alle spørsmålene.
Tusen takk for at du tok deg tid til å svare på undersøkelsen!
22. Dersom du har fått informasjon om å 
undersøke synet og øynene regelmessig, 
hvor har du fått denne informasjonen? 
JA NEI
Fastlege (ev. vikar)  
Øyelege  
Annen lege  
Optiker  
Sykehus  
Diabeteskurs  
Brosjyrer / ” Diabetes ”  
Aviser/Ukeblader/Radio/TV  
Andre som har diabetes  
Annet  
Spørsmål 22-29  omhandler behandling av diabetes 
og generell helse.
23. Hvordan behandles din diabetes nå?
JA NEI
Kost  
Mosjon  
Slanking/vektreduksjon  
Tabletter  
Insulin  
24. Hva var langtidsblodsukkeret ditt 
(HbA1c) ved siste kontroll?
        %
Usikker 
25. Har blodsukkeret ditt vært stabilt det 
siste året?
Ja 
Nei 
Usikker 
26. Hva var blodtrykket ditt ved siste måling 
hos lege?
Overtrykk
  
mmHg
Undertrykk
  
mmHg  
Usikker 
27. Bruker du blodtrykksregulerende 
medisiner?
Ja 
Nei 
Usikker 
28. Bruker du kolesterolsenkende medisiner?
Ja 
Nei 
Usikker 
29. Røyker du?
Ja 
Nei 
Antall sigaretter per dag:
30. Har du røkt tidligere?
Ja 
Nei 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 4 

            DIABETES, SYN OG ØYEHELSE
Du er blitt spurt om å delta i denne spørreundersøkelsen fordi du har diabetes (sukkersyke), 
og deltok i Glukosebelastningsprosjektet (GLUP) i Verdal i fjor. Diabetes kan, som du kanskje 
vet, skade øynene og synet. Denne undersøkelsen vil kartlegge syn og helse hos pasienter 
med diabetes. Kartleggingen kan bli benyttet som grunnlag for å bedre diabetesomsorgen i 
Norge.
Har du spørsmål angående undersøkelsen kontakt:
Stipendiat Vibeke Sundling, Institutt for optometri og synsvitenskap, Høgskolen i Buskerud
Telefon 32 86 97 59, mobil: 924 24 360, e-post: vibeke.sundling@hibu.no
Deltagelse i undersøkelsen er frivillig.
All informasjon vil bli behandlet konfidensielt.
Det utfylte spørreskjemaet tar du med til syn- og øyeundersøkelsen ved HUNT.
1. Kjønn
Kvinne 
Mann 
2. Fødselsår
1 9
3. Hvilken type diabetes har du? 
Type 1 
Type 2 
Annen 
Usikker 
4. Hvilket årstall fikk du diabetes? 
1 9
Spørsmål 5 – 13  omhandler undersøkelse av 
øyehelse og syn. Når vi spør om du regelmessig
går til undersøkelse, mener vi om du undersøkes 
jevnlig f.eks. årlig, halvårlig, eller månedlig.  I
spørsmålene skiller vi også mellom:
1. Øyeundersøkelse -
Undersøkelse av øyebunn / netthinne 
2. Synsundersøkelse –
Undersøkelse av hvor godt du ser  
5. Når ble den første øyeundersøkelsen
foretatt etter at du fikk diagnosen 
diabetes?
Innen 1 år 
I løpet av 1- 5 år  
Etter mer enn  5 år 
Ikke undersøkt 
Usikker 
6. Går du til regelmessig øyeundersøkelse
på grunn av din diabetes?
Ja 
Nei 
7. Blir det foretatt øyeundersøkelse ved 
kontroll hos fastlege?
Ja 
Nei 
8. Går du regelmessig til synsundersøkelse
hos: 
JA NEI
Optiker  
Øyelege  
Annen lege  
Annet helsepersonell  
Synsundersøkes ikke 
Dersom du går regelmessig til øyeundersøkelse ber 
vi deg om å besvare spørsmål 9- 11. Hvis du ikke 
går til regelmessig øyeundersøkelse gå videre til 
spørsmål 12.
9. Hvor lenge er det vanligvis mellom hver 
gang du er til øyeundersøkelse?
måneder
år
10. Hvordan blir øyeundersøkelsen foretatt? 
JA NEI
Fotografering  
Undersøkelse av øyelege  
Undersøkelse av fastlege  
Undersøkelse av optiker  
Usikker / vet ikke 
11. Hvor fornøyd er du med 
øyeundersøkelsen / oppfølgingen av 
øynene? 
Svært godt fornøyd 
Godt fornøyd 
Middels fornøyd 
Lite fornøyd 
Svært lite fornøyd 
Dersom du går til regelmessig synsundersøkelse 
hos optiker ber vi deg om å besvare spørsmål 12-
13. Hvis du ikke går til regelmessig 
synsundersøkelse hos optiker gå videre til spørsmål 
14. 
12. Hvor lenge er det vanligvis mellom hver 
gang du er til synsundersøkelse?
måneder
år
13. Hvor fornøyd er du med 
synsundersøkelsen / oppfølgingen av 
synet? 
Svært godt fornøyd 
Godt fornøyd 
Middels fornøyd 
Lite fornøyd 
Svært lite fornøyd 
Spørsmål 14 –21 omhandler synshjelpemidler, syn 
og øyehelse.
14. Bruker du følgende synshjelpemidler ?
JA NEI
Avstandsbriller / Gåbriller  
Lesebriller / Databriller  
Bifokale / Progressive briller  
Kontaktlinser  
Lupe / lupebrille / lese-TV  
15. Har du problemer med synet, som lege 
har sagt skyldes diabetes?
Ja 
Nei 
Usikker 
16. Har du fått behandling av øynene som 
følge av øyeforandringer som skyldes 
diabetes?
Ja 
Nei 
Usikker 
17. Har du noen kjent øyesykdom? 
JA NEI
Øyeforandring pga diabetes  
Øyeforandring pga 
blodpropp / høyt blodtrykk  
Forkalkning på netthinnen  
Grønn stær / høyt øyetrykk  
Grå stær  
Annen øyesykdom  
18. Har du i løpet av det siste året opplevd 
synsforstyrrelser som:
JA NEI
Uklart syn  
Variabelt syn  
Flekker i synsfeltet  
Deler i synsfeltet forsvinner  
Dobbelt syn  
Rette linjer er bølgede  
Andre symptomer  
19. Dersom du har opplevd synsforstyrrelser, 
forsvinner disse ved bruk av
briller eller kontaktlinser?
Ja 
Nei 
20. Hvem ville du oppsøke først dersom du 
merket forandringer med synet?
Sett ev. flere kryss
21. Har du fått informasjon om å undersøke 
synet og øynene regelmessig fordi du har 
diabetes? 
Ja 
Nei 
Usikker 
Lege 
Optiker 
Øyelege / øyeavd. sykehus 
Usikker 
KOMMENTARER:
Vennligst kontroller at du har besvart alle spørsmålene.
Tusen takk for at du tok deg tid til å svare på undersøkelsen!
22. Dersom du har fått informasjon om å 
undersøke synet og øynene regelmessig, 
hvor har du fått denne informasjonen? 
JA NEI
Fastlege (ev. vikar)  
Øyelege  
Annen lege  
Optiker  
Sykehus  
Diabeteskurs  
Brosjyrer / ” Diabetes ”  
Aviser/Ukeblader/Radio/TV  
Andre som har diabetes  
Annet  
Spørsmål 22-29  omhandler behandling av diabetes 
og generell helse.
23. Hvordan behandles din diabetes nå?
JA NEI
Kost  
Mosjon  
Slanking/vektreduksjon  
Tabletter  
Insulin  
24. Hva var langtidsblodsukkeret ditt 
(HbA1c) ved siste kontroll?
        %
Usikker 
25. Har blodsukkeret ditt vært stabilt det 
siste året?
Ja 
Nei 
Usikker 
26. Hva var blodtrykket ditt ved siste måling 
hos lege?
Overtrykk
  
mmHg
Undertrykk
  
mmHg  
Usikker 
27. Bruker du blodtrykksregulerende 
medisiner?
Ja 
Nei 
Usikker 
28. Bruker du kolesterolsenkende medisiner?
Ja 
Nei 
Usikker 
29. Røyker du?
Ja 
Nei 
Antall sigaretter per dag:
30. Har du røkt tidligere?
Ja 
Nei 
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ID:                                
REGISTRERINGSSKJEMA 
GLUP 2 – SYN
1 Anamnese
1.1 Kjønn  Kvinne
 Mann
1.2 Fødselsår 19
1.3 Symptomer  Uklart syn
 Variablet syn
 Flekker i synsfeltet
 Deler av synsfeltet forsvinner
 Dobbelt syn
 Rette linjer er bølgende
 Lysømfintlig
1.4 Forsvinner ved bruk av briller 
eller kontaktlinser
 Ja
 Nei
1.5 Synshjelpemidler  Avstandsbriller / gåbriller
 Lesebriller / databriller
 Bifokale / progressivebriller
 Kontaktlinser
 Lupe / lupebrille / lesetv
1.6 Regelmessig 
synsundersøkelse
 Ja
 Nei
 Optiker
 Øyelege          /12
1.7 Regelmessig øyeundersøkelse  Ja
 Nei
 Optiker
 Øyelege          /12
1.8 Øyesykdommer  Diabetes retinopati
 Annen retinopati
 Makuladegenerasjon
 Glaukom
 Katarakt
 Annen
1.9 Diabetes  Ja
 Nei
1.10 Diabetes i familien  Ja
 Nei
1.11 Hjerte / Karsykdom  Ja
 Nei
1.12 Blodtrykk  Lavt
 Normalt
 Høyt
 Usikker
                    /                  mmHg
2 Okulær helse
2.1 Tonometri OD OS TID
             mmHg              mmHg                .
2.2 Fundusfoto
1 1
2 2
3 3
4 4
OD OS
2.2.1 Dilateres  Ja
 Nei
 Ja
 Nei
2.3.1 Fundusvurdering  Normal
 Unormal
 Normal
 Unormal 
2.3.2 Diabetes retinopati  Ja
 Nei
 Ja
 Nei
2.3.3 Gradering diabetes retinopati  Ingen
 Mild NPDR
 Moderat NPDR
 Alvorlig NPDR
 PDR
 Makulaødem
 Ingen
 Mild NPDR
 Moderat NPDR
 Alvorlig NPDR
 PDR
 Makulaødem
2.4 Katarakt OD OS
 Ja
 Nei
 Ja
 Nei
2.5 Kommentarer:
3 Synsfunksjon
OD OS OU
3.1 Habituell korreksjon /         x /         x
3.2 Habituell visus
3.3 Refraksjon /         x /         x
3.4 Beste korrigerte visus
3.5 Visus med hullblende
3.6 Add
3.7 Refraksjons endring  Tidligere Rx ikke kjent
 Uendret
 Myop endring > 1D
 Hyperop endring > 1D
3.8 Covertest  Orto
 Fori
 Tropi
 Exo
 Eso
 Hyper
                   
OD/OD/ALT
3.9 Synsfelt - Amsler OD OS
 Normalt
 Synsfeltutfall
 Normalt
 Synsfeltutfall
3.10 Kontrastfølsomhet OD OS
 Normalt
 Redusert
 Normalt
 Redusert
Dato:
Signatur:
4 Videre håndtering og oppfølging
4.1 Brilleseddel utlevert  Ja
 Nei
4.2 Henvises  Ja
 Nei
 Fastlege
 Øyelege
 Øyeblikkelig hjelp
4.3 Henvisningsårsak  Visus
 Samsyn
 Intraokulært trykk
 Fremre segment
 Retinopati
 Makulopati
 Hodepine
 Annet
5 Kommentarer:
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Dato:
Signatur:   
FUNDUSFOTOVURDERING – GLUP2
1. Surname (id): 16
2. Alder: 36
Høyre øye Venstre øye
3.1 Netthinnevurdering  Normal
 Unormal
 For dårlig billedkvalitet
 Normal
 Unormal
 For dårlig billedkvalitet
3.2 Retinopati  Ingen
 Diabetes 
 Hypertensjon
 Annen vaskulær
 AMD
 Annen
 Ingen
 Diabetes 
 Hypertensjon
 Annen vaskulær
 AMD
 Annen
3.3 Diabetes retinopati  Ingen DR
 Mild NPDR
 Moderat NPDR
 Alvorlig NPDR
 PDR
 Laserbehandlet DR 
 Ingen DR
 Mild NPDR
 Moderat NPDR
 Alvorlig NPDR
 PDR
 Laserbehandlet DR
3.4 Papillevurdering  Normal
 Unormal
 Normal
 Unormal
4. Merknader:
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Vurdering av diabetes retinopati
Medlemsnummer i NOF:  
Legg inn ditt medlemsnummer i NOF som brukernavn 
(Medlemsnummeret finner du i eposten, 5 siffer)
Bilde nr 1, spørsmål 1 av 3. 
Etter din vurdering er dette et øye med diabetes retinopati?
 Ja
 Nei
Bilde nr 1, spørsmål 2 av 3. 
Hvilke funn på bildet la du til grunn for din vurdering?  
(Du kan sette flere kryss)
	
 Ingen retinopati
	
 Mikroaneurysmer 
	
 Blødninger
	
 Harde eksudater
	
 Fibersjiktsinfarkt (bløte eksudater/cottonwool spots)
	
 Venøs kaliberveksling
	
 IRMA (intraretinale mikrovaskulære abnormaliteter)
	
 Neovaskularisering
	
 Andre funn / annen tentativ diagnose
Bilde 1, spørsmål 3 av 3. 
Basert på retinopatifunn alene, hvordan ville du håndtert denne personen, dersom vedkommende ikke følges opp hos øyelege?  
(Du kan sette flere kryss)
	
 Ingen videre oppfølging / Rutineoppfølging 
	
 Rapport til fastlege
	
 Henvising til fastlege
	
 Henvising til øyelege
Bilde nr 2, spørsmål 1 av 3. 
Etter din vurdering er dette et øye med diabetes retinopati?
 Ja
 Nei
Bilde nr 2, spørsmål 2 av 3. 
Hvilke funn på bildet la du til grunn for din vurdering?  
(Du kan sette flere kryss)
	
 Ingen retinopati
	
 Mikroaneurysmer 
	
 Blødninger
	
 Harde eksudater
	
 Fibersjiktsinfarkt (bløte eksudater/cottonwool spots)
	
 Venøs kaliberveksling
	
 IRMA (intraretinale mikrovaskulære abnormaliteter)
	
 Neovaskularisering
	
 Andre funn / annen tentativ diagnose
Bilde 2, spørsmål 3 av 3. 
Basert på retinopatifunn alene, hvordan ville du håndtert denne personen, dersom vedkommende ikke følges opp hos øyelege?  
(Du kan sette flere kryss)
	
 Ingen videre oppfølging / Rutineoppfølging 
	
 Rapport til fastlege
	
 Henvising til fastlege
	
 Henvising til øyelege
Bilde nr 3, spørsmål 1 av 3. 
Etter din vurdering er dette et øye med diabetes retinopati?
 Ja
 Nei
Bilde nr 3, spørsmål 2 av 3. 
Hvilke funn på bildet la du til grunn for din vurdering?  
(Du kan sette flere kryss)
	
 Ingen retinopati
	
 Mikroaneurysmer 
	
 Blødninger
	
 Harde eksudater
	
 Fibersjiktsinfarkt (bløte eksudater/cottonwool spots)
	
 Venøs kaliberveksling
	
 IRMA (intraretinale mikrovaskulære abnormaliteter)
	
 Neovaskularisering
	
 Andre funn / annen tentativ diagnose
Bilde 3, spørsmål 3 av 3. 
Basert på retinopatifunn alene, hvordan ville du håndtert denne personen, dersom vedkommende ikke følges opp hos øyelege?  
(Du kan sette flere kryss)
	
 Ingen videre oppfølging / Rutineoppfølging 
	
 Rapport til fastlege
	
 Henvising til fastlege
	
 Henvising til øyelege
Bilde nr 4, spørsmål 1 av 3. 
Etter din vurdering er dette et øye med diabetes retinopati?
 Ja
 Nei
Bilde nr 4, spørsmål 2 av 3. 
Hvilke funn på bildet la du til grunn for din vurdering?  
(Du kan sette flere kryss)
	
 Ingen retinopati
	
 Mikroaneurysmer 
	
 Blødninger
	
 Harde eksudater
	
 Fibersjiktsinfarkt (bløte eksudater/cottonwool spots)
	
 Venøs kaliberveksling
	
 IRMA (intraretinale mikrovaskulære abnormaliteter)
	
 Neovaskularisering
	
 Andre funn / annen tentativ diagnose
Bilde 4, spørsmål 3 av 3. 
Basert på retinopatifunn alene, hvordan ville du håndtert denne personen, dersom vedkommende ikke følges opp hos øyelege?  
(Du kan sette flere kryss)
	
 Ingen videre oppfølging / Rutineoppfølging 
	
 Rapport til fastlege
	
 Henvising til fastlege
	
 Henvising til øyelege
Bilde nr 5, spørsmål 1 av 3. 
Etter din vurdering er dette et øye med diabetes retinopati?
 Ja
 Nei
Bilde nr 5, spørsmål 2 av 3. 
Hvilke funn på bildet la du til grunn for din vurdering?  
(Du kan sette flere kryss)
	
 Ingen retinopati
	
 Mikroaneurysmer 
	
 Blødninger
	
 Harde eksudater
	
 Fibersjiktsinfarkt (bløte eksudater/cottonwool spots)
	
 Venøs kaliberveksling
	
 IRMA (intraretinale mikrovaskulære abnormaliteter)
	
 Neovaskularisering
	
 Andre funn / annen tentativ diagnose
Bilde 5, spørsmål 3 av 3. 
Basert på retinopatifunn alene, hvordan ville du håndtert denne personen, dersom vedkommende ikke følges opp hos øyelege?  
(Du kan sette flere kryss)
	
 Ingen videre oppfølging / Rutineoppfølging 
	
 Rapport til fastlege
	
 Henvising til fastlege
	
 Henvising til øyelege
Bilde nr 6, spørsmål 1 av 3. 
Etter din vurdering er dette et øye med diabetes retinopati?
 Ja
 Nei
Bilde nr 6, spørsmål 2 av 3. 
Hvilke funn på bildet la du til grunn for din vurdering?  
(Du kan sette flere kryss)
	
 Ingen retinopati
	
 Mikroaneurysmer 
	
 Blødninger
	
 Harde eksudater
	
 Fibersjiktsinfarkt (bløte eksudater/cottonwool spots)
	
 Venøs kaliberveksling
	
 IRMA (intraretinale mikrovaskulære abnormaliteter)
	
 Neovaskularisering
	
 Andre funn / annen tentativ diagnose
Bilde 6, spørsmål 3 av 3. 
Basert på retinopatifunn alene, hvordan ville du håndtert denne personen, dersom vedkommende ikke følges opp hos øyelege?  
(Du kan sette flere kryss)
	
 Ingen videre oppfølging / Rutineoppfølging 
	
 Rapport til fastlege
	
 Henvising til fastlege
	
 Henvising til øyelege
Bilde nr 7, spørsmål 1 av 3. 
Etter din vurdering er dette et øye med diabetes retinopati?
 Ja
 Nei
Bilde nr 7, spørsmål 2 av 3. 
Hvilke funn på bildet la du til grunn for din vurdering?  
(Du kan sette flere kryss)
	
 Ingen retinopati
	
 Mikroaneurysmer 
	
 Blødninger
	
 Harde eksudater
	
 Fibersjiktsinfarkt (bløte eksudater/cottonwool spots)
	
 Venøs kaliberveksling
	
 IRMA (intraretinale mikrovaskulære abnormaliteter)
	
 Neovaskularisering
	
 Andre funn / annen tentativ diagnose
Bilde 7, spørsmål 3 av 3. 
Basert på retinopatifunn alene, hvordan ville du håndtert denne personen, dersom vedkommende ikke følges opp hos øyelege?  
(Du kan sette flere kryss)
	
 Ingen videre oppfølging / Rutineoppfølging 
	
 Rapport til fastlege
	
 Henvising til fastlege
	
 Henvising til øyelege
Bilde nr 8, spørsmål 1 av 3. 
Etter din vurdering er dette et øye med diabetes retinopati?
 Ja
 Nei
Bilde nr 8, spørsmål 2 av 3. 
Hvilke funn på bildet la du til grunn for din vurdering?  
(Du kan sette flere kryss)
	
 Ingen retinopati
	
 Mikroaneurysmer 
	
 Blødninger
	
 Harde eksudater
	
 Fibersjiktsinfarkt (bløte eksudater/cottonwool spots)
	
 Venøs kaliberveksling
	
 IRMA (intraretinale mikrovaskulære abnormaliteter)
	
 Neovaskularisering
	
 Andre funn / annen tentativ diagnose
Bilde 8, spørsmål 3 av 3. 
Basert på retinopatifunn alene, hvordan ville du håndtert denne personen, dersom vedkommende ikke følges opp hos øyelege?  
(Du kan sette flere kryss)
	
 Ingen videre oppfølging / Rutineoppfølging 
	
 Rapport til fastlege
	
 Henvising til fastlege
	
 Henvising til øyelege
Bilde nr 9, spørsmål 1 av 3. 
Etter din vurdering er dette et øye med diabetes retinopati?
 Ja
 Nei
Bilde nr 9, spørsmål 2 av 3. 
Hvilke funn på bildet la du til grunn for din vurdering?  
(Du kan sette flere kryss)
	
 Ingen retinopati
	
 Mikroaneurysmer 
	
 Blødninger
	
 Harde eksudater
	
 Fibersjiktsinfarkt (bløte eksudater/cottonwool spots)
	
 Venøs kaliberveksling
	
 IRMA (intraretinale mikrovaskulære abnormaliteter)
	
 Neovaskularisering
	
 Andre funn / annen tentativ diagnose
Bilde 9, spørsmål 3 av 3. 
Basert på retinopatifunn alene, hvordan ville du håndtert denne personen, dersom vedkommende ikke følges opp hos øyelege?  
(Du kan sette flere kryss)
	
 Ingen videre oppfølging / Rutineoppfølging 
	
 Rapport til fastlege
	
 Henvising til fastlege
	
 Henvising til øyelege
Bilde nr 10, spørsmål 1 av 3. 
Etter din vurdering er dette et øye med diabetes retinopati?
 Ja
 Nei
Bilde nr 10, spørsmål 2 av 3. 
Hvilke funn på bildet la du til grunn for din vurdering?  
(Du kan sette flere kryss)
	
 Ingen retinopati
	
 Mikroaneurysmer 
	
 Blødninger
	
 Harde eksudater
	
 Fibersjiktsinfarkt (bløte eksudater/cottonwool spots)
	
 Venøs kaliberveksling
	
 IRMA (intraretinale mikrovaskulære abnormaliteter)
	
 Neovaskularisering
	
 Andre funn / annen tentativ diagnose
Bilde 10, spørsmål 3 av 3. 
Basert på retinopatifunn alene, hvordan ville du håndtert denne personen, dersom vedkommende ikke følges opp hos øyelege?  
(Du kan sette flere kryss)
	
 Ingen videre oppfølging / Rutineoppfølging 
	
 Rapport til fastlege
	
 Henvising til fastlege
	
 Henvising til øyelege
Bilde nr 11, spørsmål 1 av 3. 
Etter din vurdering er dette et øye med diabetes retinopati?
 Ja
 Nei
Bilde nr 11, spørsmål 2 av 3. 
Hvilke funn på bildet la du til grunn for din vurdering?  
(Du kan sette flere kryss)
	
 Ingen retinopati
	
 Mikroaneurysmer 
	
 Blødninger
	
 Harde eksudater
	
 Fibersjiktsinfarkt (bløte eksudater/cottonwool spots)
	
 Venøs kaliberveksling
	
 IRMA 
	
 IRMA (intraretinale mikrovaskulære abnormaliteter)
	
 Andre funn / annen tentativ diagnose
Bilde 11, spørsmål 3 av 3. 
Basert på retinopatifunn alene, hvordan ville du håndtert denne personen, dersom vedkommende ikke følges opp hos øyelege?  
(Du kan sette flere kryss)
	
 Ingen videre oppfølging / Rutineoppfølging 
	
 Rapport til fastlege
	
 Henvising til fastlege
	
 Henvising til øyelege
Bilde nr 12, spørsmål 1 av 3. 
Etter din vurdering er dette et øye med diabetes retinopati?
 Ja
 Nei
Bilde nr 12, spørsmål 2 av 3. 
Hvilke funn på bildet la du til grunn for din vurdering?  
(Du kan sette flere kryss)
	
 Ingen retinopati
	
 Mikroaneurysmer 
	
 Blødninger
	
 Harde eksudater
	
 Fibersjiktsinfarkt (bløte eksudater/cottonwool spots)
	
 Venøs kaliberveksling
	
 IRMA (intraretinale mikrovaskulære abnormaliteter)
	
 Neovaskularisering
	
 Andre funn / annen tentativ diagnose
Bilde 12, spørsmål 3 av 3. 
Basert på retinopatifunn alene, hvordan ville du håndtert denne personen, dersom vedkommende ikke følges opp hos øyelege?  
(Du kan sette flere kryss)
	
 Ingen videre oppfølging / Rutineoppfølging 
	
 Rapport til fastlege
	
 Henvising til fastlege
	
 Henvising til øyelege
Bilde nr 13, spørsmål 1 av 3. 
Etter din vurdering er dette et øye med diabetes retinopati?
 Ja
 Nei
Bilde nr 13, spørsmål 2 av 3. 
Hvilke funn på bildet la du til grunn for din vurdering?  
(Du kan sette flere kryss)
	
 Ingen retinopati
	
 Mikroaneurysmer 
	
 Blødninger
	
 Harde eksudater
	
 Fibersjiktsinfarkt (bløte eksudater/cottonwool spots)
	
 Venøs kaliberveksling
	
 IRMA (intraretinale mikrovaskulære abnormaliteter)
	
 Neovaskularisering
	
 Andre funn / annen tentativ diagnose
Bilde 13, spørsmål 3 av 3. 
Basert på retinopatifunn alene, hvordan ville du håndtert denne personen, dersom vedkommende ikke følges opp hos øyelege?  
(Du kan sette flere kryss)
	
 Ingen videre oppfølging / Rutineoppfølging 
	
 Rapport til fastlege
	
 Henvising til fastlege
	
 Henvising til øyelege
Bilde nr 14, spørsmål 1 av 3. 
Etter din vurdering er dette et øye med diabetes retinopati?
 Ja
 Nei
Bilde nr 14, spørsmål 2 av 3. 
Hvilke funn på bildet la du til grunn for din vurdering?  
(Du kan sette flere kryss)
	
 Ingen retinopati
	
 Mikroaneurysmer 
	
 Blødninger
	
 Harde eksudater
	
 Fibersjiktsinfarkt (bløte eksudater/cottonwool spots)
	
 Venøs kaliberveksling
	
 IRMA (intraretinale mikrovaskulære abnormaliteter)
	
 Neovaskularisering
	
 Andre funn / annen tentativ diagnose
Bilde 14, spørsmål 3 av 3. 
Basert på retinopatifunn alene, hvordan ville du håndtert denne personen, dersom vedkommende ikke følges opp hos øyelege?  
(Du kan sette flere kryss)
	
 Ingen videre oppfølging / Rutineoppfølging 
	
 Rapport til fastlege
	
 Henvising til fastlege
	
 Henvising til øyelege
Hvilke instrumenter har du tilgjengelig for netthinneundersøkelse i din praksis? 
(Du kan sette flere kryss)
	
 Direkte oftalmoskop
	
 Indirekte oftalmoskop (spaltelampe og Volklinse)
	
 Funduskamera
	
 Optomap
	
 OCT
	
 Annet
Generelt, hvilken metode benytter du vanligvis for netthinneundersøkelse? 
(Kun ett kryss er mulig)
 Udilatert direkte oftalmoskopi
 Dilatert direkte oftalmoskopi
 Udilatert indirekte oftalmoskopi (spaltelampe og Volk linse)
 Dilatert indirekte oftalmoskopi (spaltelampe og Volk linse)
 Fundusfotografering
 Annet
Dersom personen du undersøker har kjent diabetes, hvilken metode benytter du vanligvis for netthinneundersøkelse? 
(Du kan sette flere kryss)
	
 Udilatert direkte oftalmoskopi
	
 Dilatert direkte oftalmoskopi
	
 Udilatert indirekte oftalmoskopi (spaltelampe og Volk linse)
	
 Dilatert indirekte oftalmoskopi (spaltelampe og Volk linse)
	
 Udilatert fundusfotografering
	
 Dilatert fundusfotografering
	
 Annet
Hvilke instrumenter har du tilgjengelig for netthinnefotografering?
(Du kan sette flere kryss)
	
 Ingen
	
 Funduskamera (film)
	
 Digitalt funduskamera
	
 Vidvinkel skanninglaser oftalmoskop (Optomap)
	
 Annet
Hvor mange år har du jobbet som optiker? 
(Fyll inn antall hele år, kun siffer)
Skriv svaret ditt: 
Har du rekvireringsrett for diagnostiske medikamenter?
 Ja
 Nei
Hva er din høyeste akademiske utdanning innen optikk / optometri? 
 Yrkesskole / fagbrev
 2årig høyskole
 3årig høyskole
 BSc
 MSc
 PhD
Er du kvinner eller mann?
 Kvinne
 Mann
Du har besvart siste spørsmål.  
Du kan fortsatt gå tilbake og endre dine svar.  
Klikk neste dersom du er ferdig og ønsker å sende inn svarene nå.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix  

Hvorfor du er invitert
Du er blitt spurt om å delta istudien: ”GLUP
2-SYN. 
Diabetes, syn og øyehelse”som oppfølging og utvidelse av 
Glukosebelastningsprosjektet, GLUP, som ble gjennomført 
ved HUNT
forskningssenteri fjor.  200personer er forespurt 
om
å delta i undersøkelsen.
Begrunnelse for forskningsprosjektet
Diabetes er en sykdom med økende forekomst. Trolig har 90-
120000 mennesker i Norge diagnostisert diabetes, mens 
nesten like mange kan ha uoppdaget diabetes. En alvorlig 
senkomplikasjon ved diabetes er diabetes retinopati, 
forandringer i øyets netthinne. I tillegg kan diabetes forårsake 
endringer i brytningsfeil og samsyn. 
Kunnskap om syn og øyehelse hos pasienter med diabetes 
er viktig for å kunne planlegge, utvikle og kvalitetsikre 
oppfølgingen av syn og øyehelse hos pasienter med 
diabetes.
Formålet med prosjektet
Formålet medundersøkelsen er å gi en beskrivelse av syn og 
øyehelse hos pasienter med kjent diabetes og nedsatt 
glukose toleranse. Undersøkelsen vil benyttes som 
forundersøkelse for studien  ”Diabetes, syn og øyehelse” som 
planlegges for HUNT 3. 
Metoder
Undersøkelsen vil ta ca. 1timeoginkluderer et 
spørreskjema, synsundersøkelseogfotografering av 
øyebunnen.
Praktiske ulemperi forbindlese m
ed undersøkelsen
Dersom detmå benyttes øyedråper for å oppnå godnok
kvalitet på bildene av øyebunnen,kanduoppleve kortvarig 
forbigående lysfølsomhet og manglende evne til å se på næ
rt
hold. Dette skyldes at pupillen blir midlertidig utvidet. 
Fordeler ved deltagelse
Du vil fåskrevet ut brilleseddel. 
Undersøkelsen erstatter ikke regelm
essig undersøkelse av 
øynene som
 foretas av øyelege/lege.
Frivillighet
Deltagelse i studien er frivillig. Du kan på hvilket som helst 
tidspunkt trekke deg fra studienuten å oppgi grunn.
Konfidensialitet
All informasjon vil blibehandlet konfidensielt, og alle 
prosjektmedarbeidere har taushetsplikt. 
Prosjektet er meldt til Personvernombudet for forskning,
Norsk samfunnsvitenskapelig datatjeneste AS og tilråd i den 
regionale komitéfor medisinsk forskningsetikk. 
Dersom du velger å avslutte deltagelsen, vil dataene som er 
registrert bli slettet.
Du vil ikke kunne identifiseres i publikasjoner fra studiet.
Studien finansieres av Norges Optikerforbund, høgskolen i 
Buskerud og HUNT forskningssenter.
Studiet er knyttet til HUNT forskningssenter og Høgskolen i 
Buskerud, Institutt for optometri og synsvitenskap. 
Prosjektleder er stipendiat Vibeke Sundling.
Prosjektleder har ingen økonomiske interesser i prosjektet.
Har du spørsmål om studien ta kontakt med:
Stipendiat Vibeke Sundling
Høgskolen i Buskerud
Institutt for optometri og synsvitenskap
tlf: 32 86 97 59
email: vibeke.sundling@
hibu.no
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Appendix 
Variable list 1 Questionnaire - Optometric practice – Cross-section survey 
No. Variable Definition Type Definition 
1 Optometrist demographic    
1.1 Gender  Nominal 1 = male 
2 = female 
1.2 Age Age of optometrist at the time of survey Interval Years 
1.3 Academic background Highest academic degree in optometry Ordinal 1 = technical college 
2 = 2 year university college 
3 = 3 year university college 
4 = BSc 
5 = MSc 
6 = PhD 
1.4  Specialist competency  Specialty / accreditation / course Nominal 1 = yes 
2 = no 1.4.1 Diagnostic drugs Speciality 
1.4.2 Contact lenses Speciality 
1.4.3 Low vision  Accreditation 
1.4.4 Occupational optometry Accreditation 
1.4.5 Anterior segment Course 
1.4.6 Behavioural optometry Course 
1.5  Work experience Number of years in optometric practice Interval Years 
1.6 Working hours Number of working hours per week Interval Hours 
1.8 Area Practice location  Nominal 1 = city 
2 = village 
3 = rural 
1.9 Practice Type of practice Nominal 1 = independent 
2 = regional group  
3 = national group  
1.10 Geography Health region Nominal 1 = East  
2 = South 
3 = West 
4 = Middle 
5 = North 
2 Patient population    
2.1 Patient volume Number of eye examinations per week Interval Number 
a. Excluding contact lenses    
b.  Including contact lenses    
2.2 Diabetic patients Estimated of patients with known 
diabetes  
Interval Percentage 
3 Eye examination    
3.1 Routine examination Tests included in the examination Nominal 1 = yes 
2 = no 3.1.1 Patient history  
3.1.2 Cover test  
3.1.3 Donders / confrontation test  
3.1.4 Motility  
3.1.5 Refraction  
3.1.6 Slit lamp examination  
3.1.7 Ophthalmoscopy  
3.1.7 Tonometry  
a. All patients  
b.  All patients > __ years of age  
3.1.8 Visual field   
a. All patients  
b.  All patients > __ years of age  
c.  If suspicion of field defect  
Variable list 1 Questionnaire - Optometric practice – Cross-section survey 
No. Variable Definition Type Definition 
3.2 Patient history Questions directly related to diabetes   
3.2.1 General health General health status Nominal 
 
1 = yes 
2 = no 
 
3.2.2 Diabetes Presence of diabetes 
3.2.3  Routine Specific routine for patients with diabetes 
3.2.4 Type of diabetes Frequency of question; when the patient has 
diabetes 
 
Ordinal 
 
1 = 0% 
2 = < 25% 
3 = 25-49% 
4 = 50% 
5 = 51-75% 
6 = > 75% 
7 = 100% 
3.2.5 Duration 
3.2.6 Blood glucose level 
3.2.7 Blood pressure 
3.2.8 Treatment 
3.2.9 Care of ocular health 
3.2.10 Treatment of DR 
3.2.11 Variable VA 
3.2.12 Diplopia 
3.2.13 Transient ischemic attacks 
3.3 Vision  Visual problems related to diabetes Ordinal 
 
1 = 0% 
2 = < 25% 
3 = 25-49% 
4 = 50% 
5 = 51-75% 
6 = > 75% 
7 = 100% 
3.3.1 Stability of refraction Frequency of examination in patients with 
diabetes 
 
3.3.2 Cover test and motility 
3.3.3 Colour vision 
3.3.5 Tonometry 
3.3.6  Visual field 
3.3.7 Slit lamp examination 
Anterior segment 
3.3.8 Fundus examination  
3.3.9 Fundus photography 
3.3.10 Indication for tonometry Indication for performing the test Nominal Open answer 
 3.3.11 Indication for visual field 
3.4 Fundus examination Method used to examine fundus Ordinal 1 = 0% 
2 = < 25% 
3 = 25-49% 
4 = 50% 
5 = 51-75% 
6 = > 75% 
7 = 100% 
3.4.1 Dilated fundus examination Extent of use 
3.4.2 Direct ophthalmoscopy 
3.4.3 Slit lamp indirect 
ophthalmoscopy  
3.4.4 Monocular  
indirect ophthalmoscopy 
3.4.5 Binocular  
indirect ophthalmoscopy 
3.4.6 Fundus photography 
3.5 Skills Optometrist evaluation of own skills Ordinal 1 = poor 
2 = fairly poor 
3 = fairly confident 
4 = confident 
 
3.5.1 Direct ophthalmoscopy Grading of skill 
3.5.2 Slit lamp  
indirect ophthalmoscopy 
3.5.3 Fundus photography 
3.5.4 Assessment of fundus 
4 Report and referral Report and referral to other health care providers  
4.1 Report to general 
practitioner 
When report about patients with diabetes is 
sent to GP   
Ordinal 1 = never 
2 = if ocular changes present 
3 = depend on ocular change 
4 = always 
5 = if asked by GP or patient 
4.2 Referral to 
GP/Ophthalmologist 
When signs of  retinopathy leads to referral Nominal 1 = always 
2 = patients seen by      
ophthalmologist, depend on 
degree 
3 = depend on degree 
4.2.2 Diabetes retinopathy Number of patients with unknown diabetes 
referred with possible diabetic retinopathy 
during the last year 
Interval Number 
4.2.3 Diabetes Number of patients with unknown diabetes 
referred with suspect diabetes (refractive 
shift, other ocular signs) during the last year 
 
Variable list 1 Questionnaire - Optometric practice – Cross-section survey 
No. Variable Definition Type Definition 
5 Collaboration  Collaboration with  other health care providers  
5.1 General Practitioners Formal collaboration with GP Nominal 
 
1 = yes 
2 = no 
 5.1.1 No collaboration  
5.1.2 Refer / confer by phone 
5.1.3 Send reports 
5.1.4 Send referrals 
5.1.5 Receive patient summary 
5.1.6 Receive referral 
5.1.7 Joint practice 
     
5.2  Ophthalmologists Formal collaboration with ophthalmologist Nominal 
 
1 = yes 
2 = no 
 
5.1.1 No collaboration  
5.1.2 Refer / confer by phone 
5.1.3 Send reports 
5.1.4 Send referrals 
5.1.5 Receive patient summary 
5.1.6 Receive referral 
5.1.7 Joint practice 
 
 
Variable list 2 Practice registration - Optometric practice – Cross-section survey 
No. Variable Definition Type Definition 
1 Optometrist demographic    
1.1 Gender  Nominal 1 = male 
2 = female 
1.2 Age Age of optometrist at the time of survey Interval Years 
1.3 Academic background Highest academic degree in optometry Ordinal 1 = technical college 
2 = 2 year university college 
3 = 3 year university college 
4 = BSc 
5 = MSc 
6 = PhD 
1.4  Specialist competency  Specialty / accreditation / course Nominal 1 = yes 
2 = no 1.4.1 Diagnostic drugs Speciality 
1.4.2 Contact lenses Speciality 
1.4.3 Rehabilitation of visual impairment  Accreditation 
1.4.4 Occupational optometry Accreditation 
1.4.5 Anterior segment Course 
1.4.6 Behavioural optometry Course 
1.5  Work experience Number of years in optometric practice Interval Years 
1.6 Working hours Number of working hours per week Interval Hours 
1.8 Area Practice location  Nominal 1 = city 
2 = village 
3 = rural 
1.9 Practice Type of practice Nominal 1 = independent 
2 = regional group  
3 = national group  
1.10 Geography Health region Nominal 1 = East  
2 = South 
3 = West 
4 = Middle 
5 = North 
2 Patient demographic    
2.1 Age Age of patient at the time of study Interval Years 
2.2 Sex Patient sex Nominal 1 = male 
2 = female 
3 Ocular examination Applicable to all patients   
3.1 Patient history Questions with positive answer Nominal 1 = yes  
2 = no 3.1.1 Glaucoma 
3.1.2 AMD 
3.1.3 Cataract 
3.1.4 Diabetes Mellitus 
3.1.5 Hypertension 
3.1.6 Heart disease 
3.1.7 Diabetes Mellitus in the family 
3.2 Vision and ocular health Applicable to all patients   
3.2.1 Best corrected visual acuity Best corrected visual acuity  
Monocular od and os 
Interval Snellen Decimal 
3.2.2 Intra ocular pressure Intra ocular pressure od and os Interval mmHg 
3.2.3 Cataract Presence of cataract od and os Nominal 1 = yes  
2 = no 3.2.4 Ophthalmoscopy Examination performed 
3.2.5 Dilated fundus examination Examination performed 
3.2.6 Diabetic retinopathy Retinopathy present 
3.2.7 Type of retinopathy Type of retinopathy present Nominal String 
 
Variable list 2 Practice registration - Optometric practice – Cross-section survey 
No. Variable Definition Type Definition 
4 Communication     
4.1 None No referral or routine follow up Nominal 1 = yes  
2 = no 4.2 Patient  Patient contacts GP 
4.3 Report  Report sent 
4.4 Referral Referral sent 
5 Diabetes status Only applicable to patients with diabetes  
5.1 Type of diabetes Questions asked and answer specified Nominal 1 = Type 1 
2 = Type 2 
5.2 Duration Interval Years 
5.3 Blood glucose level Interval HbA1c 
5.4 Blood pressure Nominal 
or 
Interval 
1 = too low 
2 = normal 
3 = too low  
5.5 Treatment Nominal 1 = diet  
2 = oral medication  
3 = insulin  
5.6 Presence known retinopathy Nominal 1 = yes 
2 = no 5.7 Treatment of retinopathy 
6 Vision Only applicable to patients with diabetes or patients referred  
6.1 Variable VA  Nominal 1 = yes 
2 = no 6.2 Visual impairment  
6.3 Diplopia  
6.4 Refraction Stability /  Refractive shifts  Nominal 1 = previous Rx unknown 
2 = stable 
3 = myopic shift (>1D) 
4 = hyperopic shift (>1D) 
7 Referral Only applicable to patients referred 
7.1 Health care provider Recipient of referral 
 
Nominal 1 = GP 
2 = ophthalmologist 
3 = emergency clinic 
4 = other 
7.2 Reason  Reason for referral 
Applicable to referred patients 
Nominal 1 = reduced VA 
2 = intra ocular pressure
  
3 = binocular vision  
4 = anterior segment 
5 = diabetic retinopathy 
6 = hypertensive retinopathy 
5 = unspecified retinopathy 
6 = AMD  
7 = headache  
   
Variable list 3  Questionnaire member of the Norwegian Diabetes Association  – Cross-section survey 
No. Variable Definition Type Definition 
1. Patient demographic    
1.1 Gender  Nominal 1 = male 
2 = female 
1.2 Age Year of birth Interval Year 
1.3 Diabetes Type of diabetes Nominal 1 = type 1 
2 = type 2 
3 = other 
4 = unsure 
2.  Risk factors of diabetic retinopathy 
2.1 Diabetes Duration of diabetes Interval Years 
2.2 
 
 
Treatment Type of treatment Nominal 1 = diet  
2 = exercise  
3 = weight reduction  
4 = oral medication  
5 = insulin  
2.3 Blood glucose    
2.3.1 HbA1c HbA1c at previous diabetes examination Interval Given in % 
2.3.2 Control Stability of blood glucose level previous year Nominal 1 = yes 
2 = no 
3 = unsure 
2.4 Blood pressure Blood pressure at previous diabetes 
examination, systolic and diastolic 
Interval Given in mmHg or unsure 
2.5 Medication    
2.5.1 Blood pressure  Blood pressure lowering medication Nominal 1 = yes 
2 = no 
3 = unsure 
2.5.2 Cholesterol Cholesterol lowering medication 
2.6 Smoking    
2.6.1 Present Present smoking Nominal 1 = yes 
2 = no 
2.6.2 Amount Number of cigarette a day Interval Number 
2.6.3 Previous Previous smoking Nominal 1 = yes 
2 = no 
3.  Vision and ocular health care 
3.1 Vision examination    
3.1.1 Examination Who perform regular examination of vision  Nominal 1 = no regular exam 
2 = optometrist 
3 = ophthalmologist 
4 = other MD 
5 = other 
3.1.2 Examination interval Frequency of eye examination Interval Years / Months 
3.1.3 Patient satisfaction Patient satisfaction with vision care Ordinal 1 = very unsatisfied 
5 = very satisfied 
 
Variable list 3  Questionnaire member of the Norwegian Diabetes Association  – Cross-section survey 
No. Variable Definition Type Definition 
3.2 Fundus examination    
3.2.1 First examination Time of first fundus examination Ordinal 1 = never examined 
2 = within 1 year 
3 = within 5 years 
4 = unsure 
5 = other 
3.2.2 Regular fundus examination Regular examination of the retina with regard 
to diabetic retinopathy 
Nominal 
 
1 = yes 
2 = no 
3.2.3 Examination interval Frequency of retina examination Interval Months / years 
3.2.4 Examination method How the fundus is examined Nominal 1 = photography 
2 = ophthalmologist 
3 = GP 
4 = optometrist 
5 = unsure  
3.2.5 General practitioner Fundus examination performed by GP. Nominal 1 = yes 
2 = no 
3 = unsure 
3.2.6 Patient satisfaction Patient satisfaction with ocular health care Ordinal 1 = very unsatisfied 
5 = very satisfied 
3.3 Patient behaviour and knowledge    
3.3.1 Vision care provider Patient choice of vision care provider in case 
of visual problems 
Nominal 1 = MD 
2 = optometrist 
3 = ophthalmologist  
4 = hospital eye dep. 
5 = unsure 
3.3.2 Information Received information about importance of 
regular eye exams due to diabetes 
Nominal 1 = yes 
2 = no 
3 = unsure 
3.3.3 Source of information Source of information about importance of 
regular eye exams. 
Nominal 1 = GP 
2 = ophthalmologist 
3 = other MD 
4 = optometrist 
5 = hospital 
6 = course in diabetes 
7 = brochures/Diabetes 
8 = newspaper/ 
      magazine/radio/TV 
9 = other with diabetes 
10 = other 
4 Vision   
4.1 Optical correction Type of optical correction used  Nominal 1 = distance  
2 = reading / do 
3 = bifocal / multifocal 
4 =  contact lenses 
5 = loupe / LVA 
6 = none 
4.2  Vision    
4.2.1 Visual problems due to diabetes Visual problems related by medical 
practitioner to diabetes 
Nominal 1 = yes 
2 = no 
3 = unsure 
4.2.2 
 
Visual problems Visual problems experienced by the patient Nominal 1 = blurred vision  
2 = variable vision 
3 = visual field defects  
4 = diplopia  
5 = metamorphopsia 
6 = other 
    
4.2.3 Visual problems relived by spectacles/contact 
lenses 
Nominal 1 = yes 
2 = no 
 
Variable list 3  Questionnaire member of the Norwegian Diabetes Association  – Cross-section survey 
No. Variable Definition Type Definition 
4.3 Ocular health    
4.3.1 Treatment of diabetic retinopathy Previous treatment of diabetic retinopathy Nominal 1 = yes 
2 = no 
3 = unsure 
     
4.3.2 Ocular disease Known ocular disease Nominal 1 = diabetic retinopathy 
2 = other retinopathy 
3 = AMD 
4 = glaucoma 
5 = cataract 
6 = other 
 
Variable list 4  Clinical examination of a sample of the HUNT population  – Cross-section survey 
No. Variable Definition Type Definition 
1. Patient demographic    
1.1 Gender  Nominal 1 = male 
2 = female 
1.2 Age Year of birth Interval Year 
2.  Patient history Vision, ocular and general health    
2.1 Visual symptoms Experience visual symptoms Nominal 
 
1 = yes 
2 = no 
 
2.1.1 Blurred vision  
2.1.2 Variable vision  
2.1.3  Visual field defects Positive and negative visual field defects 
2.1.4 Diplopia  
2.1.5 Metamorphopsia  
2.1.6 Photophobia  
2.1.7 Optically corrected Symptoms alleviated with optical correction   
2.2 Optical correction  Use of optical correction  Nominal 
 
1 = yes 
2 = no 2.2.1 Distance correction  
2.2.2 Near correction 
2.2.3 Multifocal correction 
2.2.4 Contact lenses 
2.2.5 Low vision aids 
2.3 Vision and eye examination     
2.3.1 Regular vision examination Examination of vision (visual acuity) Nominal 
 
1 = yes 
2 = no 
2.3.2 Health care provider Profession undertaking the vision examination Nominal 1 = optometrist 
2 = ophthalmologist 
2.3.3 Follow-up vision Examination interval Interval Months 
2.3.4 Regular eye examination Examination of ocular health  Nominal 
 
1 = yes 
2 = no 
2.3.5 Health care provider Profession undertaking the eye examination Nominal 1 = optometrist 
2 = ophthalmologist 
2.3.6 Follow-up ocular health Examination interval Interval Months 
2.4 Ocular health History of ocular disease Nominal 
 
1 = yes 
2 = no 2.4.1 Diabetic retinopathy  
2.4.2 Other retinopathy  
2.4.3 AMD  
2.4.4 Glaucoma  
2.4.5 Cataract  
2.4.6 Other ocular disease  
2.5 General health History of systemic disease   
2.5.1 Diabetes  Nominal 
 
1 = yes 
2 = no 2.5.2 Family history of diabetes  
2.5.3 Cardio-vascular disease  
2.5.4 Blood pressure Knowledge of blood pressure Ordinal 
 
1 = low 
2 = normal 
3 = high 
4 = unsure 
2.5.4 Blood pressure level Value at last physical examination Interval mmHg 
3 Ocular health Examination of ocular health   
3.1 Tonometry Intra ocular pressure (IOP) Interval mmHg 
3.2 Lens assessment Cataract present Nominal 
 
1 = yes 
2 = no 
3.3 Fundus photography Examination of retinal photographs   
3.3.1 Retinal assessment  Normal retina  Nominal 
 
1 = yes 
2 = no 
3 = ungradeable photos 
3.3.2 Type of retinopathy  Nominal 
 
0 = none 
1 = diabetic  
2 = hypertensive  
3 = other vascular  
4 = AMD 
5 = other retinopathy 
     
 
Variable list 4  Clinical examination of a sample of the HUNT population  – Cross-section survey 
No. Variable Definition Type Definition 
3.3.3 Diabetic retinopathy Grading of diabetic retinopathy (DR) 
Non-proliferative: NPDR  
Proliferative: PDR 
Ordinal  0 = no  
1 = mild NPDR 
2 = moderate NPDR 
3 = severe NPDR 
4 = proliferative 
5 = laser-treated  
3.3.4 Optic nerve assessment Normal optic nerve head Nominal 1 = yes 
2 = no
4. Visual function     
4.1 Refraction and acuity   Optical correction and visual acuity   
4.1.1 Habitual optical correction Current optical correction Interval DS/DC 
4.1.1 Habitual VA Visual acuity with current correction  Interval logMAR and Snellen 
4.1.1 Optimal optical correction Best optical correction  Interval DS/DC 
4.1.1 Best corrected VA Visual with best optical correction  Interval logMAR and Snellen 
4.2 Visual field Assessment of central visual field   
4.2.1 Amsler field  Nominal 1 = normal 
2 = visual field defect 
4.3 Contrast sensitivity Assessment of contrast sensitivity   
4.3.1 CSF Contrast sensitivity function curve Nominal 1 = normal 
2 = abnormal 
4.3.2 Contrast sensitivity 1.5 Contrast level at 1.5 c/deg Ordinal 1 = 3 
2 = 7 
3 = 12 
4 = 20 
5 = 35 
6 = 70 
7 = 120 
8 = 170 
4.3.2 Contrast sensitivity 3 Contrast level at 3 c/deg Ordinal 1 = 4 
2 = 9 
3 = 15 
4 = 24 
5 = 44 
6 = 85 
7 = 170 
8 = 220 
4.3.2 Contrast sensitivity 6 Contrast level at 6 c/deg Ordinal 1 = 5 
2 = 11 
3 = 21 
4 = 45 
5 = 70 
6 = 125 
7 = 185 
8 = 260 
4.3.2 Contrast sensitivity 12 Contrast level at 12 c/deg Ordinal 1 = 5 
2 = 8 
3 = 15 
4 = 32 
5 = 55 
6 = 88 
7 = 125 
8 = 260 
4.3.2 Contrast sensitivity 18 Contrast level at 18 c/deg Ordinal 1 = 4 
2 = 7 
3 = 10 
4 = 15 
5 = 26 
6 = 40 
7 = 65 
8 = 90 
 
 
Variable list 5 Visual identification of Ophthalmological Conditions (VIMOC) Examination 
No. Variable Definition Type Definition 
1 Diabetic Retinopathy    
1.1 Diabetic retinopathy Presences of clinical findings of diabetic 
retinopathy 
Nominal 1 = yes 
2 = no 
1.2 Clinical findings Specification of clinical findings Nominal 1 = no retinopathy 
2 = microaneurysms 
3 = hard exudates 
4 = cotton wool spots 
5 = venous beading 
6 = intraretinal microvascular 
abnormalities (IRMA) 
7 = neovascularisation 
8 = other findings 
2 Patient management    
2.1 Patient management Further patient management based on retinal 
findings 
Nominal 1 = None/routine follow-up 
2 = Report to GP 
3 = Referral to GP 
4 = Referral to 
ophthalmologist 
3 Retinal examination    
3.1 Instruments  Available instruments for retinal examination Nominal  
3.2 Method of retinal examination Preferred method of retinal examination Nominal  
3.3 Retinal examination in diabetes Preferred method of retinal examination in 
patients with diabetes 
Nominal  
3.4 Retinal imaging Available instruments for retinal imaging Nominal  
     
4 Optometrist    
4.1 Gender  Nominal 1 = male 
2 = female 
4.2 Work experience Number of years in optometric practice Interval Years 
4.3 Academic background Highest academic degree in optometry Ordinal 1 = technical college 
2 = 2 year university college 
3 = 3 year university college 
4 = BSc 
5 = MSc 
6 = PhD 
4.4 Specialist competency  Accredited to use diagnostic drugs Nominal 1 = yes 
2 = no
 
